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Abstract 
Whiplash injury results in persistent pain and disability for a significant number 
of individuals.  Clinically, these individuals present with a complex presentation of 
physical features (including central hyperexcitability and motor dysfunction) and 
psychological manifestations (e.g. psychological distress, pain catastrophization and 
posttraumatic stress symptoms) that may be resistant to conservative care.  Understanding 
this complex symptom presentation is made challenging by the inability of current 
diagnostic imaging techniques to clearly identify potential pathoanatomical causes for 
these symptoms.  Nevertheless, anatomical structures contributing to chronic whiplash 
associated disorders (WAD) have been identified in clinical and basic science research.  
Diagnostic facet joint injections implicate the cervical facet joint as the most likely 
anatomical structure responsible for neck pain in individuals with chronic WAD.  Basic 
science research has also provided empirical evidence of a possible association between 
nociception in the cervical facet joints and the clinical features of WAD, in particular 
behavioural hypersensitivity (quantified pain response following stimulation with a non-
noxious stimulus). 
Individuals with cervical facet joint-mediated pain respond favourably to 
radiofrequency neurotomy (RFN), with significant reductions in neck pain and 
psychological distress.  Yet it is unknown whether persistent cervical facet joint 
nociception contributes to the clinical features evident in individuals with chronic WAD, 
and whether effective modulation of this nociception through RFN improves these 
features.  There has been no detailed study of the relationship between cervical facet joint 
nociception and the variety of clinical features demonstrated in individuals with chronic 
WAD.  The primary aim of this thesis was to determine if the physical and psychological 
manifestations of chronic WAD could be effectively modulated through successful 
response to RFN.  The null hypothesis was that reducing nociception via successful RFN 
would not result in improvements in central nociceptive processing, motor function or 
psychological features of chronic WAD.  
A series of studies was undertaken to test the hypothesis for this body of research.  
Data were collected using a range of clinical psychophysical, physical and psychological 
tests pertinent to chronic WAD: thermal and pressure pain thresholds (PPT), nociceptive 
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reflex threshold (NFR), cervical range of movement (ROM) and cranio-cervical flexion 
test (CCFT); and questionnaires of self-reported pain (visual analogue scale: VAS) and 
disability (neck disability index: NDI), general well being (general health questionnaire 
(GHQ-28), pain catastrophization (PCS) and psychological distress (Post Traumatic 
Stress Diagnostic Scale: PDS).   
Study 1 compared the outcome of these tests between participants, aged 18-65 
years, who successfully responded to diagnostic facet joint injections (n=58); individuals 
who did not respond (n=32), and healthy controls (n=30).  The results demonstrated no 
differences in clinical features between those who responded and did not respond to 
cervical facet joint injections, with both groups significantly differing from the healthy 
controls. Both WAD groups demonstrated generalized sensory hyperexcitability, loss of 
neck ROM and increased sternocleidomastoid muscle activity during the CCFT, and 
similar psychological features, although increased pain catastrophizing was evident in the 
group who did not respond to the facet injections.      
Studies 2-4 focussed on the individuals who responded to diagnostic facet joint 
blockade and proceeded to RFN.  For these studies, participants attended the research 
laboratory at two time periods prior to RFN (after the diagnostic facet joint injections had 
been performed when original symptoms returned: t(1); and then immediately prior to 
RFN being performed – approximately 12 months later: t(2)); and then at one- (t(3)) and 
three-months (t(4)) post-RFN and finally when pain returned (t(5)).  The clinical 
measurements were taken at each time point.  The results indicated that following RFN, 
most physical and psychological measures improved significantly, apart from post 
traumatic stress symptoms (Study 2 and 3).  Upon the subsequent return of the 
participants’ neck pain, most physical (except PPTs and CCFT electromyography) and 
psychological measures returned to pre-RFN values (Study 4).     
Study 5 investigated whether any physical or psychological clinical 
manifestations predicted a successful response (defined as a Global Rating of Change 
questionnaire score of ≥ 4) to RFN.  The results of this study indicated that lower levels 
of disability or pain catastrophizing independently predicted a successful response. 
The null hypothesis for this body of research was rejected.  The results suggested 
that peripheral nociception contributes to central hyperexcitability, motor dysfunction and 
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psychological manifestations (except post-traumatic stress symptoms) of chronic WAD.  
These results provide further knowledge of processes underlying chronic WAD.  The 
finding that peripheral nociception is one of the drivers of central hyperexcitability, motor 
dysfunction and psychological manifestations in chronic WAD is a vital step forward 
towards more effective management for this difficult patient group, allowing healthcare 
providers to provide patients with appropriate treatment options, especially when 
conservative therapy has failed.  
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MDC: Minimal detectable change 
MRI: Magnetic resonance imaging 
MVC: Motor vehicle collision 
NDI: Neck Disability Index 
NFR: Nociceptive flexion reflex 
PCS: Pain Catastrophizing Scale 
PDS: Posttraumatic stress Diagnostic Scale 
PFActS-C: Pictorial Fear of Activity Scale - Cervical 
PPT: Pressure pain threshold 
PTSD: Posttraumatic stress disorder 
QST: Quantitative Sensory Testing 
QTF: Quebec Task Force 
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RCT: Randomized Controlled Trial 
RFN: Radiofrequency neurotomy 
RMS: Root mean squared 
ROM: Cervical range of movement  
SCM: Sternocleidomastoid 
SD: Standard Deviation 
s-LANSS: Self report Leeds Assessment of Neuropathic Symptoms and Signs 
SMD: Significant Mean Difference 
SP: Substance P 
SPNTT: Smooth Pursuit Neck Torsion Test 
TSK: TAMPA Scale of Kinesphobia 
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t(2): time period immediately prior to receiving radiofrequency neurotomy  
t(3): time period one-month following radiofrequency neurotomy 
t(4): time period three-months following radiofrequency neurotomy 
t(5): time period following return of pain after effects of RFN have abated 
t1: time period prior to receiving RFN (mean of t(1) and t(2)) 
t2: time period following RFN (mean of t(3) and t(4)) 
t3: time period following return of pain after effects of RFN have abated (=t(5)) 
TPT: Thermal pain threshold 
VAS: Visual Analogue Scale 
WAD: Whiplash associated disorders 
WAD_NR: WAD non-responders 
WAD_R: WAD responders 
WAD_RF: WAD individuals who proceeded to and underwent radiofrequency 
neurotomy 
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CHAPTER 1 
1.1 Introduction 
Whiplash injury following a motor vehicle collision (MVC) was first described by 
Crowe in 1928 [1].  Whiplash associated disorders (WAD) were subsequently defined to 
accommodate the variety of symptoms that are reported following a whiplash injury [2].   
Unfortunately, individuals do not always recover from whiplash injury, with recent 
systematic reviews concluding that approximately 50% of whiplash injured individuals 
continue to reveal symptoms 12 months following the initial event [3-8].  Thus, WAD is 
costly, both for the individual and society in general [2], with a significant proportion of 
medical costs associated with management of individuals who develop chronic pain and 
disability [9].   
The heterogeneous nature of WAD makes treatment of these individuals 
challenging.  Although the predominant symptom is neck pain, individuals can present 
with a variety of symptoms (e.g. headaches, dizziness, visual and auditory disturbances, 
temporo-mandibular joint pain, photophobia, fatigue, cognitive difficulties such as 
concentration and memory loss, anxiety, depression and insomnia amongst others) [10-
13].  It is challenging to determine the underlying cause of these symptoms.  It is 
unknown if these symptoms stem from discrete pathoanatomical lesions; as current 
diagnostic imaging techniques fail to identify a specific pathoanatomical lesion in the 
majority of patients.  Although anatomical lesions have been implicated from 
biomechanical [14-21], autopsy [22-25] and clinical studies [26-28], some authors 
question the credibility of patients’ subjective symptoms and question whether factors 
such as exaggeration (or even secondary gain) may be responsible for ongoing symptom 
presentation [29].   
Despite this cynicism, recent research has identified several factors that may 
contribute to chronic symptoms in individuals with WAD, more specifically, various 
altered sensory, motor and psychological manifestations [30].  In regard to sensory 
features, clinical studies (generally involving psychophysical tests investigating the 
relationship between physical stimuli and pain) have demonstrated the presence of both 
local and widespread sensory hypersensitivity to a variety of stimuli, including induced 
experimental pain [31], electro-cutaneous stimulation [32] and mechanical stimulation 
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[33,34], which are suggestive of altered central nervous system (CNS) processing [35].  
Aberrant CNS processing manifesting as pain hypersensitivity has been described as 
being indicative of central sensitization or central hyperexcitability [36].  Reduced active 
cervical range of motion (ROM); altered muscle recruitment patterns in the upper 
quadrant and morphological changes in the neck extensor and flexor muscles [37-44] 
have also been demonstrated; whilst aberrant sensori-motor features include an inability 
to accurately relocate the head in space, balance deficits and disturbed ocular movement 
control [13,45-47].  Further to these physical features, psychological manifestations have 
also been identified [48-50]; generally in those with poor recovery and ongoing pain and 
disability [51,52], and these features could also contribute to the persistence of 
symptoms.  The mechanisms underlying the persistence of these factors in those with 
chronic WAD are not clear.  There is much debate as to whether these manifestations are 
driven by an ongoing peripheral nociceptive source (the anatomical lesion) [53-55] or are 
self-maintaining due to neuroplastic changes in the central nervous system [56].   
The determination of an anatomic source of nociception is required to explore the 
proposal that the various symptomatic manifestations of chronic WAD are driven by an 
ongoing peripheral nociceptive source, (such as a lesion to a cervical facet joint).  Current 
diagnostic imaging usually fails to identify an accurate pathoanatomical diagnosis in 
individuals with WAD, but diagnostic criteria have been established for cervical facet 
joint dysfunction using alternate diagnostic methods [57].  Comparative medial branch 
blocks (MBB) are one such alternative, demonstrating face validity, construct validity 
and criterion validity for the diagnosis of neck pain arising from the cervical facet joint 
[58,59].  Using placebo controlled MBB, one study estimated that the prevalence of 
cervical facet-mediated pain in individuals with persistent neck pain following whiplash 
trauma was approximately 60% [28], whilst in another study using controlled double-
blind anaesthetic blocks, prevalence was estimated to be approximately 75% [60].  It 
must be noted that these studies involved small sample sizes, and the participants in the 
studies were highly selected subsets of the overall whiplash-injured population.  
However, an effective treatment for patients who respond to cervical MBB is available, 
namely radiofrequency neurotomy (RFN), which has been demonstrated to provide long-
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lasting pain relief (between 7-14 months) for those individuals previously responding to 
comparative cervical MBB [61].   
The model of facet joint lesions, diagnosis with MBB and alleviation of 
symptoms with RFN allows research into the question of whether the persistence of 
nociception arising from injured structures is responsible for the variety of sensory, motor 
and psychological symptoms demonstrated in individuals with chronic WAD [30], and 
whether these features can be modulated by reducing peripheral nociception through 
successful RFN.  This will allow clinicians information to assist with management of 
patients with these clinical features.       
1.2 Thesis Aims and Hypotheses  
This research program investigated the effects of modulation of cervical facet 
joint nociception on sensory, motor and psychological features identified in patients with 
chronic WAD [62].  Reliable and validated outcome measures of sensory, motor function 
and psychological distress as used in previous research of chronic WAD [34,35,63-68] 
were used in a pre-post test, prospective cohort design involving individuals with chronic 
WAD and healthy control participants to investigate these relationships further.     
1.2.1 Aims of the Research 
The overall purpose of this thesis was to determine if there was modulation of 
central nervous system hyperexcitability, motor function and psychological distress in 
individuals with chronic WAD grade II (patient complaint of neck pain with presence of 
musculoskeletal signs including decreased ROM and point tenderness [2]) following 
RFN to the cervical spine.   
 The specific aims of the research were: 
1) To determine differences in the physical and psychological manifestations of 
individuals with chronic WAD who respond to MBBs compared to those who 
do not respond and healthy controls; 
2) To determine if there was attenuation of psychophysical indicators of central 
hyperexcitability, improvements in motor function and psychological 
manifestations in individuals with chronic WAD following RFN to the cervical 
spine; 
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3) To determine if changes in central hyperexcitability, motor function and 
psychological distress reverted when pain returns post-RFN; 
4) To determine which clinical factors predict a successful response to cervical 
RFN. 
1.2.2 Thesis Hypotheses 
The hypotheses for these studies were: 
1) Individuals with chronic WAD who do not respond to facet blocks will 
demonstrate greater levels of central hyperexcitability, poorer motor function 
and increased psychological distress compared to responders to facet blocks.  
Both groups will demonstrate greater impairments in these measures 
compared to a healthy cohort;  
2) There will be significant improvements in psychophysical indicators of central 
hyperexcitability, motor function and psychological distress following RFN; 
3)  There will be a significant deterioration of psychophysical indicators of 
central hyperexcitability, motor function and psychological distress when pain 
eventually returns when the effects of RFN abate; 
4)  Higher levels of pain, disability, sensory hypersensitivity, psychological 
distress and pain catastrophization will be associated with poor response to 
RFN. 
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CHAPTER 2 
Sensory, Motor and Psychological Features of Chronic Whiplash 
Associated Disorders. 
This chapter presents an overview of whiplash including features related to the 
pathomechanics of injury, the pathoanatomical and pathophysiological mechanisms of WAD 
and the impairments that characterize the chronic condition.  As the body of work in this 
thesis concentrates on the modulation of features evident in chronic WAD, this chapter 
provides the background and basis for understanding the development of these clinical 
features. 
2.1 The Problem of Whiplash 
Whiplash can be defined as an acceleration–deceleration mechanism of energy 
transfer to the neck, usually as a result of a motor vehicle collision (MVC).  The impact may 
result in bony or soft-tissue injuries (whiplash injury), which in turn may lead to a variety of 
clinical manifestations (Whiplash Associated Disorders - WAD) [2].  Neck pain is the 
primary symptom, but other symptoms such as headaches, dizziness, memory and 
concentration difficulties are also reported [69].  As a result, some authors describe the 
consequences of chronic WAD as being like those of a systemic illness or chronic pain 
syndrome [70,71].  Cumulative incidence rates for whiplash injury vary between countries 
and reporting procedures, with recent studies reporting a range from 114 (Victoria, Australia) 
to 300 (Saskatchewan, Canada) per 100,000 inhabitants [72-75].  Individuals still 
symptomatic six months or more after the injury, are designated as ‘chronic’ by the Quebec 
Task Force [2].  Recently, the Bone and Joint 2000-2010 Task Force on neck pain and its 
associated disorders, in a best evidence synthesis of the literature, reported that approximately 
half of those with WAD report symptoms one year after their injury [3].  Other studies have 
reported various chronicity rates; ranging from 15-84% [2,76-78].  This compares to the 
background prevalence of neck pain in the general population of between 40-50%, although 
the same best-evidence synthesis noted that the prevalence of activity-limiting pain was 
between 2-12% [79].    
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Much of the medical cost associated with WAD can be attributed to the management 
of those patients with chronic symptoms [80], with one study revealing that 12% of patients 
with chronic whiplash pain account for 47% of the costs [9].  In 2007, the Insurance Bureau 
of Canada (IBC) reported that whiplash injuries account for 2 million insurance claims each 
year at a cost of approximately $8.5 billion [81].  The annual societal costs in the United 
States approach $231 billion annually [82], whilst in the UK it is estimated that ₤3 billion is 
spent annually on claims [83].  The societal costs in the United States include medical and 
ancillary costs, property damage; loss of wages, workplace disruption, legal fees, vocational 
rehabilitation, emergency services, administrative fees, traffic congestion caused by accidents, 
and lost quality of life [82].  Thus, approaches that help prevent and effectively treat pain 
arising from WAD would assist in easing the financial and social burden on the individual and 
society in general. 
2.2 The Mechanism of Injury 
It is generally considered that acute whiplash symptoms are as a result of injuries to 
cervical structures being sustained in the MVC [84-87].  Such anatomical lesions may also 
explain the presence of non-resolved chronic pain [28].  However, since a pathoanatomical 
diagnosis for whiplash pain cannot usually be made, it has been proposed that other factors 
such as psychological ones or factors associated with the compensation process may be the 
drivers of a chronic condition [29,83].  Support for an anatomical basis for ongoing 
symptomatology arises from epidemiological studies evaluating injury rates following 
changes in motor vehicle seat design, which were associated with a 43% reduction in reported 
neck injury rates  [88].  The changes in car seat design were developed in response to the 
study of the biomechanical forces being transmitted to the neck during a MVC.   
The biomechanics of the human spine in a rear-end MVC have been studied 
extensively, through cadaveric observations, human volunteer collision tests and finite 
analysis modeling [15,17,18,89-91].  The kinematics of the spine as it is subjected to this 
vector is described consistently in a number of studies [15,17,18,89].  In the rear end 
collision, an S-shaped curvature within the cervical spine has been described [15,89,92,93].  
This results in the upper cervical spine moving into relative flexion and the lower cervical 
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spine into extension (Fig. 2.1).  In this vector of collision at impact, the car seat begins to 
move forward, whilst the occupant remains stationary due to inertia.       
 
Figure 2.1: S-shaped cervical spine curve occurring approximately 50-75 ms following rear impact 
Based on BodyMind Publications, 2002; reprinted with permission. 
At approximately 50milliseconds (ms), the car seatback ramps the torso upward and 
forward moving the spine forward with concurrent cervical spine posterior rotation, resulting 
in a straightening of the lumbar, thoracic and cervical spines.  This adds further compressive 
forces to the cervical spine [94]  (Fig. 2.2).   
 
 
 
  
 
 
Figure 2.2: The development of motion resulting in the S-shaped cervical spine curve and supposed injury 
mechanism. Based on BodyMind Publications, 2002; reprinted with permission. 
Lower cervical 
extension 
a 
 
b 
 
Upper cervical 
flexion 
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At approximately 100-120ms, as the car seat pushes into the occupant’s torso, the 
torso is accelerated forward of the lower cervical spine, thus resulting in extension (C-shape) 
of the head and lower cervical spine as the centre of gravity results in the head lowering 
[93,94] (Fig. 2.3).  By 160ms, the torso is fully accelerated by the car seat, thus causing the 
lower neck to be pulled forward by the rapidly moving torso [94].  After 200-300ms, the head 
and torso are accelerated forward ahead of the car seat, resulting in flexion of the spine [94].  
By approximately 600 ms the occupant has returned to the initial position [94].  
Unfortunately; the reflexive muscle actions that may restrain this action are unable to do so as 
a result of the latencies associated with initiation of muscular contraction being longer than 
the duration of this event [93].   
 
 
 
 
 
 
 
Figure 2.3: The ‘C’ shaped aspect of the cervical spine occurring at approximately 100-120ms of the 
whiplash event.  Based on BodyMind Publications, 2002; reprinted with permission. 
This non-physiological S-shaped motion is thought to be responsible for the injuries 
observed, as at no time does the cervical spine as a whole exceed its physiological motion 
[89,90].  However, the lower cervical spine has been shown to exceed its physiological 
posterior rotation range of motion (ROM) [90,94].  It is proposed that this mechanism results 
in synovial fold impingement [15].  This motion also results in increased tension in the 
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anterior vertebral structures (e.g. disc, anterior longitudinal ligament), facet joint capsular 
ligaments and synovial membrane [19,20,23,24,95-98].  Replicating this mechanism of injury, 
simulated whiplash acceleration trauma models have revealed peak facet joint compression at 
C4/5 with maximum capsular ligament strains occurring at C6/7 [18].   
Recently, similar studies have been performed to describe the segmental kinematics of 
the cervical spine utilising the side impact vector of collision [99,100].  Proposed segmental 
kinematics have also been described for frontal collision vectors [101,102], confirming that 
these mechanisms of injury also demonstrate the potential to result in cervical spine injury.     
2.3 Possible Pathoanatomical Lesions Following Motor Vehicle Collisions 
Evidence for a pathoanatomical lesion following a whiplash injury comes from several 
sources.  Taylor and Twomey performed studies on road trauma victims, who died from 
causes other than spinal injuries [23,24].  The cervical spines were subjected to radiographic 
and magnetic resonance imaging (MRI) scanning prior to autopsy.  They were then re-
sectioned and examined microscopically.  The autopsy results were compared to those of the 
imaging.  It was found that imaging often did not reveal a variety of injuries in and around the 
cervical bone and soft tissue structures.  Autopsy findings included bleeding into the facet 
joints, bleeding in and around the nerve root and dorsal root ganglion, tearing of the discs at 
the rim attachments and vertebral bodies, tearing and bruising of the ligaments of the spine, as 
well as tearing and bleeding into the muscles.  They also noted occasional bruising of the 
spinal cord [24].  Other dissection studies have revealed similar findings [22,25].  
Furthermore, studies utilising high speed cinematography in healthy controls and cadavers 
[15], animal studies [103,104] and cryomicroscopy [105] provide evidence that injuries to the 
majority of cervical spine structures including the disc, dorsal root ganglion, ligamentous 
tissue, nervous tissue, vertebral artery and neck muscles are possible [97,98,103,104,106-
113].  Thus, injuries to various cervical neuromusculoskeletal tissues have been demonstrated 
via autopsy and in a variety of basic science and human experimental settings. 
2.3.1 Pathoanatomical Lesions and Imaging 
Despite advances in imaging technology (primarily MRI), imaging the neck for 
whiplash injuries (excluding fractures) usually fails to reveal any significant pathology 
[25,114].  Conventional imaging is likely not sensitive enough to reveal possible 
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pathoanatomical lesions in WAD grades I-III [23,24,105,115].  Even when lesions are 
identified, their clinical significance has been debated.  A recent example was MRI findings 
demonstrating possible tears of the craniovertebral ligaments [116-120].  Similar ‘pathologic’ 
changes were subsequently observed in these ligaments in asymptomatic, aged individuals 
and individuals with insidious onset neck pain [121-123].  Moreover, even when these 
changes were detected by MRI, correlation with clinical symptoms of WAD was questionable 
[124].   
2.3.2 Pathoanatomical Lesions and Clinical Findings 
As diagnostic imaging is largely unhelpful, there is a necessary reliance on other 
clinical findings to guide decision making regarding diagnosis and patient care.  There is 
considerable similarity in symptoms from various musculoskeletal pathologies in the neck 
region.  Pain mapping reveals considerable overlap in areas of symptoms from cervical disc 
pathology [125], cervical facet-joints [126], nerve root pathology [127] or muscle [31].  
Physical examination also fails to identify distinct pathoanatomical findings with any greater 
clarity than self-report of symptoms [128].  The close anatomical relationship of cervical 
structures indicates the possibility of multiple lesions following whiplash trauma (e.g. cervical 
disc and facet joint pathology) [27] to further confound the clinical picture.  As it is difficult 
to accurately locate specific pathoanatomical lesions, it is unknown what role these lesions 
have in an individual’s clinical presentation.   
Attention has therefore diverted to the mechanisms and impairments underlying 
clinical symptoms.  Many advocate that a treatment approach directed towards subgrouping 
individuals with consistent underlying impairments [129,130], or successful treatment of the 
mechanisms and processes underlying impairments of painful musculoskeletal conditions may 
improve outcomes [131].  This would allow the manifestations of any underlying pathology to 
be treated appropriately, no matter where the lesion exists.     
2.4 Pathophysiological Processes Following Injury 
Augmented central nervous system (CNS) nociceptive processes (or central 
hyperexcitability) can explain many features of persistent pain hypersensitivity after 
peripheral tissue injury [132].  Central hyperexcitability has been defined as changes in the 
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CNS that occur after injury which are responsible for enhanced neuronal excitability and pain 
perception [54] and is induced by peripheral nociceptive stimulation [133].  It has been 
described as a possible mechanism for the persistence of pain [54].  The presence of central 
hyperexcitability is one of the factors that may explain the discrepancy between the apparent 
lack of tissue damage and the magnitude of pain complaints in individuals with WAD.  
Clinical identification of central hyperexcitability [134] may assist in screening patients for 
specific treatment approaches (such as appropriate education and medication) in an attempt to 
improve outcomes [35,135].   
The development of central hyperexcitability is generally thought to arise from the 
initial injury [36] and inflammatory response (marked by release of potassium ions, substance 
P, bradykinin, prostaglandins, and other chemical mediators) that sensitizes peripheral 
nociceptors [136].  Resultant gene expression in the dorsal root ganglion leads to increased 
excitability in peripheral nociceptors, which results in an overall increase in nociceptive input 
to the spinal cord [136].  This prolonged afferent input (glutamate is considered the principle 
neurotransmitters of nociceptors in the CNS [137]) may result in an irreversible or reversible 
change in the excitability of central sensory neurons resulting in activation of voltage-gated 
channel receptors  throughout the whole spinal cord and supraspinal centers in addition to the 
neural structures connected to the original site of the initiating lesion [138].  The resultant 
hyperexcitability of the CNS may lead to positive sensory signs such as allodynia and 
hyperalgesia [137].  Expansion of the receptive fields (cutaneous area innervated by a single 
spinal neuron [139]) of dorsal horn neurons has also been noted. This results in widespread 
pain being produced through excitation of the sensitized dorsal horns by afferent input 
produced outside the area of the initial injured region [136].   
In conjunction with these findings, there is evidence that supraspinal modulation is 
disrupted; resulting in an imbalance of descending facilitatory and inhibitory signals 
[133,140].  This may explain the role of psychological distress and cognitive factors in 
contributing to the maintenance of chronic pain states [54].   
2.5 Measurement of Pain Processes in Chronic WAD 
Sensory hypersensitivity (or decreased pain thresholds) has been identified using 
quantitative sensory testing (QST) in various chronic painful musculoskeletal conditions such 
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as WAD, fibromyalgia, temporo-mandibular disorders, tension-type headaches and migraine 
[141-143].  Sensory hypersensitivity over healthy tissues (especially in anatomical bodily 
regions remote to the site of injury) indicates the presence of CNS hyperexcitability [54].  
Typically, the pain threshold, or occasionally the pain response after suprathreshold 
stimulation is assessed [144].  Several psychophysical studies add to evidence that CNS 
hyperexcitability is a clinical feature in individuals with WAD.  QST has revealed both local 
and widespread sensory changes in individuals with chronic WAD [35,145,146]; with reduced 
pressure and thermal pain thresholds demonstrated [147-149].  Participants with WAD also 
show less effective conditioned pain modulation [149], reduced computerized cuff pressure 
pain thresholds (facilitated temporal summation) [150]; increased pain [33] and reduced 
sensibility [151] to vibration stimuli and to differing electrocutaneous modalities [32,63,152-
154].  Widespread pain was also reported by participants with chronic WAD following 
injection of intramuscular hypertonic saline, into either infraspinatus or tibialis anterior 
muscles [31,150].  Heightened bilateral responses to the clinical brachial plexus provocation 
test have also been identified and proposed to reflect augmented central motor responses 
[35,108,149,155].  These clinical research findings support the basic science research, 
indicating that central hyperexcitability is a feature of chronic WAD, however further 
research remains to be performed in this area, as other tests of perceptual sensory dysfunction 
(such as two point discrimination threshold), indicative of altered cortical mechanisms in 
other conditions (e.g. low back pain) have yet to be investigated in the WAD population 
[156,157].    
Psychophysical tests require an alert individual’s cognitive response and require 
appropriate attention and concentration for accuracy of results.  In contrast, the nociceptive 
flexion reflex (NFR) is independent of a participant’s cognitive response.  The NFR is a 
spinal reflex of the lower limb that is produced by a painful electrical stimulation of a sensory 
nerve (usually the sural nerve) [158], eliciting a flexion reflex that is recorded by 
electromyography (EMG) in the hamstrings musculature (biceps femoris) [159].  Voluntary 
hamstring contractions to application of the electrical stimulus can be ruled out by the timing 
of this reflex, as a defined latency (reflex threshold) is required for production of this reflex 
(<150milliseconds) [159].  Thus, this reflex is free of a subject’s cognitive response and is 
considered an objective electrophysiological parameter for quantifying the excitability of 
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spinal neurons [160].  The minimal electrical stimulus required to produce this reflex is 
considered to be the reflex threshold [154].  It has been shown that the threshold required to 
elicit this reflex in individuals with chronic WAD is lower than that measured in 
asymptomatic individuals indicating the presence of spinal cord hyperexcitability [63,154].  A 
recent study revealed that a lowered NFR threshold determined in all participants in the acute 
stage following injury, persisted in individuals with chronic moderate to severe disability at 6 
months, but resolved in those who recovered or reported mild disability at 6 months [161].  In 
contrast, generalized sensory hypersensitivity (pressure and cold hyperalgesia) was only ever 
present in those with moderate/severe symptoms and remained unchanged throughout the 
study period.  The authors suggested that different mechanisms underlie sensory 
hypersensitivity and NFR responses.  It was also reported that initial levels of pain related 
disability were a unique predictor of persistent spinal cord hyperexcitability, and therefore it 
was possible that ongoing peripheral nociception following whiplash injury resulted in lower 
NFR thresholds [161].  As different mechanisms may underlie individuals’ clinical features, it 
would seem important to incorporate both measures of sensory hypersensitivity and spinal 
cord hyperexcitability in the body of research forming the thesis.    
Recently, studies have also demonstrated that sensory changes may be related to 
psychological factors in individuals with chronic WAD [63,162].  Correlations between pain 
catastrophizing, psychological distress and various QST measures – including cold pain 
thresholds (CPT) [63]; heat pain thresholds (HPT), and sensory detection thresholds have 
been demonstrated [162].  These studies found no relationship between these psychological 
measures and PPT [162], catastrophization and the NFR threshold [63].  These findings 
indicate that although psychological factors are associated with some of the sensory features 
evident in WAD, the association is inconsistent; indicating that psychological features alone 
cannot explain the sensory manifestations of WAD.  However, the role of these features needs 
to be considered to fully understand the clinical manifestations experienced by individuals 
with chronic WAD.    
The presence of sensory hypersensitivity in chronic WAD also appears to differentiate 
this condition from idiopathic non-traumatic neck pain.  In one study, participants with 
chronic WAD demonstrated lowered pain thresholds to pressure, heat, and cold stimuli in 
areas both local and remote to the cervical spine, when compared to participants with chronic 
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idiopathic neck pain [146].  Both groups demonstrated local mechanical hyperalgesia in the 
cervical spine.  It was proposed that the findings of isolated local hyperalgesia in the 
idiopathic neck pain group were indicative of peripheral sensitization resulting from local 
neck structure involvement, whereas the generalized hypersensitivity shown within the WAD 
group was indicative of augmented central pain processing mechanisms [146].  The people 
with chronic WAD did have higher reported pain and disability levels and a relationship 
between pain and disability levels and sensory disturbance has also been demonstrated in 
manual office workers with neck pain [163].  Thus, consideration of pain and disability levels 
is required and was measured in the research forming this thesis.     
2.5.2 Summary of Changes in Pain Processing Mechanisms 
It is evident that the changes observed in the sensory system in individuals with 
chronic WAD occur across dermatomes within a particular body region and also are 
widespread across different body regions.  Such widespread changes appear to be a result of 
abnormal or augmented central processing of afferent input, resulting in the altered sensory 
responses.  These findings have been supported by two recent systematic reviews [164,165], 
with another systematic review supporting the presence of reduced NFR threshold in 
individuals with WAD [166].  This may explain the persistence of symptoms in individuals 
with chronic WAD.  These changes do not appear to be present in chronic neck pain of non-
traumatic onset.  However, of relevance to this body of research, it has not been determined 
whether or not central hyperexcitability in chronic WAD is related to ongoing peripheral 
nociceptive activity from injured cervical structures or is self maintaining. 
2.6 Neuromuscular and Movement Dysfunction in the Presence of Neck 
Pain 
2.6.1 Clinical Findings in WAD 
Varying changes have been observed within the neuromuscular system in individuals 
with chronic WAD.  These can be broadly classified into morphological changes, behavioural 
changes (changes in motor control strategies) and sensorimotor dysfunction. 
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2.6.2 Morphological Changes 
Magnetic resonance imaging (MRI) has revealed that individuals with chronic WAD 
have infiltration of fatty tissue in the cervical flexor [167] and extensor muscles [43,168].  
The fatty changes are especially noticeable in the sub occipital region (rectus capitis major 
and minor and C3 multifidus; and longus capitis/colli at C2/3) [43,167,168].  It is postulated 
that the changes observed in this region of the cervical spine may be as a result of 
transformation of Type I slow-oxidative to Type IIB fast-glycolytic fibres [169], general 
disuse, denervation atrophy or inflammatory responses associated with injury [43].  Tissue 
biopsy has also revealed the presence of biochemical alterations in the upper trapezius 
muscles, consisting of higher interstitial interleukin and serotonin levels in individuals with 
persistent pain in the chronic stage of WAD [170].   
It is apparent that ongoing pain and disability of chronic WAD is associated with 
significant morphological muscle changes in the cervical spine region that persists in 
individuals with chronic WAD. 
2.6.3 Changes in Motor Control  
Reductions of strength and endurance of the neck musculature has been measured in 
individuals with chronic WAD, with a wide variation in values apparent, likely reflecting 
between-individual differences [171-174].  Not only are there changes in strength and 
endurance in the presence of neck injury or pain, but re-organization of motor control 
strategies has been demonstrated in a range of cervical muscles whilst performing various 
activities.  Evidence of the relationship between excitation of cervical nociceptors and a 
variety of changes in motor behaviour come from electromyographic (EMG) studies, 
predominantly after inducing experimental pain [175-177].  For example, after intramuscular 
injection of hypertonic saline into the sternocleidomastoid (SCM) musculature, contraction of 
the cervical flexors resulted in pain-induced inhibition in the agonist splenius capitus muscle 
[176,177].  Likewise it was shown that SCM activity reduced during cervical rotation 
(agonist) with pain evoked in the splenius capitis muscles [178].  Thus, one reason for muscle 
re-organization may be to minimize the use of the painful muscle [175].     
Altered patterns of cervical and shoulder girdle muscle recruitment have also been 
documented, both in automatic function [179] and whilst performing prescribed tasks 
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[64,180].  The cranio-cervical flexion test (CCFT) is one example of a task which illustrates 
the motor control deficits in the neck region.  During this task, subjects are positioned in 
supine lying and asked to perform a gentle, progressive nodding of the head (cranio-cervical 
flexion) [39].  Cranio-cervical flexion is the primary action of the deep cervical flexors, 
(longus colli and capitis), with little contribution from the SCM muscles to this task [181].  
Patients with neck pain disorders have been shown to have lesser ability to recruit the deep 
cervical flexor musculature when performing the CCFT and their motor behaviour changes to 
complete the task via a compensatory increase in activity of the superficial SCM and anterior 
scalene muscles [182].  Thus the superficial and deep muscles display an altered spatial 
relationship in the presence of neck pain.  Changes in activity (increased on the non-dominant 
and decreased on the dominant side) have also been recorded in the upper trapezius muscles 
in individuals with chronic WAD during a functional pencil tapping task [40].  Likewise, 
muscles such as SCM and upper trapezius are slower to relax following a task [42,181].  In 
relation to automatic function, it has been shown that there is a delay in activation of the 
cervical flexor (both superficial and deep) muscles during voluntary arm movements, 
indicating that the anticipatory feed forward mechanism involving activation of these muscles 
is impaired [179].  Poor motor control could contribute to the persistence or recurrence of 
neck pain episodes [51], as despite resolution of pain and disability, longitudinal studies 
reveal the persistence of motor deficits [51,64].   
2.6.4 Movement Dysfunction 
Various movement dysfunction has also been demonstrated in individuals with 
chronic WAD, including loss of active cervical ROM [38,64,69,149,183,184] and reduced 
conjunct motion [185].  Dall’Alba at al demonstrated that active cervical ROM discriminated 
between patients with chronic WAD and subjects with no history of neck complaint [38].  
Reduced ROM is present within one-month of injury [64], and persists into the chronic phase 
of WAD [51,64].  Of interest, one study has shown that it is only the group with self-reported 
moderate-to-severe symptoms that continue to present with loss of ROM 2-3 years following 
the initial injury [51].   
The motor control and movement dysfunction observed in individuals with WAD are 
common to neck pain disorders and are observed in individuals with chronic neck pain of 
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insidious onset [180] and across different sub-groupings (mild to moderate/severe pain and 
disability) of WAD individuals [13,64].  Although treatment of these dysfunctions 
(improvement in ROM and motor control/co-ordination) has proven beneficial in reducing 
pain and disability in studies of chronic WAD subjects [186,187], some degree of ongoing 
pain and disability remain in many subjects, indicating, not unexpectedly, that these deficits 
are not fully responsible for the persistence of symptoms [188].  It is unknown why these 
features persist in individuals with chronic WAD. 
2.6.5 Sensorimotor Dysfunction 
Patients with chronic WAD commonly complain of dizziness and/or unsteadiness, 
episodic loss of balance [13,46] and visual disturbances [45,189].  Balance and postural 
stability [46,190-197], ability to accurately relocate head position [13,198-202] and 
occulomotor control have also been shown to be altered in many individuals with chronic 
WAD [45,47,189,194,203-206].  This may be due to dysfunction in the CNS, cervical spine, 
vestibular or ocular systems [207].  Afferent information from the vestibular, visual, and 
somatosensory systems converge in multiple areas within the CNS, which is important for 
general equilibrium, body orientation, and oculomotor control [208].  Thus, it follows that 
abnormal afferent input from these systems can result in abnormal sensorimotor control.        
One group of authors mused on the likelihood of medication, anxiety or secondary 
gain being possible causes of sensorimotor disturbance [209].  However, an experimental 
study found that balance deficits could not be attributed to medications, compensation or 
anxiety [46].  Thus, it is more likely, and more commonly reported that trauma to the cervical 
spine region and aberrant information from this region is the most likely cause of these 
symptoms [47,195,210-213].   
Nociceptive afferent fibres from both joint and muscles affect the proprioceptive 
activity of muscle spindle afferent fibres [214].  In accord, greater joint repositioning errors 
(JPE) have been found in patients with both acute and chronic WAD, particularly in those 
with higher reports of pain and disability [13,64].  Individuals with chronic WAD with 
dizziness symptoms may also present with a positive Smooth Pursuit Neck Torsion Test 
(SPNTT), a test specifically developed to differentiate ‘cervicogenic dizziness’ following 
whiplash injury [45].  An abnormal ‘gain’ is measured when the neck is torsioned (i.e. trunk is 
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rotated left or right underneath the stationary neck, producing a relative neck rotation) whilst 
performing an ocular horizontal tracking motion (i.e. smooth pursuit motion to follow a visual 
target right and left) as compared to the ‘gain’ measured when the neck is in a neutral position 
[45].  This test was able to discriminate individuals with chronic WAD from patients with 
vestibular or CNS disorders, spondylosis or fibromyalgia [189].  Treleaven et al, found that 
individuals with chronic WAD (with and without dizziness) had altered eye movement 
control utilizing the SPNTT, which was likely a result of increased aberrant afferent 
nociceptive input [47].       
2.6.6 Summary 
It is clear that motor deficits occur very soon after injury [42,64], and greater deficits 
are evident in those subjects with higher levels of pain and disability [64].  However; even in 
subjects who recover, motor deficits are observed to persist [51].  Whether these motor 
changes are due to distinct pathoanatomical lesions (arthrogenous muscle inhibition) or as a 
result of chronic pain is unclear in many cases [215].  This requires further investigation. 
The measures for this body of research to evaluate motor performance were chosen to 
reflect established measures in individuals with chronic WAD [64].  Active cervical ROM 
was selected as it is a commonly used outcome measure in individuals with chronic WAD.  
The CCFT was chosen to further evaluate the role of pain on muscle function and in respect 
of its previous use in individuals with chronic WAD [180]. 
2.7 Psychological Features in WAD 
Various psychological features have been demonstrated in individuals with chronic 
WAD [67], including distress, anxiety, depression and fear of movement [48,216-219].  In a 
cross-sectional study, Nijs et al reported an association between personality traits 
(inadequacy, self-satisfaction and resentment), social support and poor functional recovery in 
those with chronic WAD [220].  In contrast, in a prospective study design, Radanov et al. 
found that distress was not related to factors such as personality traits or cognitive abilities, 
but more related to the initial pain intensity reported following the MVC [48,69].   
Psychological distress is present soon after the MVC [67,221], with some level of 
psychological distress apparent irrespective of initial pain or disability levels [67].  Gargan et 
al. found that psychological disturbances were associated with reduced neck ROM at three 
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months post collision, indicating a relationship between the physical and psychological 
presentation of WAD [221].  Wenzel et al found that psychological distress was related to 
symptom persistence, with individuals in the acute phase after the MVC less likely to 
demonstrate anxiety and depression compared to those whose collision was more than two 
years previously [52].  These data suggest that ongoing distress in the chronic phase of WAD 
seems to be a consequence of persistent pain and disability [69,221].  However, a more recent 
large prospective population cohort study found that pre-existing psychological symptoms 
[222], and poor general health prior to the injury [223] increased the likelihood of reporting 
whiplash symptoms.  These results were confirmed by a recent systematic review, which 
concluded that individuals may have a pre-disposing vulnerability to develop chronic WAD 
as a result of inter-relationships between various psychosocial factors [50].  
There is evidence contrary to this view regarding the influence of pre-disposing 
factors.  It has been found that whiplash-injured patients with ongoing pain and disability at 
three months report greater psychological distress and a poorer quality of life than individuals 
who have recovered from their initial injuries [221,224].  Notably those individuals who 
recovered did report initial distress but it resolved concomitant with the decrease in pain and 
disability [67].  This relationship between persistent pain/disability and distress is supported 
by other clinical data. Resolution of psychological distress occurred once an individual’s 
persistent pain was resolved with radiofrequency neurotomy [225]. 
All injured people display some psychological distress, but in the context of neck pain, 
the presence of posttraumatic stress symptoms seems to be unique to those with poor recovery 
following whiplash injury [67].  Drottning et al. [226] reported that a posttraumatic stress 
response may occur in the initial presentation of symptoms (within hours) following a 
whiplash event; with symptoms shown to persist into the chronic phase of the condition 
[51,67].  Higher levels of posttraumatic stress symptoms are also related to moderate levels of 
pain and disability [227,228] and are a prognostic indicator for poor functional recovery [229-
232].  The presence of a specific diagnosis of posttraumatic stress disorder (PTSD) following 
whiplash is not uncommon  [227,229,232-238], with a 12 months post injury prevalence of 
approximately 30% [239].  Chronic pain and PTSD often co-exist [240-243], with an 
increasing recognition of a shared vulnerability between WAD and PTSD [244].  A recent 
preliminary randomized controlled trial (RCT) in individuals with chronic WAD 
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demonstrated that a cognitive behavioural intervention was successful in decreasing PTSD 
symptoms, together with decreasing levels of pain related disability; although there were no 
changes in pain intensity or sensory pain thresholds [234], thus providing partial support for 
the possibility that PTSD symptoms impact pain-related factors.   
Emerging evidence indicates that pain catastrophizing is also relevant in the 
presentation of WAD [50].  Catastrophization is defined as a negative orientation towards 
noxious stimuli [245], or actual or threatened pain [246]; and is associated with enhanced pain 
reports, disability [247,248].  It correlates significantly with anxiety, fear and depression 
[246].  In patients with WAD, catastrophizing is associated with poor mental health outcomes 
and adverse health effects [248,249].  Greater reductions in pain catastrophizing have resulted 
in increased return to work rates in individuals with WAD following a 10-week rehabilitation 
program targeting psychosocial barriers (pain catastrophizing, fear of movement/reinjury and 
perceived disability) [250].  There is debate on whether catastrophization is a stable 
(enduring) [246], or a dynamic trait, related to particular constructs such as pain [251].  
Reduction of pain catastrophizing has been measured following total knee arthroplasty [252], 
but no data exists in the WAD literature as to the effects of pain on catastrophization.  
Fear-avoidance behaviour is common in patients with low back pain [253] and has 
also been studied in acute, sub-acute and chronic WAD [67,218,254,255] with conflicting 
results.  Nederhand et al [218] and Nieto et al [255] found that initial scores on the TAMPA 
scale of kinesphobia (TSK) predicted the persistence of symptoms following the initial 
whiplash event, whereas Buitenhuis and colleagues found no significant association between 
fear of movement and duration of symptoms when the analysis was adjusted for variables of 
age, gender and pain intensity [254].  These contrasting results may be due to the different 
outcome measures used in the studies or that the TSK may not adequately reflect fear 
avoidance in individuals with neck pain.  In order to address this problem, the Pictorial Fear 
of Activity Scale – Cervical (PFActS-C) was developed.  The PFActS-C includes a series of 
photographs of movements that place different biomechanical stresses on the cervical spine 
that may be threatening to patients with neck pain [256].  Sterling et al. found differences 
between individuals with chronic WAD with moderate to severe symptoms disability and 
those with milder disability when using the TSK as a measure of fear-avoidance behaviour 
[67].  The individuals with mild symptoms reported a reduced TSK score as their pain and 
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disability improved at the two-month mark.  Similarly, the individuals with moderate to 
severe symptoms reported reduced TSK scores between three to six months, such that their 
scores did not differ from those individuals who reported full recovery [67].  Sensing that this 
may have been due to insensitivity of the TSK, a further prospective study was performed 
[257].  This revealed that the two questionnaires seemed to measure different outcomes.  The 
PFActTS-C scale was predictive of loss of cervical motion; whilst the TSK questionnaire 
(together with initial pain intensity) was predictive of poor functional outcome at 6 months 
[258].  Sterling et al. examined this response further with a novel experiment utilizing a vest 
and electronic diary to investigate the relationship between activity levels, fear of movement, 
posttraumatic stress and whiplash-injury related pain [219].  This demonstrated that the 
relationship between trauma symptoms and pain perception was mediated by fear of pain.  
Physiological arousal associated with thoughts or reminders of the MVC was reported to have 
an immediate or short term (less than an hour) impact on perceived pain/symptomatology 
through activation of the fear network.  Trauma related avoidance symptoms (rather than fear 
of pain) predicted decreased levels of activity [219].  A subsequent prospective study 
reproduced these results (using questionnaires), demonstrating that fear mediated the 
relationship between pain and disability over a 6 month period [259].   
Other factors such as coping styles have also been investigated in WAD [50].  There is 
some evidence that individuals with passive coping styles recover less quickly after a MVC 
[260,261].  In contrast, other studies have found that coping styles were not predictive of 
outcome at 1-year following injury [262].  In the study finding the relationship between 
coping styles and recovery, depression acted as an effect modifier in the relationship, such 
that participants with depression and passive coping styles took approximately four times 
longer to recover than those with depression and less passive coping styles [260].  Depression 
is a common psychological feature of WAD and related to pre-existing mental health [263].  
The early presentation of depression (i.e. at six-weeks following the MVC, approximately 
40% reported the presence of depression) suggests that chronic pain is not responsible for 
these symptoms [263]. 
Thus, there appears to be a complex interaction between physical and psychological 
characteristics in individuals with chronic WAD [63,66,248,264].  This is supported by 
empirical evidence suggesting that functional improvement occurs in both physical symptoms 
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(reduced pain intensity) and psychological symptoms (reduced fear avoidance) with programs 
directed towards graded exposure [250,265].  There is interest in emerging psychological 
factors in WAD, such as perceived injustice [264,266], self efficacy [8] and beliefs and 
attitudes regarding expected recovery [247,267,268].  Their influence on pain and recovery 
are yet to be fully determined. 
2.7.1 Summary of Psychological Features 
Research regarding the psychological features in chronic WAD continues to develop 
rapidly.  However, it is still unclear whether the psychological features arise as a result of 
being involved in a traumatic event (MVC); the distress of having persistent pain and 
disability [52], pre-existing psychological issues or general health concerns [50], which are 
exacerbated by a stressful event [65] or other undefined factors.  Further investigation of the 
interaction between psychological distress, post traumatic stress symptoms and pain 
catastrophization is required and warranted in defined sub-groupings of chronic WAD.  
Longitudinal studies would more clearly define the relationship between ongoing nociception, 
pain and disability and psychological responses.  
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CHAPTER 3 
The cervical facet joint as a nociceptive source in chronic 
whiplash associated disorders: Diagnosis, treatment and 
modulation of clinical features. 
The body of work in this thesis explores the role of ongoing peripheral nociception in 
the sensory, motor and psychological presentation of chronic whiplash associated disorders 
(WAD).  This chapter presents a review of cervical facet joint pain and its diagnosis.  An 
overview of treatment options for chronic WAD will be provided, with a focus on 
interventions for the facet joint.  The possibilities for modulating the underlying physical and 
psychological manifestations of chronic WAD are discussed and an argument is made for 
such modulation in people who respond to diagnostic cervical medial branch blocks (MBBs) 
and progress to treatment via radiofrequency neurotomy (RFN).  
3.1 Introductory Remarks 
The traditional biomedical model of illness assumes a direct relationship between 
nociception and pain.  It is based on the premise that identifying and treating the source of the 
nociception will result in improvements in pain and disability [269].  However, the 
biopsychosocial model acknowledges the interaction between psychosocial factors and 
biological ones (including a peripheral nociceptive source) on an individual’s expression of 
pain [269].  Psychological treatments have been recognized in other musculoskeletal disorders 
with persistent pain (such as low back pain, headache, and fibromyalgia) to be as effective as 
standard medical treatment [270-272].  Despite many different interventions being applied to 
individuals with acute WAD (including multi-professional, multidisciplinary management), it 
has not prevented a significant proportion of individuals from developing chronic pain and 
disability [3,273].    
It would be beneficial to understand the relationship between distinct pathoanatomical 
lesions (with resultant nociception) and the pathophysiological disturbances (altered sensory 
and motor findings) and psychological factors in chronic WAD.  It would also be of interest to 
understand whether sensory, motor and psychological processes can be modulated when 
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nociception from an underlying pathoanatomical lesion is reduced (i.e. are these 
manifestations dependent on, or independent of, a peripheral nociceptive source?).  As some 
of these features (such as cold hyperalgesia or posttraumatic stress symptoms) are prognostic 
of poor functional recovery [7,147,231], it is important to determine if these features can be 
reduced with effective treatment of underlying nociception, or if they are self-maintaining due 
to neuroplastic changes in the central nervous system [56], indicating that other treatments 
would be required for their management.  The tenet of this body of research is that sustained 
nociceptive input from the periphery (especially in deep pain-generating structures), results in 
persistence of central hyperexcitability [54], motor dysfunction and psychological distress 
[225].  Sustained nociception may arise when there is persistent inflammatory pain or in 
chronic neuropathic pain [137,274].  In both cases nociception from the periphery is amplified 
by central hyperexcitability, which is itself maintained by peripheral nociceptive input.  
Reducing the peripheral input may allow the combined reduction of both the noxious input 
and central hyperexcitability [137].   
Clinical studies have shown that patients with painful osteoarthritis of the hip 
demonstrate pressure and thermal hyperalgesia when compared with sex- and age-matched 
controls [275], but the hyperalgesia normalizes after arthroplastic surgery and subsequent pain 
relief.  These findings implicate the role of ongoing afferent nociception in the augmentation 
of central pain processes.  Similar sensory features are also evident in WAD and generally 
thought to occur as a result of central hyperexcitability [136,276].  The role of peripheral 
nociception in the persistence of central hyperexcitability is not clear [53-55], with possible 
self-maintenance arising from neuroplastic changes in the central nervous system [56].   
Motor deficits in individuals with chronic WAD are common [39,42,64], with greater 
deficits observed in those with higher levels of pain and disability [64].  Ongoing motor 
deficits remain despite self-reported recovery [64].  It would be beneficial to know whether 
the presence (or not) of a nociceptive source modulates the physical motor manifestations in 
individuals with chronic WAD.    
Psychological distress has been shown to be related to ongoing pain and disability in 
individuals with chronic WAD [52,67].  Psychological distress may result from posttraumatic 
stress disorder (PTSD), affective disturbances, anxiety, depression and behavioural 
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abnormalities such as fear of movement [52,216,218].  It would thus seem logical that the 
modulation of pain has the potential to also modulate psychological changes in WAD.   
3.2 The Facet Joint as a Source of Nociception in WAD 
3.2.1 Basic Science Experiments 
Research abounds regarding the capacity of the cervical facet joint to generate and 
potentially modulate widespread neck pain [23,24,26,28,225,277-285], as well as refer pain to 
the head and upper extremities [286,287].  Mechanoreceptors and free (unmyelinated 
nociceptive) nerve endings have been found within the cervical facet joint and in particular, 
the subsynovial and capsular tissue [279,284] that collectively cover the entire joint [288].  
Neuropeptides involved with nociception (substance P (SP) and calcitonin-gene related 
peptide (CGRP)) [289,290] in the peripheral and central nervous system have also been 
measured in human cadaveric cervical facet joint capsules [279]. 
 Numerous cadaveric studies have shown that excessive facet capsule strain during the 
whiplash injury exceeds strains experienced during normal neck bending [16,18,291].  These 
strains can be increased by head rotation [292].  The strains in both cadaveric and animal 
studies produce partial tissue rupture, but do not involve tissue failure (sub-failure).  Thus, 
they replicate the strains observed in capsules during simulated whiplash loading [19,21], 
suggesting that capsule lengthening during whiplash is a potential mechanism of injury.  
Subsequent progressive capsular deformation and pain generation on the sensory neural 
response was investigated in a goat model [282].  A significant number of capsular 
nociceptive afferents were activated [282] at strain values similar to those experienced in the 
lower cervical spine during whiplash loading [18,95].   
It has also been shown that inflammation of the facet joints leads to elevated baseline 
discharge and decreased thresholds of capsule receptors (peripheral sensitization) [282].  In 
the same goat model, high capsular strain damaged axons in the capsular tissue, which may 
lead to persistent pain [293].  These strains corresponded to those detected in the human 
capsule during whiplash loading [18,19,21].  Thus, deformation of capsular tissue has been 
shown to activate peripheral nerve tissue/axon in a goat model.  Cadaveric dissection models 
(with muscle force replication) exposed to whiplash trauma has also revealed the possibility 
of human capsules exceeding this ‘injury threshold’ [18,291].  Re-organization of collagen 
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tissue has also been observed following capsular distraction despite the absence of complete 
tissue failure (i.e. sub-failure) [294,295].  Pain can result from these capsular responses 
without major mechanical failure [282].  Thus, significant tearing and structural disruption of 
tissues (as observed in cadaveric dissection studies) [23], is not required for ongoing 
nociception.    
Tensile forces under different strain conditions (sham, low and high) have been 
applied to rat facet joint capsules to examine the relationship between cervical facet joint 
capsule injury and behavioural hypersensitivity [281].  Behavioural hypersensitivity (pain 
response) was measured by the number of times the animal’s forepaw withdrew from the 
applied innocuous tactile stimulus (forepaw mechanical allodynia) after the tensile force was 
applied to the capsule.  Despite no evidence of observed capsular damage (even 
microscopically) following these experiments, behavioural hypersensitivity was observed 
following a certain amount of distraction.  In the high strain group, mechanical allodynia 
existed for 7 days.  There was no evidence of mechanical allodynia between the low strain 
and sham groups and it was postulated that there may be a mechanical threshold for capsular 
injury that results in persistent pain responses [281].  In regard to clinical whiplash, the high 
strains applied were similar to those applied during simulated whiplash loading [95].  Thus, it 
was postulated that persistent pain responses following whiplash injury may result from sub-
catastrophic injury to the joint capsule.  Subsequent experiments have also revealed that this 
mechanical allodynia likely happens if injury occurs to an intact facet capsule [296].   
The combination of anatomical, mechanical and electrophysiological findings in these 
basic science experiments suggests that facet joint capsule stretch resulting from whiplash 
loading (which exceeds strains observed during normal neck bending [93]) has the potential to 
initiate physiological pain responses.  In fact, a recent study in rats revealed the presence of 
ongoing central nervous system changes indicative of central sensitization following painful 
distraction of the facet joint capsule (presence of increased spinal cord substance P (SP) 
mRNA and SP protein expression in the dorsal root ganglion when compared to non-painful 
distraction).  Even a non-painful distraction (sham procedure) resulted in expression of SP 
protein in the spinal cord [297].  Thus, it appears that the presence of afferent nociceptive 
input, producing peripheral sensitization in the cervical facet capsule, could theoretically 
result in subsequent central sensitization (increased responsiveness of nociceptive neurons in 
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the central nervous system to their normal or subthreshold afferent input [298]); which may 
explain the symptoms commonly observed in individuals with chronic WAD [54].  These 
experiments in animals have also been extended to investigate neuronal discharge rate in the 
dorsal horn of a rat [299].  The authors suggest that excessive facet capsule stretch, while not 
producing visible tearing, can produce functional plasticity of dorsal horn neuronal activity 
and suggests that facet-mediated chronic pain following whiplash injury is driven, at least in 
part, by central sensitization.   
3.2.2 Clinical Diagnosis of Facet Joint Pain 
The incidence of cervical facet joint pain in WAD is relatively high. A placebo-
controlled prevalence study in patients with chronic neck pain following whiplash injury 
employing comparative facet joint blocks revealed that the prevalence of C2-C3 facet joint 
pain was 50%, with 49% of these patients also having lower cervical facet joint pain.  Overall, 
the prevalence of cervical facet joint pain (C2-C3 or below) was 60% (95% confidence 
interval: 46-73%) [28].  A further study using controlled double-blind diagnostic facet blocks 
determined that the prevalence of cervical facet joint involvement was 74% (65-83%) in 
drivers who sustained a whiplash injury at higher impact speeds [60].   
Studies have investigated the capacity of clinical procedures to detect a cervical facet 
as the origin of a patient’s neck pain.  One study comparing the findings of manual 
intervertebral segmental examination against that of diagnostic facet blocks demonstrated 
excellent reliability in confirming the presence or not of facet joint pain [300], but another 
study failed to achieve the same level of concordance [301].  A recent study has added to this 
body of knowledge by investigating the accuracy of a combination of physical examination 
findings in order to develop a clinical decision guide [302].  It was determined that a 
combination of positive findings with manual intervertebral segmental examination, cervical 
spine segmental palpation and extension-rotation test may assist with the diagnosis of facet 
joint pain (specificity = 84%).  In addition, negative findings with manual spinal examination 
and/or segmental palpation suggests that the cervical facet joint is not the primary source of 
nociception (sensitivity = 92% and 94% respectively) [302].   
Other physical examination methods have been evaluated in a study attempting to 
predict success of RFN (based on a prior successful response to a single diagnostic medial 
branch block) [303].  Paraspinal tenderness in the neck region was predictive of successful 
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outcome of RFN but ‘facet loading’, combining active rotation and/or extension movement 
was not predictive of success with RFN.  Success was defined as greater than 50% pain relief 
six months after the procedure was performed [303].  
Thus, the findings of manual intervertebral segmental examination are showing 
promise to assist in determining patient suitability for interventional procedures to the facet 
joint and providing direction towards which facet joint should receive the intervention.  When 
a patient proceeds to RFN, determination for suitability of this intervention is guided by 
response to randomized, comparative (utilizing two different local anaesthetics with different 
duration of pharmacological action for each anaesthetic), or placebo-controlled diagnostic 
facet joint injections [283].  Diagnostic facet blocks in the neck have face validity and target 
specificity [57] together with construct validity [304].  The effectiveness of this technique has 
been determined by short-term relief of symptoms, improved cervical range of motion post-
procedure and effective long-term follow-up [305].  Some authors [306,307] dispute this 
‘gold standard’ as not fulfilling  appropriate methodological criteria of diagnostic test 
accuracy as per accepted guidelines [308,309], although two recent systematic reviews 
considered the diagnosis of facet joint pain by controlled local anaesthetic blocks as safe, 
reliable and valid [310,311].  In summary, the validity of facet joint injections is disputed; 
primarily in regard to the existence of a criterion reference standard, which would allow 
determination of whether a positive response to diagnostic blocks also accurately corresponds 
to an actual putative facet joint (whether it be via single injection, comparative injections or 
when performed within a placebo-controlled fashion).  [307].  In acknowledgement of this 
‘refernce standard dilemma’ for the subjective experience of pain, whereby a physical 
criterion cannot be established, a set of criteria have since been established (based on 
‘Bradford-Hill’ criteria) to assist with development of a metric for validation and 
quantification of different diagnostic blocks [312].     
Currently, two techniques are commonly employed within clinics to determine 
whether the facet joint is a source of pain for a patient with persisting symptoms following 
their whiplash trauma [313].  Firstly, injections of anaesthetic can be made directly into the 
facet joint (intra-articular) under fluoroscopic guidance once a contrast medium has been 
injected to ascertain diagnostic accuracy.  Secondly, a MBB can be performed (under the 
same stringent conditions with utilization of fluoroscopy and contrast medium for 
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confirmation of needle placement and injection location) to anaesthetize the medial branch of 
the dorsal ramus.  As the medial branch of the dorsal ramus innervates the facet joint and the 
associated facet joint above [314], two levels of the dorsal ramus need to be anaesthetized to 
implicate one individual facet joint as the underlying nociceptive generator.  Two procedures 
are performed with two different anaesthetics on two separate occasions [305].  Different 
anaesthetics have distinct and different duration periods of effect; such that a patient’s 
equivalent pain relief can be measured.  This helps eliminate the presence of false positive 
findings that predominate with single block procedures [28,305].  Thus, a patient can be 
injected with lidocaine and then followed up with bupivacaine at a later date; as the duration 
of effect of these medications are consistent within an individual.  An individual should have 
a longer pain response to bupivacaine [315].  A patient who has longer-lasting relief for 
bupivacaine in comparison to lidocaine has an appropriately positive response to this 
procedure, thus implicating the facet joint as the underlying pain generator.  A definitive 
response is greater than 80% concordant pain relief for that facet joint for the duration of the 
anaesthetic [316].  Many clinical studies use a cut-point of 50% improvement in pain relief to 
control for concurrent spinal pathology [303].  For research studies investigating diagnostic 
accuracy, performance of placebo-controlled blocks are recommended, whilst in clinical 
environments, comparative blocks demonstrate high levels of specificity (88%), allowing 
certainty regarding low false positive rates [304] 
As previously mentioned, the diagnostic accuracy for a single injection has been 
questioned, with various authors demonstrating false-positive rates of between 27-63% when 
single blocks were used (for either intra-articular injection or MBB) [28,305].  This 
necessitates performance of controlled, double-block paradigms to determine if the facet joint 
is the source of an individual’s neck pain.  However, irrespective of whether comparative or 
placebo-controlled blocks are performed, there has been no demonstrable difference in 
predictive capacity of subsequent response to RFN [283].  It has also been shown that a 
patient’s psychological profile (in this case, major depression) can affect the false-positive 
rates of diagnostic facet joint injections in the neck [317].  Thus, studies incorporating 
interventional radiological procedures need to consider the psychological profile of their 
subjects when evaluating the outcomes resulting from performance of these procedures. 
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3.3 The Need for an Effective Treatment Solution for Chronic WAD 
3.3.1 Conservative Treatment Efficacy 
 The treatment of chronic WAD presents challenges.  A study incorporating 
multimodal treatment (manual therapy, exercise therapy and advice/education) for those with 
idiopathic neck pain and cervicogenic headache resulted in significant functional 
improvements [318], but a recent randomized controlled trial (RCT) using the same treatment 
approach in chronic WAD did not provide a similar level of overall benefit [186].  
Preliminary results revealed that pain and disability levels improved with multimodal 
physiotherapy in many the patients with chronic WAD; however post hoc analysis 
demonstrated that those who did not respond (approximately 25% of the cohort) were 
characterized by the presence of a combination of mechanical and cold hyperalgesia [186].  
This preliminary study has assisted in shedding light on individuals that may or may not 
respond to conservative care.     
Several clinical trials have also failed to substantially reduce pain and disability in 
chronic WAD [187,319] or decrease the incidence of transition to chronicity for patients with 
an acute whiplash injury [187,262,273,320-322], whether it involved multimodal therapy, 
multi-professional management or psychological intervention.  One RCT demonstrated that 
exercise therapy is more efficacious than advice in patients with higher baseline pain intensity 
and disability status in individuals with chronic WAD, but only immediately after the 
intervention [187].  More recently, multimodal physiotherapy, incorporating exercises was 
demonstrated to be no more effective than advice [319].  Thus, when taken together, the 
results of these studies indicate that conservative care fails to provide significant long-term 
benefit for certain individuals with chronic WAD.  These results may be explained by the 
heterogeneous nature of WAD; lack of subgrouping of individuals into appropriate treatment 
interventions; pre-existing risk factors for poor outcomes and inter-individual treatment 
responses [323].  Thus, conservative interventions have provided only modest benefit to 
patients enrolled in the trials [324].   
3.3.2 Efficacy of RadioFrequency Neurotomy (RFN) 
Given the modest benefits of conservative care, other treatment solutions are required 
for those individuals with chronic WAD.  Currently, the only treatment that has reported total 
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pain relief for patients with chronic WAD is RFN [316,325].  RFN involves neurolysis of the 
medial branch of the cervical dorsal ramus.  Pain relief following RFN has been reported to be 
independent of medication intake, psychological status, operator, electrode type, litigation and 
return to work status [225,326].  This procedure has proven to be efficacious in a randomized, 
double blind clinical trial comparing the effects of RFN to sham [61].  The pain relief is not 
permanent and the median time for return of pain to at least 50% of the pre-operative level has 
been demonstrated to be 263 days [61].  The procedure may be repeated with similar success 
[283].  McDonald et al demonstrated that RFN provided complete relief of pain in 71% of 
their cohort of patients with chronic WAD with cervical facet-mediated pain [327].  The mean 
duration of pain relief in their study was 422 days (if only successes were included) or 219 
days (if failures were included).  Either way, this is a significant improvement for most 
patients, given that the definition of ‘failure’ was when a patient returned to 50% of their pre-
procedure symptoms.  Barnsley and colleagues subsequently performed an observational 
study in which 80% of subjects with chronic neck pain obtained significant pain relief of 
median duration of 35 weeks [328].   
The original study justifying the benefits of RFN [61] has recently been criticized on 
methodological grounds, especially in regard to possible inappropriate selection criteria, 
potentially confounding baseline differences between treatment groups, lack of effective 
blinding and the lack of short-term benefit in pain relief [329].  Despite these criticisms two 
systematic reviews conclude that the evidence available to support cervical RFN is fair 
[330,331].  Thus, RFN provides one efficacious treatment option for individuals with chronic 
WAD.   
3.3.3 Other Considerations 
Despite the efficacy of RFN in successfully reducing pain in individuals with cervical 
facetogenic nociception, not everyone benefits [61,326,328].  There is a need to determine 
who does and does not respond to RFN, and if RFN can successfully modulate those features 
of WAD that are associated with persistent and chronic moderate/severe pain and disability 
levels.   
RFN studies have tended to concentrate on outcomes involving pain, opioid use, 
psychological distress and/or compensation status to help determine which factors may 
determine the success of the procedure [332].  Few studies have explored other factors that 
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may be associated with a lesser or poor response to the intervention.  It has been found that in 
patients with chronic low back pain undergoing RFN, those reporting reduced life control, 
disturbed mood, negative self-efficacy, catastrophizing, high anxiety levels, inadequacy, and 
poor mental health tended not to respond to this form of treatment [333].  Patients reporting 
less pain and interference levels, positive expectations, and reasonable physical and social 
functioning, responded more favorably [333].  It was advocated that from both a clinical and a 
financial perspective, psychosocial evaluation and selection of patients seems appropriate, 
before applying RFN procedures for chronic low back pain [333].  Research in the neck 
region is lacking in this regard.  Thus, psychological factors need to be considered when 
investigating the efficacy of RFN, together with the ability of RFN to modulate the other 
clinical features of chronic WAD. 
3.4 Modulation of the Physical and Psychological features of WAD 
Despite the wealth of data now demonstrating the presence of sensory disturbances, 
motor and movement dysfunction and psychological distress in chronic WAD, little is known 
about whether or not these features can be successfully modulated and if such modulation 
would improve health outcomes.  This section will explore what is known about the capacity 
to modulate these physical and psychological features, and also describe the ‘gaps’ that 
currently exist in the literature which the body of research in the thesis will investigate. 
3.4.1 Sensory Features 
Peripheral tissue damage results in excitation of central neurons [133].  The resulting 
hyperexcitability is responsible for amplification of the peripheral nociceptive signal and the 
significant neuronal plasticity within the brain and spinal cord [133].  There are a number of 
small studies that have investigated the influence of education [334], manual therapy 
[335,336] and acupuncture [337] on sensory measures.  They have demonstrated slight 
improvements in measures of central hyperexcitability (mainly increased pressure pain 
thresholds - PPTs), but such improvements  have been  small and below those recognised as a 
minimal clinical detectable change [338].  It is unclear if the lack of effectiveness is due to 
small sample sizes of the studies, ineffective treatment doses, heterogeneity of participants or 
the inability of the intervention to successfully modulate the central hyperexcitability.   
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Two studies have attempted to investigate the relationship between peripheral 
nociception and central sensitization in individuals with chronic WAD [32,339].  In one 
study, anaesthetic was injected into painful and tender points in muscles of the cervical spine.  
Neither the intensity of neck pain nor sensory hypersensitivity to electrical stimulation or heat 
pain tolerance (at local or remote bodily regions) was attenuated by anaesthetic injection into 
the painful areas.  However, when examining each individual’s responses, it was apparent that 
some patients did have a decrease in their neck pain intensity, whilst in others their pain 
increased [32].  A subsequent study investigated individual responses to anaesthetic injections 
into painful and tender neck muscles [339].  Statistically significant negative correlations 
were found between change in pain score and changes in PPT measurements performed at 
two different sites in the neck (‘most painful’ site and ‘non-painful’ site), but not at the toe 
[339].  Following anaesthetic injection, the ‘most painful’ neck site experienced a decrease in 
PPT and an increase in pain; whilst at the distant ‘non-painful’ neck site, an increased PPT 
and reduced pain was measured.  The authors concluded that different mechanisms underlie 
hyperalgesia localized at areas surrounding the site of pain (i.e. region of secondary 
hyperalgesia) and hyperalgesia generalized to distant body areas (i.e. healthy tissue such as 
the toe in this study).  It was proposed that ongoing nociception likely influenced central 
hyperexcitability and with it, pain perception.  Thus, effective attenuation of peripheral 
nociception could provide a reduction in central hyperexcitability [339].  It was also proposed 
that the tender muscles may have been due to underlying facet-mediated pain, and thus 
injections into these muscles would not have effectively anaesthetized the nociceptive focus 
[32]. 
A recent pilot study in our laboratory utilized intra-articular diagnostic facet joint 
injections and confirmatory MBB in patients with chronic WAD to investigate whether 
central hyperexcitability could be modulated through reducing nociception of the cervical 
facet joints [62].  There were significant increases in PPTs at all sites, and significant 
decreases in cold pain thresholds (CPTs) at the cervical spine post-MBB (with concomitant 
greater than 80% relief in pain as measured by VAS).  The individuals with chronic WAD 
showed evidence of widespread sensory hypersensitivity to mechanical and thermal stimuli 
(when compared to a healthy control group) which decreased following a decrease in 
peripheral nociception via facet joint blocks.  As the effect of MBB is short-term (pain relief 
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for duration of local anaesthetic only); these measures were not expected to be maintained.  
This research did not consider psychological variables or more direct measures of central 
hyperexcitability (such as nociceptive flexion reflex: NFR) and whether these were modulated 
by the changes in pain and sensory measures observed.  
One study has investigated whether various physical measures can be modulated via 
RFN [340].  Significant improvement in cervical range of motion (ROM), cervical muscular 
isometric strength (of the male participants) and PPTs resulted following RFN [340].  
However, several limitations were apparent in this longitudinal study.  RFN was performed on 
a variety of structures in and around the neck (medial branch of dorsal ramus, C2 dorsal root 
ganglia and the suprascapular nerve) based upon patient-reported symptoms, clinical 
examination and imaging findings, without diagnostic procedures such as facet joint 
injections or MBB, thus potentially resulting in inappropriate patient selection for RFN.  
Other treatments received during the RFN intervention period (such as concurrent 
rehabilitation, psychological intervention or medication) may have confounded the results and 
were not documented.  The results of this study do provide some support that nociception has 
a significant effect on certain patient outcomes but they need to be further evaluated and 
replicated in a well-designed study.    
It appears possible that sensory changes in chronic WAD may be able to be modulated 
through effective utilization of RFN when a clear controlled, diagnostic standard is met.  As 
the effect of RFN is prolonged (in comparison to MBB) [283,328], it is possible that 
modulation of sensory changes that characterize chronic WAD may be achieved.  The body of 
research in this thesis proposes to investigate the capacity of cervical RFN to modulate the 
sensory features of individuals with chronic WAD.  
3.4.2 Movement and Motor Control Dysfunction 
 Many studies have documented the presence of ongoing movement dysfunction in 
patients with chronic WAD [38,40,41,64,211,341].  Kasch et al. [183] reported that loss of 
neck ROM resolved within three months of injury in all individuals, irrespective of recovery 
status.  However, if  individuals are classified according to pain and disability levels, it was 
shown  that those with persistent moderate/severe symptoms continue to lack neck ROM at 2-
3 years post injury [51], whilst those who recover or report milder symptoms regain ROM 
within 2-3 months of injury [64].  This indicates the importance of sub-grouping individuals 
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based on pain and disability levels.  Individuals with chronic WAD also demonstrate ongoing 
altered patterns of upper quadrant muscle recruitment.  However, this occurs irrespective of 
pain and disability levels, even being apparent in individuals reporting full recovery [64].  
Individuals with higher levels of pain and disability 2-3 years post MVC had greater deficits 
in motor function [51].  It is unclear whether these clinical features are related to ongoing 
peripheral nociceptive input from cervical structures originally injured such as the facet joints 
[339], although this is possible, given the improvements in ROM and strength that resulted 
following RFN in one study [340].   
Resolution of pain from these underlying nociceptive structures through effective 
response to RFN would allow investigation into the mechanisms surrounding these movement 
deficits and assist with determining appropriate treatment options for those individuals with 
chronic WAD and persistent movement dysfunction.   
3.4.3 Psychological Features 
Effective treatment of chronic neck pain through utilization of RFN has been shown to 
decrease psychological distress (measured with SCL-90-R or General Health Questionnaire-
12), in addition to pain [225,326,342].  Since the time of this study, additional psychological 
factors such as posttraumatic stress symptoms [228] and pain catastrophizing [248] have been 
shown to be common in chronic WAD and the effect of pain modulation via RFN on these 
factors has not been investigated.  Posttraumatic stress symptoms and chronic pain often co-
exist [240-243], with higher levels of posttraumatic stress symptoms also related to pain and 
disability [227,228].  Pain catastrophization also results in greater disability for individuals 
with chronic pain, irrespective of physical impairment [247,248,343,344].  Due to the 
relationship between these psychological factors and pain and disability in WAD, it is 
important to determine if they will improve with effective modulation of pain is, or whether 
other treatment strategies are required.   
3.5 Conclusions 
The cervical facet joint is a common source of chronic neck pain in chronic WAD 
patients.  Through the use of comparative diagnostic facet joint injections, it can be 
determined if the cervical facet joint is a source of nociceptive input.  When appropriate, the 
patient can undergo RFN with the goal of obtaining more long-term pain relief of facet joint 
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mediated pain.  RFN provides a method to further investigate the effect of modulating 
nociception and pain on factors such as central hyperexcitability, motor function and 
psychological factors.  It is vital to know if modulating nociception from the cervical facet 
joint can affect these factors as it could direct new treatment approaches for the difficult 
condition of chronic WAD.  The role of nociception and the effect of its modulation is the 
topic of this thesis.   
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CHAPTER 4 
This chapter presents the initial study of the thesis. It was first necessary to determine 
if the clinical manifestations (physical and psychological features) of individuals with neck 
pain arising predominantly from cervical facet joint nociception differed in any significant 
manner from individuals without facet-mediated neck pain and a healthy cohort of 
individuals.  These features then formed the basis of the clinical manifestations that could 
possibly be modulated through later performed RFN.   
For clarification, the aim of this study was: 
1. To examine a sample of individuals who did and did not respond to facet blocks 
(intra-articular facet joint injection followed by confirmatory medial branch block 
– MBB) as well as healthy controls to determine whether there were differences in 
their physical and psychological features once the effects of the blocks had abated 
and symptoms had returned.  
Publications: 
Study 1: Smith AD, Jull GA, Schneider GM, Frizzell B, Hooper RA, Sterling M.  A 
Comparison of Physical and Psychological Features of Responders and Non-Responders to 
Cervical Facet Blocks in Chronic Whiplash. BMC Musculoskel Disord 2013 Nov 4; 
14(1):313 doi: 10.1186/1471-2474-14-313 
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4.1 Study 1 
A Comparison of Physical and Psychological Features of Responders and Non-
Responders to Cervical Facet Blocks in Chronic Whiplash 
4.1.1 Abstract 
Background:   
Cervical facet block (FB) procedures are often used as a diagnostic precursor to 
radiofrequency neurotomies (RFN) in the management of chronic whiplash associated 
disorders (WAD).  Some individuals will respond to the FB procedures and others will not 
respond, which provides the guidance for suitability for RFN before usual symptoms return.  
Such responders and non-responders provided a sample of convenience to question whether 
there were differences in their physical and psychological features once the effects of the 
blocks had abated and symptoms had returned.  This information may inform future 
predictive studies and ultimately the clinical selection of patients for FB procedures. 
Methods: 
This cross-sectional study involved 58 individuals with chronic WAD who responded 
to cervical FB procedures (WAD_R); 32 who did not respond (WAD_NR) and 30 Healthy 
Controls (HCs).  Measures included: quantitative sensory tests (pressure; thermal pain 
thresholds; brachial plexus provocation test); nociceptive flexion reflex (NFR); motor 
function (cervical range of movement (ROM); activity of the superficial neck flexors during 
the cranio-cervical flexion test (CCFT).  Self-reported measures were gained from the 
following questionnaires: neuropathic pain (s-LANSS); psychological distress (General 
Health Questionnaire-28), posttraumatic stress (PDS) and pain catastrophization (PCS).    
Results: 
Following FB procedures, both WAD groups demonstrated generalized 
hypersensitivity to all sensory tests, decreased neck ROM and increased superficial muscle 
activity with the CCFT compared to controls (p<0.05).  There were no significant differences 
between WAD groups (all p>0.05).  Both WAD groups demonstrated psychological distress 
(GHQ-28; p<0.05), moderate posttraumatic stress symptoms and pain catastrophization. The 
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WAD_NR group also demonstrated increased medication intake and elevated PCS scores 
compared to the WAD_R group (p<0.05).   
Conclusions. 
Chronic WAD responders and non-responders to FB procedures demonstrate a similar 
presentation of sensory disturbance, motor dysfunction and psychological distress.  Higher 
levels of pain catastrophization and greater medication intake were the only factors found to 
differentiate these groups.  
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4.1.2 Introduction 
Whiplash associated disorders (WAD) are defined as the variety of symptoms arising 
from an initial whiplash injury usually as a result of a motor vehicle collision (MVC) [2].  The 
costs associated with WAD are substantial [2,82,83] with the majority of costs incurred by 
those individuals who transition to chronicity [9].  Approximately 50% of those injured report 
pain and disability at 12 months following the initial event [3].   
There is now extensive evidence demonstrating marked physical and psychological 
changes in individuals with chronic WAD.  These include sensory disturbances of widespread 
hypersensitivity [31,32,35] and hyperexcitable spinal cord reflexes [63,154] indicative of 
augmented central nervous system nociceptive processing (central sensitization). In addition, 
motor disturbances such as movement loss and altered muscle recruitment patterns have been 
clearly demonstrated [180,189,200].  Psychological distress (including affective disturbances, 
anxiety, depression and posttraumatic stress disorder symptoms (PTSD)) is also common in 
individuals with chronic WAD [8,67,226].   
From a pathoanatomical perspective, the cervical facet joint is a common source of 
nociception in the neck region in individuals with chronic WAD [26,28,60].  Effective 
treatment of facetogenic nociception has been demonstrated with RFN [61], and may offer 
benefit to individuals who do not respond to conservative treatment following whiplash injury 
[345].  Recent synthesis of the literature and systematic reviews provide moderate levels of 
evidence of facet blocks (FB) as being effective for determination of suitability for RFN 
[331,346,347], thus understanding the differences between those who do and do not respond 
to these procedures is important.   
Limited data is available describing individuals who do and do not respond to these 
procedures.  Cohen et al. [303] demonstrated that responders to cervical RFN had greater 
midline tenderness and Wasan et al. [348] showed that high comorbid pscychopathology was 
associated with less pain reduction following a single MBB.  However these studies have not 
included a wide range of measures reflecting the physical and psychological features 
consistently demonstrated to be present in chronic WAD.  Some of the sensory, motor and 
psychological measures may influence responsiveness to these procedures.  For example, 
central sensitization has been demonstrated to be a predictor of poor prognosis in individuals 
with musculoskeletal pain undergoing conservative treatment [186,349] and individuals 
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undergoing surgery [350]; whilst catastrophization predicts poor response to painful 
procedures [245,351] and increased pain and disability ratings post surgery [352].  The 
presence of posttraumatic stress symptoms has also been demonstrated to result in more 
frequent pain and poorer prognosis in headache patients [240].   
This preliminary study examined a sample of individuals who did and did not respond 
to FB as well as healthy controls to determine whether there were differences in their physical 
and psychological features once the effects of the blocks had abated and symptoms had 
returned. It was hypothesized that those who did not respond would have greater sensory, 
sensori-motor and psychological features than the responders and both groups would be 
different to the healthy controls.  Such information is important to inform future predictive 
studies and ultimately the clinical selection of patients for FB procedures. 
4.1.3 Methods 
4.1.3.1 Design: 
This study was conducted in a tertiary spinal intervention centre in Calgary, Alberta, 
Canada.  A cross-sectional study design was used to compare the clinical manifestations of 
two WAD groups: 1) WAD participants who responded to cervical facet joint double 
blockade and subsequently proceeded to, and were awaiting RFN (WAD_Responders); 2) 
WAD participants who failed to respond to cervical facet joint double blockade (WAD_Non-
Responders); and a 3) healthy control group (HC).  Individuals were admitted into the study at 
a time post-cervical facet joint injections when symptoms had returned and they reported were 
no different from those prior to receiving facet joint injections.  
4.1.3.2 Participants: 
Inclusion Criteria:  
Consecutive participants were recruited from individuals aged 18-65 years with WAD 
Grade II [2] of a duration > 6 months post MVC who underwent scheduled cervical spine 
facet double block procedures (for predominant neck pain) (Intra-articular block - IAB and 
MBB).  Those who responded (>50% relief of ‘neck’ pain) to both of the cervical facet 
double blockade procedures, and who were scheduled to progress to RFN entered as the 
WAD Responder (WAD_R) group.  Individuals who did not respond to the initial cervical 
IAB procedure formed the WAD Non Responder (WAD_NR) group.  Healthy control 
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individuals with no previous history of neck pain, whiplash injury or recent treatment for 
musculoskeletal pain (within previous 2 years) were recruited from advertisements placed 
around the spinal intervention centre.   
Exclusion Criteria:  
Individuals were excluded from the study if they were classifiable as WAD Grade III 
or IV [2], or sustained a concussion or loss of consciousness as a result of the trauma.  They 
were also excluded if their general health status prevented them from undergoing cervical 
facet double blockade procedure or RFN (e.g. central or peripheral neurological dysfunction 
such as stroke; peripheral vascular disease or coronary artery disease; pregnant, psychiatric 
history), or if they were not fluent in spoken or written English.  Healthy controls were also 
excluded on these general health status criteria and all participants were excluded if they had 
sought recent treatment (previous two years) for a musculoskeletal condition or had received 
previous treatment for neck pain prior to the MVC. 
All the participants were unpaid volunteers.  Ethical clearance for this study was 
granted from the medical research ethics committee of the University of Queensland and the 
conjoint health research ethics board at the University of Calgary. All participants provided 
informed consent. 
4.1.3.3 Instrumentation: 
            Individuals underwent laboratory testing, including QST (pressure pain thresholds 
(PPTs), thermal pain thresholds, brachial plexus provocation test (BPPT) and NFR) and 
measures of their motor performance (range of motion (ROM) and CCFT.  A full description 
of these tests is provided in Appendix 1. 
Questionnaires: 
Individuals also completed a series of questionnaires.  Baseline measures included a 
description of symptoms, symptom dominance (unilateral or bilateral) and severity, collision 
parameters, treatments since the collision, compensation status, list of medications and 
demographic variables including gender, age, marital status, employment status, education 
level and duration of neck pain as per a standard clinical examination. 
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The visual analogue scale (VAS) was used to measure neck pain intensity.  The Neck 
Disability Index (NDI) [353], was utilized to measure neck-pain related disability, whilst the  
s-LANSS [354] was used to determine if the pain was predominantly neuropathic in nature.    
The General Health Questionnaire 28 (GHQ-28) [355] was used as a measure of 
general psychological distress, whilst the four subscales were also investigated, those being: 
somatic symptoms, anxiety/insomnia, social dysfunction , and severe depression .  Each item 
has a 4-point rating scale ranging from (0) to (3).  The total scores can be used as a measure of 
psychological distress, with a higher score (>23/24) indicating greater distress.  
The Posttraumatic Diagnostic Scale (PDS) [356] was included to assess number of 
symptoms and symptom severity according to the Diagnostic and Statistical Manual of 
Mental Disorders (fourth edition, text revision; DSM– IV–TR) diagnostic criteria for PTSD.  
For every item, the frequency of the 17 PTSD symptoms is assessed on a 4-point Likert scale, 
ranging from 0 (never) to 3 (daily).  The items referred to a 1-month period prior to the study 
period.  A total symptom severity score (ranging from 0 to 51) is derived with larger scores 
indicating greater symptom severity.  A probably diagnosis of PTSD is made only when a 
specified number of DSM IV criteria are met across symptom clusters.   
Pain catastrophizing was evaluated using the Pain Catastrophizing Scale (PCS) [245].  
Each of the 13 items has a 5-point rating scale ranging from (0) not at all to (4) all the time 
and scores provide a total for the PCS.  A total “cut-off score” of 30 reflects that an individual 
has clinically relevant pain catastrophizing [357]. 
For a full description of these questionnaires, including detailed scoring criteria and 
appropriate clinimetrics, please refer to Appendix 1. 
In both WAD groups, the following measures were completed: VAS, NDI, s-LANSS, 
GHQ-28, PDS and PCS.  In the HC group, only the GHQ-28 questionnaire was completed.   
4.1.4 Procedures 
Patient Screening and Participant Group Allocation: 
The referring physician nominated the spinal level and side of the facet joint block 
based on the individuals’ clinical presentation which the interventional radiologist 
reconfirmed based on clinical findings, including established pain maps [126].  Patients 
underwent a diagnostic IAB.  A 25-gauge spinal needle was advanced under fluoroscopic 
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guidance, into the target facet joint with the individual in the prone position.  A small amount 
of nonionic contrast (0.5 cc of Omnipaque 300® Amerslan Health, Oakville, ON, Canada) 
was used to confirm needle position.  Subsequently, an injection of 0.5cc of local anaesthetic 
(1% Bupivicaine; AstraZeneca, Mississauga, ON, Canada), and 0.5cc of corticosteroid 
(Celestone; Celestone Soluspan®, Schering, Pointe-Claire, Quebec, Canada) was made into 
the target facet joint, until resistance was felt.  If the contrast-medication mixture leaked from 
the joint, this was noted in the procedure report, as diagnostic specificity may be affected. 
During the post-injection follow-up period (a minimum of two hours), participants 
who reported a decrease in ‘neck’ pain intensity of at least 50%, and concurrently reported a 
significant improvement in symptoms (of their ‘main’ and familiar pain) for the duration of 
the anaesthetic were determined to have responded to the IAB.  If pain returned within the 
following days or weeks, they underwent a second diagnostic cervical facet joint block, a 
confirmatory MBB as advocated for the diagnosis of facet joint pain [58,59,316].  The MBBs 
were only performed at a time when the familiar pain returned.  If an individual had 
prolonged relief of pain (generally > 3 months) following the IAB, then confirmatory MBBs 
were not performed.  As these individuals did not receive subsequent MBB, a diagnosis of 
‘facet pain’ could not be confirmed, and these individuals were not included in the study.  The 
MBB involved the placement of a 25-gauge spinal needle, under fluoroscopic guidance, onto 
the medial branch of the dorsal ramus as it courses over the waist of the articular pillar at each 
spinal level.  An injection of nonionic contrast material (0.5 cc of Omnipaque 300® Amerslan 
Health, Oakville, ON, Canada) was made to confirm needle position.  Subsequently, 0.5 cc of 
2% Lidocaine (AstraZeneca, Mississauga, ON, Canada), was injected onto the medial branch 
of the dorsal ramus.  Both medial branches to the target facet joint were anaesthetized in order 
to effectively anaesthetize the joint [316].   
For the purposes of this current study, the patient was assigned to the WAD_R group 
if they had a successful response to the MBB (>50% relief of neck pain) for the duration of 
the anaesthetic and agreed to participate in the study.  If the first IAB block was negative, 
investigations were either terminated or initiated at another segmental level that might 
reasonably have been responsible for the pain.  In this manner, blocks were continued until all 
such possible levels either proved negative or until a positive response was encountered.  This 
practice was recently recommended to assist with diagnostic accuracy and in an attempt to 
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reduce the false negative rate [307].  Thus, these patients underwent procedures directed at 
their familiar pain, such that if their predominant symptom was ‘upper’ neck pain, the upper 
cervical facet joints (C2-4) were injected, whilst if their predominant symptom was ‘lower’ 
neck pain, then the lower cervical facet joints (C4-7) were injected [126].  If an individual had 
‘upper’ and ‘lower’ neck pain, or mid-level neck pain, then all facet joints were injected (C2-
7) to rule out the presence of facet-mediated pain.  A negative response was defined as no 
relief of pain with any procedure. These individuals were subsequently assigned to the 
WAD_NR group.  
Clinically, this diagnostic pathway is used prior to consideration for RFN [62].  There 
is some discussion in the literature regarding the optimum percentage of pain relief an 
individual should experience to fulfill the operational definition of a ‘successful response’ 
[303,358].  To our knowledge, only one study has investigated this response in the cervical 
spine, with no significant difference in outcomes reported in patients with either 50% or 80% 
pain relief after their diagnostic block [303].  While 80% relief of pain is cited as the 
reference standard for research purposes [310], many clinicians feel that 50% relief is 
clinically significant [359].  From a practical perspective, individuals with this response were 
historically noted in our clinic to successfully respond to future RFN.   
Study Measurements: 
Measurements occurred approximately one month following the ‘failed’ IAB (for the 
WAD_NR group participants), or ‘successful’ MBB (for the WAD_R participants).  All 
participants attended the research laboratory at a time point following procedures whereby 
their ‘familiar’ pain had returned to the level reported prior to receiving the procedures.  On 
arrival at the research laboratory, all participants underwent an examination by an experienced 
physiotherapist with postgraduate qualifications to reconfirm their eligibility before inclusion 
in the study.  Participants were given a written description of the study procedures and 
informed consent was gained before proceeding to the questionnaires and testing.  
Familiarization sessions were performed for each measure. Participants practiced all 
movements or instructions until they felt comfortable to proceed. 
After completion of the questionnaires, a standard protocol was used for the order of 
tests [184].  The participants were seated, the Fastrak sensors applied and ROM was 
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measured.  The participants were then positioned supine, EMG electrodes were applied, and 
the CCFT was performed.  For all of the following bilateral tests, the left side was measured 
first.  PPTs were measured in the following order: tibialis anterior, median nerves and C5/6.  
Thermal pain thresholds were then measured over the cervical spine, HPTs followed by 
CPTs; followed by the BPPT.  The NFR was the final testing procedure.  The same examiner 
tested all participants.  No feedback or cues were given to the participants regarding their 
performance on any tests.  
4.1.5 Data Analysis 
Data were analyzed with Stata 9.0 statistical software.  Based on our previous research 
[62], our statistical calculations indicated that this study required 26 participants (with 80% 
power at 5% level of significance) to adequately detect a minimally clinically important 
difference for the following physical measures: change in Tibialis Anterior PPT, change in 
CPT, or change in NFR threshold.   
Assumptions of normality, nonmulticollinearity, and homoscedasticity were tested 
through examination of histograms, box plot graphs, correlation matrices, and a plot of 
predicted to residual values, respectively.  If the data were not normally distributed, 
transformation of the data was applied to interval data.  PPT, NFR, CCFT and BPPT data 
required log transformation.  If normality was not achieved following transformation (CPT, 
HPT), medians and interquartile ranges were generated.  The Wilcoxon matched-pairs signed-
rank test was used initially used to determine within participant side to side differences and 
followed by the exploratory analysis for all the measures and in all groups.  Where no side-to-
side differences existed (CPT, BPPT), the data from each side was compiled and averaged, 
with the mean compiled data used for analysis.  Where ‘side-to-side’ differences existed 
within groups for various measures, the mean measure of each ‘side’ was analyzed between 
groups.  There was a significant side to side difference in the WAD_R group for HPT 
(p=0.007).  There was also a significant difference in PPT measurements between right and 
left cervical spine (p= 0.001) and Tibialis Anterior (p=0.04) Pin the HC group (p= 0.001).  As 
a result, group analyses for these measures were performed for each individual test site 
performed.  
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Chi-squared analysis was utilized to determine if there was a difference in proportions 
of individuals in the WAD groups with respect to compensation status, employment, 
education, marital status, number of bodily symptoms and above threshold scores for GHQ-
28, PCS, PDS and s-LANSS. 
Multivariate analysis of variance (MANOVA) was performed to investigate the effect 
of group (WAD_R, WAD_NR or HC) on the following log-transformed measures: PPT and 
CCFT, and normally distributed ROM.  One way analysis of variance (ANOVA) tests were 
used for log-transformed BPPT and NFR measures.  Where there was a significant group 
difference, post hoc tests of simple effects were performed to determine where these 
differences occurred.  Non-parametric Kruskal-Wallis rank tests were used to determine any 
significant group differences for CPT and HPT measures. Non-parametric tests were used to 
analyze group differences in the following ordinal-scored questionnaires where 
homoscedasticity was present, but normality was not achieved (GHQ-28: Kruskal-Wallis; 
PCS, PDS and s-LANSS: Mann-Whitney).   Differences between groups were analysed using 
a priori contrasts.  Significance level was set at 0.05 with Bonferroni adjustments used (for 
normally distributed data); and the Least Significant Difference (LSD) in ranks was calculated 
if significance was achieved using the Kruskal-Wallis rank test [360]. 
4.1.6 Results 
4.1.7 Participants 
Ninety individuals undergoing IAB injections fulfilled the inclusion criteria and 
agreed to participate (32 males, 58 females, mean age 45.1 +/- 10.6 (SD) years).  Fifty-eight 
individuals responded to the cervical facet double block procedure (IAB and MBB: 18 males, 
40 females, mean age 44.9 +/- 11.1 years) and formed the WAD_R group.  The C5/6 facet 
joint was the most common symptomatic joint either alone or in combination with another 
joint (Table 4.1).   
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Group 
(n) 
C2/3 
(%) 
C3/4  
(%) 
C4/5  
(%) 
C5/6  
(%) 
C6/7  
(%) 
WAD_R 
(58) 
41 47 33 48 28 
WAD_NR 
(32) 
33 34 38 64 42 
Table 4.1: The prevalence of cervical joints injected (n=90) 
Legend: WAD_R = WAD Responders; WAD_NR = WAD Non-Responders 
Thirty-two individuals did not respond to the IAB (14 males, 18 females, mean age 
45.4 +/- 9.7 years) and formed the WAD_NR group.  Thirty healthy individuals (9 males, 21 
females, mean age 44.2 +/- 9.7 years) formed the HC group.  Figure 4.1 demonstrates the 
flow of participants through the study. 
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Figure 4.1: Flow of participants through study 
Legend: WAD_R = WAD Responders; WAD_NR = WAD Non-Responders 
 
The median [range] duration of symptoms post whiplash was 42 [9 – 195] months.  
All participants received initial treatment following the MVC, consisting mainly of 
pharmaceutics (a combination of various medications such as over-the-counter analgesics, 
anti-inflammatories, anti-depressants, opioids and anti-convulsants – Table 4.2) and various 
therapeutic treatments, including physiotherapy, massage therapy, acupuncture, and 
chiropractic.   
Intra-Articular Facet Joint Injection (IAB) 
(n=177) 
Success (≥ 50% relief of pain) 
(n=69) 
Fail (< 50% relief of pain)  
(n= 55) 
 
 
Success (≥ 50% relief of pain) 
(n=58) 
Assessed for Study (Analyzed) 
Non Responder (WAD-NR) 
(n=32) 
 
Assessed for Study (Analyzed) 
Responder (WAD-R) 
(n=58) 
 
Inclusion Criteria Met 
(n=124) 
 
n 
Diagnostic Medial Branch Block (MBB) 
(n=69) 
 
 
Excluded (n=53) 
 Not meeting inclusion criteria 
(n=49) 
 Other reasons (n=4) 
 
 
 
Inclusion (n=4) 
 
 
Declined to participate (n=23) Declined to participate (n=11) 
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Medication WAD_R 
n = 58  
(%) 
WAD_NR 
n = 32  
(%) 
Anti-
Inflammatory 
38 47 
Over-the-
counter 
Analgesics 
29 34 
Anti-
Convulsant 
17 19 
Opioid 16 25 
Muscle 
Relaxant 
9 16 
Anti-
Depressant 
(SNRI) 
7 9 
Anti-
Depressant 
(TCA) 
7 16 
Table 4.2: Medication Use at Intake of Each Participant 
Legend: WAD_R = WAD Responders; WAD_NR = WAD Non-Responders; SNRI = Serotonin-Norepinephrine 
Reuptake Inhibitors; TCA = Tricyclic Antidepressants 
A greater proportion of WAD_NR individuals were taking each class of medication 
(Table 4.2).  Thirty-four participants in the WAD_R group (59%) and 16 in the WAD_NR 
group (50%) were receiving conservative treatment at the time of participation in the study.  
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Group  
(n) 
Gender  
 
(% F/M) 
 
Age 
 
mean yrs  
(+/- SD) 
Duration of 
symptoms 
median mths 
[Range] 
VAS 
 
mean (+/- SD) 
(0-100mm) 
NDI 
 
mean (+/- SD) 
(%) 
s-LANSS 
 
median 
[IQR] 
WAD_R 
(58) 
69% 44.3 
(10.4) 
44 
[9 – 195] 
59 (18) 42 (15) 11 
[8-17] 
WAD_NR  
(32) 
56% 45.4 
(9.7) 
34 
[10 – 190] 
63 (19) 47 (14) 13 
[8-16] 
HC 
(30) 
70% 44.2  
(9.7) 
   
Table 4.3: The demographic characteristics of subject groups 
Legend: WAD_R = WAD Responders; WAD_NR = WAD Non-Responders; HC = Healthy Controls; VAS = 
Visual Analogue Scale; NDI = Neck Disability Index; s-LANSS = self-administered Leeds Assessment of 
Neuropathic Signs and Symptoms; IQR = Interquartile Range  
There were no significant differences in gender or age between the three groups 
(p>0.2) and no differences in pain (VAS and s-LANSS) and disability (NDI) scores between 
the WAD groups (p>0.1: Table 4.3).  Twenty-nine participants in the WAD_R group (50%) 
and 19 participants in the WAD_NR group (59%) were involved in ongoing compensation 
claims but this difference was not significant (2 = 0.73,1 d.f.,p=0.39).  Likewise there were 
no differences between the WAD groups with respect to the presence of other bodily pain 
(number of symptoms), education levels, marriage or employment status (p>0.1). WAD 
groups did not differ to the healthy control group in relation to education levels, marriage and 
employment status (p>0.1).  
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4.1.8 Physical Measures 
Pressure Pain Thresholds (PPTs) 
MANOVA revealed a significant difference between the three groups at all test sites 
(neck, median nerve and tibialis anterior: F12,224=4.71, p<0.001; Table 4.4).  Post-hoc tests 
showed that both whiplash groups demonstrated lower PPTs at all sites compared with the 
healthy control group (F6,112=9.53, p<0.001).  There were no significant differences between 
the whiplash groups (F6,112=0.71, p=0.64).   
Thermal Pain Thresholds (TPTs) 
Kruskal-Wallis Rank tests revealed a significant difference between the mean ranks of 
TPTs per individual (for both cold pain threshold (CPT) and heat pain threshold (HPT) 
measurements) among the three groups (H>18.9, 2 d.f., p<0.001; Table 4.4).  Post hoc testing 
revealed that both whiplash groups demonstrated elevated CPT (LSD>30.2, p<0.05) and 
reduced HPT (LSD>30.7, p<0.05) when compared to the healthy control group.  There were 
no differences between the two whiplash groups for either CPTs (LSD=5.2, p>0.05) or HPTs 
on either side of the neck (LSD<2.3, p>0.05).  
 Brachial Plexus Pain Provocation Test (BPPT) 
ANOVA revealed significant differences between the three groups for elbow 
extension ROM (F2,100=27.72, p<0.001; Table 4.4).  Post-hoc tests showed that the WAD_R 
and WAD_NR groups demonstrated restricted elbow extension ROM when compared to 
healthy controls (p<0.001).  There were no significant differences between the whiplash 
groups (p=0.87).  
Nociceptive Flexion Reflex 
ANOVA revealed significant differences between the three groups for NFR threshold 
(F2,116=5.52, p<0.01; Table 4.4).  Post-hoc tests showed that the whiplash groups required less 
current to elicit the reflex than the healthy control subjects (p<0.05).  There were no 
significant differences between the two whiplash groups (p=1.00). 
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Range of Motion (ROM) 
MANOVA revealed significant differences between the three groups in ROM 
(F8,228=22,88, p<0.001).  Post-hoc tests revealed that the two whiplash groups demonstrated 
significant less ROM compared to the healthy control subjects (F4,114=62.29,p<0.001).  There 
were no statistically significant differences in ROM in any direction between the two 
whiplash groups (F4,114=1.09,p=0.37; Fig. 4.2).  
 
Figure 4.2: Comparison of cervical range of motion (means +/- SE) between groups 
Legend: HC = Healthy Controls; WAD_R = WAD Responders; WAD_NR = WAD Non-Responders; SE = 
Standard Error of the Mean 
 
Cranio-cervical Flexion Test (CCFT) 
MANOVA revealed significant differences between the three groups for EMG activity 
of the superficial neck muscles at all stages of the CCFT (F10,224=3.34, p<0.001).  Post-hoc 
tests revealed significant differences between the whiplash and healthy control groups 
(F5,112=5.98, p<0.001).  No statistically significant differences existed between the two 
whiplash groups (F5,112=1.7, p=0.14; Fig. 4.3).  
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Figure 4.3: Cranio-cervical flexion test performance (means +/- SE) across groups 
Legend: RMS = Root Mean Square; HC = Healthy Controls; WAD_R = WAD Responders; WAD_NR = WAD 
Non-Responder; SE = Standard Error of the Mean 
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4.1.9 Psychological Measures 
The median scores, interquartile ranges and proportion of participants exceeding 
threshold scores for GHQ-28, PCS, and PDS for the three groups are presented in Table 4.5.    
Group  
(n) 
GHQ-28 
% 
≥23 
 
Score 
[IQR] 
PCS 
% 
≥30 
 
Score 
[IQR] 
PDS 
% met criteria 
probable PTSD 
 
                       
Severity Score 
[IQR] 
WAD_R  
(58) 
64% 24 
[19-32] 
16% 15 
[7-23] 
29% 7 
[2-13] 
WAD_NR 
(32) 
66% 28 
[21-41] 
50% 30 
[13-39] 
44% 12 
[5-20] 
HC      
(30) 
7% 14 
[10-16] 
    
Table 4.5: Median [Interquartile Range] scores of each group for psychological measures  
Legend: GHQ = General Health Questionnaire; PCS = Pain Catastrophization Scale; PDS = Post Traumatic 
Stress Diagnostic Scale; PTSD = Post Traumatic Stress Disorder; IQR = Interquartile Range; HC = 
Healthy Controls; WAD_R = WAD Responders; WAD_NR = WAD Non-Responders 
Both whiplash groups demonstrated significantly higher GHQ-28 total scores 
(H=38.2, 2 d.f., p<0.001) compared to healthy controls.  There was also a significant greater 
proportion of whiplash individuals with generalized psychological distress (GHQ-28>23/24, 
p<0.001) - 64% of WAD_R individuals and 66% of WAD_NR individuals scored above 
threshold (>23/24), compared to 7% of controls.  There was no significant difference in 
psychological distress between the two whiplash groups (LSD=8.1, p>0.05).     
There was no difference in the proportion of individuals in the two whiplash groups 
fulfilling the criteria for PTSD (2 = 1.90,1 d.f.,p=0.168) with 29% of WAD_R and 44% of 
WAD_NR group meeting the PDS criteria.  The results also suggest that there is no 
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statistically significant difference between the post traumatic stress severity scores of the two 
whiplash groups (z=1.69, p = 0.09).   
There was a significantly greater proportion ((2 = 12.22,1 d.f., p<0.001) in the 
WAD_NR group (50%) with elevated Pain Catastrophization scores (PCS≥30) [357], 
compared to 16% in the WAD_R group.  Significantly higher PCS scores were also reported 
by the WAD_NR individuals (z=2.7, p=0.006). 
4.1.10 Discussion  
Our hypothesis, that individuals with chronic WAD who did not respond to FB 
procedures (WAD_NR), would have greater sensory, sensori-motor and psychological 
features than responders (WAD_R) was largely rejected; with few between group differences 
demonstrated.  However, the results did reveal that both WAD groups were different to the 
healthy controls (HC).  Possible reasons for these findings are discussed. 
Our participants with WAD presented similar profiles to previous studies and support 
findings that chronic WAD demonstrates a complex clinical presentation including sensory 
hypersensitivity, sensori-motor dysfunction and psychological distress [30,66].  Pain and 
disability levels were comparable to other patients undergoing MBB [26,28,61,328].  Some 
individuals reported an extensive duration of neck pain, and although the literature indicates 
the episodic nature of neck pain over time [79], all individuals reported that their symptoms 
were attributable to an original MVC.  In concert with other studies, our participants reported 
lower pain thresholds to pressure and thermal stimuli [51,145,148] heightened responses 
bilaterally to BPPT [108,155], reduced NFR thresholds [63,154], decreased cervical ROM 
[38,64,361] and impaired control of cranio-cervical flexion [39,64,180].  Our healthy control 
data were likewise similar to that previously reported [180,362,363].  The psychological 
profile of our whiplash participants is also consistent, with high levels of psychological 
distress [8,67], moderate post traumatic stress symptoms [364] and levels of pain 
catastrophizing [247] evident.   
The presence of sensory hypersensitivity likely reflects central nervous system 
hyperexcitability [136,161] indicating that similar nociceptive processes underlie the 
conditions of both groups.  Higher levels of pain and disability have been associated with the 
presence of these sensory features in WAD [35] and 82% of our participants reported 
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moderate to severe levels of pain related disability.  Thus, it could be expected that sensory 
hypersensitivity would be a feature of both groups irrespective of responsiveness to the joint 
block techniques. There were also no differences in measures of motor function between the 
two whiplash groups.  Loss of neck movement and impaired performance on the CCFT are 
also features of other neck pain conditions including non-traumatic idiopathic neck pain and 
cervicogenic headache [38,365]. Whilst there may be some relationship with levels of pain 
and disability [64], the uniform presence of motor dysfunction across neck pain conditions 
suggest that our findings are not unexpected.  
Levels of psychological distress as measured with the GHQ-28 were no different 
between our whiplash groups and are not surprising considering the levels of pain and 
disability reported by the participants.  Whilst not reaching statistical significance, a greater 
proportion of non-responders fulfilled the criteria for a PTSD diagnosis on the PDS 
questionnaire (44% of non-responders versus 29% of responders) and reported higher 
symptom severity levels.  The lack of statistical significance may be a consequence of the 
sample size of the study and this factor requires further investigation, especially given recent 
studies that demonstrate a relationship between PTSD, and pain/disability in WAD 
[219,233,366].  
There was one notable difference between the two whiplash groups.  Higher levels of 
pain catastrophization were demonstrated in the WAD_NR group.  Catastrophization has been 
associated with enhanced pain reports, concurrent disability [247,248] and lower pain 
threshold/tolerance levels, but is not significantly related to nociceptive flexion reflex (NFR) 
threshold in healthy and clinical pain samples [63,367].  Sullivan et al. [245] reported that 
higher levels of catastrophization predicted higher levels of pain following medical 
procedures, such that these individuals may actually be less responsive to invasive 
interventions.  It is possible that the higher levels of catastrophization and tendency towards 
higher psychological distress and post traumatic stress symptoms observed in the WAD_NR 
group may have contributed to the lack of response to the facet joint injection.  The exact 
mechanisms responsible for this lack of responsiveness require further investigation, but may 
even include diminished placebo responses, where individuals may not ‘believe’ in the blocks 
or invasive procedures.  Alternately, the higher PCS scores in our non-responder group may 
be a consequence of the study methodology.  PCS scores were obtained following diagnostic 
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facet joint procedures in both whiplash groups.  It is possible that a lack of response may 
increase levels of catastrophization.   
The WAD_NR group reported greater medication intake than the responder group and 
this was the case for all medication types.  Given that pain and disability levels were no 
different between the groups, it could suggest that higher levels of catastrophization may 
explain the need for increased medication; or alternately, the lack of effectiveness of 
medication in reducing pain and disability may result in higher levels of catastrophization.  
There is some data available to support the initial claim suggesting that catastrophization is 
associated with greater medication intake [352].  However, this requires further investigation.     
The few differences found between the two groups in both physical and psychological 
measures would seem to indicate that similar processes are contributing to the clinical 
presentation, regardless of whether or not facet joint nociception is involved.  It is possible 
that the WAD_NR group may have nociception arising from other structures.  Cadaver and 
biomechanical studies indicate that various cervical spine structures can be potentially injured 
during whiplash trauma mechanisms and structures other than the cervical facet joints may be 
responsible for ongoing nociception [20,23,97].  However, it has also been proposed that 
factors other than peripheral nociception, for example physiological stress responses, can 
induce hyperalgesic responses and these may explain the presence of various symptoms in 
individuals with chronic WAD [65,368,369].  Future studies are currently underway to 
investigate the attenuation of the physical and psychological features of chronic WAD 
following modulation of facet joint nociception, to assist in understanding this relationship 
further.   
Wasan et al. [348] previously demonstrated that psychiatric co-morbidity is associated 
with reduced pain reduction following MBB, however they utilized different scales (Hospital 
Anxiety and Depression Scale); focussing on symptoms of anxiety and depression whereas 
this current study evaluated psychological distress (GHQ) and post traumatic stress symptoms 
(PDS).  It may be that affective/anxiety symptoms have a greater association with response to 
MBB.  Additionally, symptoms may not be as important as actual diagnosis in predicting 
response to MBB.  There was certainly a trend towards an increased proportion of PTSD 
diagnoses in the WAD_NR group that may be of significance in a larger study.  Therefore, 
further investigation of psychological diagnoses, and the role of pain catastrophization and 
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posttraumatic stress symptoms in outcomes following procedural interventions would be 
indicated.    
Consideration must be given to the diagnostic facet joint blockade procedures and 
‘cut-points’ used in our study.  The use of comparative local anaesthetic blocks or placebo 
blocks has been advocated to guard against false positive responses [316].  In this study, two 
diagnostic injection procedures were used, IAB followed by MBB.  This combination of 
diagnostic techniques possesses a similar construct to comparative MBB’s, with individuals 
reporting relief of their predominant pain for the duration of the anaesthetic.  Target 
specificity was ensured with each procedure by the use of radiographic confirmation of 
contrast medium (without note of radiate spread) to ensure needle location [370].  The 
responder patients in this study reported a consistent response to both procedures (50% or 
greater decrease in pain intensity). 
Whilst placebo blocks are preferred for ensuring diagnostic accuracy in the cervical 
region [304], this was not possible at the clinic where our study was conducted. Therefore, 
whilst the approach used in our clinic was stringent, we cannot fully exclude a placebo effect 
in responders or a nocebo effect in non-responders.  A lack of differences between the 
whiplash groups may have also resulted from the criterion standard utilized in our study for 
determining ‘success’ of the intervention.  The clinic used in the study refers individuals for 
RFN if they report ‘greater than 50% relief of pain’ following confirmatory MBB.  This cut-
off may not be sufficiently sensitive to detect differences between the responder and non-
responder groups. Eighty percent pain relief has been suggested for use in research studies 
[310], but our study was required to use 50% to adhere to the protocol required by the clinic 
involved.  However, previous research has shown no difference in clinical outcomes 
following RFN when 50% versus 80% pain relief from FB was used as the criterion standard 
[303]. 
It was also noteworthy that more individuals who failed to respond to the MBB were 
lost to follow-up.  As figure 4.1 demonstrates, 23/55 (42%) people who did not respond to 
IAB were lost to follow-up, compared to only 11/69 (16%) of those who responded.  
Comparison of these individuals was not possible and the effects on the results are not known.    
Another possible limitation of this study was that the measures performed in this study were 
performed by the study author, who was aware of the study hypotheses, however considerable 
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care was made to avoid describing study aims to the participants during the study (and 
expectations of results were unknown given it was a descriptive study); however bias is 
possible when examiners are not blinded.   
This study was a preliminary cross-sectional study to investigate any physical or 
psychological differences in a cohort of individuals with chronic WAD who did and did not 
respond to cervical FB procedures.  The design has limitations, but the results serve to inform 
future predictive studies.  Inclusion of the physical measures (i.e.  sensory and motor 
measures) in future prospective studies, may be necessary for profiling patients, but is 
unlikely to be predictive of response. Our findings do suggest that a wider raft of 
psychological measures be explored, given some differences in these domains.  In addition, 
the inclusion of measures such as locus of control, coping styles and expectations, may 
ultimately assist the clinical selection of patients for FB procedures.  
4.1.11 Conclusion. 
 Individuals with chronic WAD who respond and who do not respond to facet joint 
injections display similar complex clinical manifestations involving sensory disturbances, 
motor dysfunction and psychological distress.  The presence of high levels of pain 
catastrophization and posttraumatic stress symptoms requires further investigation to 
determine their roles in non-responsiveness to FB.   
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CHAPTER 5 
In this chapter, the results of two studies are discussed.  Study one demonstrated that 
individuals with facet-mediated neck pain following a traumatic whiplash injury presented 
with a complex array of physical and psychological manifestations.  In study two, we 
investigated whether the physical manifestations could be effectively modulated by reducing 
nociception through the use of RFN; whilst study three investigated if the psychological 
manifestations could be modulated by the same procedure. 
The primary aims of these studies were: 
1. To determine if the physical features of the clinical manifestations of individuals with 
chronic WAD arising from facet-mediated neck pain could be modulated by reducing 
nociception following RFN; 
2. To determine if the psychological features of the same individuals could be modulated 
by reducing pain following RFN. 
Publications: 
Study 2: Smith AD, Jull GA, Schneider GM, Frizzell B, Hooper RA, Sterling M.  Cervical 
Radiofrequency Neurotomy Reduces Central Hyperexcitability and Improves Neck 
Movement in Individuals with Chronic Whiplash. Pain Med 2014;15(1):128-141. 
Study 3: Smith AD, Jull GA, Schneider GM, Frizzell B, Hooper RA, Dunne-Proctor R, 
Sterling M.  Cervical Radiofrequency Neurotomy Reduces Psychological Features in 
Individuals with Chronic Whiplash. Pain Physician (In Press) 
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5.1 Study 2 
Cervical Radiofrequency Neurotomy Reduces Central Hyperexcitability and Improves 
Neck Movement in Individuals with Chronic Whiplash 
5.1.1 Abstract 
Objective:  
This study aims to determine if cervical medial branch radiofrequency neurotomy 
reduces psychophysical indicators of augmented central pain processing, and improves motor 
function in individuals with chronic whiplash symptoms. 
Design:  
Prospective observational study of consecutive patients with healthy control 
comparison.   
Setting:  
Tertiary spinal intervention centre in Calgary, Alberta, Canada.  
Subjects:  
Fifty-three individuals with chronic whiplash associated disorder symptoms (Grade 2).  
30 healthy controls. 
Methods:  
Measures were made at four time points: two prior to radiofrequency neurotomy and 
1- and 3-months post radiofrequency neurotomy.  Measures included: comprehensive 
quantitative sensory testing (including brachial plexus provocation test); nociceptive flexion 
reflex; and motor function (cervical range of movement; superficial neck flexor activity 
during the cranio-cervical flexion test).  Self-report pain and disability measures were also 
collected.  One-way repeated measures analysis of variance and Friedman’s tests were 
performed to investigate the effect of time on the above measures. Differences between the 
whiplash and healthy control groups were investigated with two-tailed independent samples t-
test or Mann-Whitney tests.    
Results:  
Following cervical radiofrequency neurotomy there were significant early (within 1-
month) and sustained (3-months) improvements in pain, disability, local and widespread 
hyperalgesia to pressure and thermal stimuli; nociceptive flexion reflex threshold, and 
brachial plexus provocation test responses as well as increased neck range of motion (all 
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p<0.0001).  A non-significant trend for reduced muscle activity with the cranio-cervical 
flexion test (p>0.13) was measured. 
Conclusions. 
Attenuation of psychophysical measures of augmented central pain processing and 
improved cervical movement imply that these processes are maintained by peripheral 
nociceptive input.  
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5.1.2 Introduction 
Approximately 50% of individuals who sustain a whiplash injury will continue to 
report ongoing neck pain and disability 12 months later [3].  Chronic whiplash associated 
disorder (WAD) is characterised by sensory disturbances (widespread hypersensitivity) 
[31,32,35] and heightened spinal cord flexion withdrawal responses [63,154], both indicative 
of augmented central nociceptive processing [56].  Changes in motor function are also evident 
with reduced neck range of movement and altered muscle recruitment patterns [38,180].  
The processes underlying and contributing to these features are not clear.  Whilst it is 
generally accepted that sensory features result from augmented central nociceptive processing 
(central hyperexcitability) [136,276], there is much debate as to whether these are driven by 
an ongoing peripheral nociceptive source [53-55] or are self-maintaining due to neuroplastic 
changes in the central nervous system [56].  Previous studies of patients with painful hip or 
knee osteoarthritis demonstrated improvement in sensory measures following successful 
arthroplastic surgery, indicating that central pain processes are being maintained by peripheral 
nociceptive input [275,371].   
Similarly, persistence of motor changes following whiplash injury, such as 
morphometric muscular changes, local muscular weakness and loss of range of movement, 
suggests the presence of ongoing peripheral mechanisms [43,169,341,372,373].  However, 
these changes cannot be separated from changes in central nervous system control; with 
neuromotor performance in individuals with neck pain associated with reorganization of 
control strategies [176,177,179].  
Whilst tissue damage usually cannot be detected in the patient with WAD with current 
imaging techniques, evidence to date suggests that a peripheral lesion of some kind is likely to 
be present [87,274].  Most available evidence would support the cervical facet joint as one 
source of nociception in individuals with chronic WAD [26,28,60].  Animal studies have 
demonstrated that cervical facet joint injury may be responsible for hypersensitivity and 
increased neuronal excitability [281,296,297,374].  Injury to the facet joint has also been 
implicated in local muscle responses in a cat model [214].  Modulating nociception from facet 
joints is possible via medial branch blocks (MBB) or radiofrequency neurotomy (RFN).  
There are suggestions that MBB or RFN may attenuate sensory hypersensitivity [62,340,375]; 
although the evidence is weak, with studies involving limited subjects, measures or 
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procedures; or only investigating immediate post-procedure effects.  Thus the role of the 
cervical facet joint in regard to sensory and motor changes in chronic WAD requires further 
investigation, with a wider range of measures of central hyperexcitability, and inclusion of 
measures of motor function.       
The aim of this study was to investigate changes in measures of central 
hyperexcitability following RFN of cervical spine facet joints in individuals with chronic 
WAD.  We also investigated changes in motor function following the same procedure.  The 
null hypothesis proposed that reducing nociception via RFN would not result in changes in 
psychophysical indicators of central hyperexcitability or changes in motor function. 
5.1.3 Methods 
5.1.3.1 Design: 
A prospective cohort study design was employed at a tertiary spinal intervention 
centre in Calgary, Alberta, Canada.  Participants included individuals with chronic WAD who 
underwent RFN, following a successful response to cervical facet joint double blockade.  A 
healthy control (HC) cohort was also investigated to provide comparative data.  Individuals 
with WAD attended the research laboratory at four time points: one month following cervical 
facet joint injections (double blockade procedure), immediately prior to receiving RFN, one 
month following RFN, and three months following RFN.  HC individuals attended one 
session of laboratory testing.    
5.1.3.2 Participants: 
Inclusion Criteria:   
Consecutive participants were recruited from individuals aged 18-65 years with WAD 
Grade II [2] of a duration greater than 6 months post motor vehicle collision (MVC) following 
successful response (greater than 50% of neck pain relief) to cervical facet joint blockade 
(intra-articular block followed by confirmatory MBB) [376], who subsequently underwent 
RFN.   
HC individuals with no previous history of neck pain, whiplash injury or recent 
treatment for musculoskeletal pain (within previous 2 years) were recruited from 
advertisements placed around the spinal intervention centre.  
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Exclusion Criteria:  
Individuals were excluded from the study if they were classifiable as WAD Grade III 
(neurological deficit) or IV (fracture or dislocation) [2]; sustained a concussion or loss of 
consciousness as a result of the trauma; or if they were not fluent in spoken or written 
English.    
All the participants were unpaid volunteers.  Ethical clearance for this study was 
granted from the institutional medical research ethics committees (University of Calgary and 
University of Queensland) in 2009.  All participants provided informed consent. 
5.1.3.3 Instrumentation: 
            Individuals underwent laboratory testing, including quantitative sensory testing 
(pressure pain thresholds (PPTs), thermal pain thresholds (TPTs), brachial plexus provocation 
test (BPPT) and nociceptive flexion reflex (NFR)) and measures of their motor performance 
(range of motion (ROM) and cranio-cervical flexion test (CCFT)).  A full description of these 
tests is provided in Appendix 1. 
Questionnaires: 
Individuals also completed a series of questionnaires.  Baseline measures included a 
description of symptoms, symptom dominance (unilateral or bilateral) and severity, collision 
parameters, treatments since the collision, compensation status, list of medications and 
demographic variables including gender, age, marital status, employment status, education 
level and duration of neck pain as per a standard clinical examination. 
The visual analogue scale (VAS) was used to measure neck pain intensity.  The Neck 
Disability Index (NDI) [353], was utilized to measure neck-pain related disability.  For a 
fuller description of these questionnaires, including detailed scoring criteria and appropriate 
clinimetrics, please refer to Appendix 1. 
5.1.3.4 Procedure: 
Participants were assessed on all outcome measures at the following time points: (t1) 
at a time period when their familiar baseline neck pain was present (when symptoms returned 
following successful cervical facet joint double blockade) [62]; (t2): immediately prior to 
receiving RFN; t(3)one month following RFN and t(4): 3 months following RFN .  
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Attendance at two time points prior to receiving RFN allowed us to determine if time alone 
(t(1) vs. t(2)) resulted in improvements in measures, prior to RFN being performed.   
Participants first completed all questionnaires, after which a standard protocol was 
used for the order of tests [184].  The participants were seated, the Fastrak sensors applied and 
ROM was measured.  They were instructed to assume a comfortable position looking straight 
ahead, then to perform each movement three times, moving at a comfortable speed as far as 
possible and to return to the start position between each repetition.  The order of movements 
assessed were flexion, extension, left rotation and right rotation.  The participants were then 
positioned supine, EMG electrodes were applied, and the CCFT was performed. For all of the 
following bilateral tests, the left side was measured first.  PPTs were measured in the 
following order: tibialis anterior, median nerves and C5/6.  Thermal pain thresholds were then 
measured over the cervical spine, HPTs followed by CPTs.  These were followed by the 
BPPT.  The NFR was the final testing procedure.  The same examiner tested all participants.  
No feedback or cues were given to the participants regarding their performance on any tests.  
5.1.3.5 RFN Procedure: 
Details of the RFN procedure are provided in Appendix 2. 
5.1.4 Data Analysis 
Data were analyzed with Stata 9.0 statistical software.  Based on our previous research 
[62], utilizing the standard deviation of changes observed (in distal PPT pre/post 
interventional procedure), our statistical calculations indicated that this study required 26 
participants (with 80% power at 5% level of significance) to adequately detect a minimally 
clinically important difference for the primary outcome measures (change in PPT in Tibialis 
Anterior, change in CPT, or change in NFR threshold).  Extra participants were recruited in 
the whiplash group to power a further study.         
Assumptions of normality, non-multicollinearity, and homoscedasticity were tested 
through examination of histograms, box plot graphs, correlation matrices, and a plot of 
predicted to residual values, respectively.  If the data were not normally distributed, 
transformation of the data was applied.  PPT, BPPT, NFR threshold and CCFT data required 
log transformation.  Despite various transformations being attempted, normality for CPT and 
HPT was unable to be achieved (primarily due to floor and ceiling effects).  A paired t-test 
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was used to determine within participant side-to-side differences for all measures and 
followed by the exploratory analysis for all the measures.  As no side-to-side differences were 
found (PPT, CPT, HPT and BPPT), the data from each side were averaged and the mean data 
used for analysis.  
All assumptions for repeated measures ANOVA were satisfied, except for HPT and 
CPT.  One-way repeated measures analysis of variance (ANOVA) was performed to 
investigate the effect of time (four levels: one month following cervical facet blockade; one 
month prior to receiving RFN; one month following RFN, and three months following RFN) 
on the following log-transformed measures: PPT, BPPT, NFR, and CCFT, and normally 
distributed ROM.  Non-parametric Friedman’s repeated measures test was used to analyze the 
effects of time on CPT and HPT.  The baseline data for each dependent measure was entered 
into each ANOVA (but not Friedman’s) analysis as a covariate.  As this did not alter the 
significance of any of the results, further mention of baseline adjustment will not be made.   
For ease of interpretation, results are presented using non-transformed data for 
medians and interquartile ranges, with probability estimates taken from analyses using 
transformed data.  Where there was a significant difference over time, post hoc tests of simple 
effects were performed to determine where these differences occurred.  Significance level was 
set at 0.05 with Bonferroni adjustments used where appropriate.  When the Friedman test was 
significant, multiple Wilcoxon Signed Rank tests were performed with Bonferroni adjustment 
(p < 0.008) utilized to determine where those differences occurred.  Differences between the 
whiplash and healthy control (HC) groups were investigated with two-tailed independent 
samples t-test or Mann-Whitney tests (for CPT and HPT respectively).  
The data were assessed for effect size using Cohen’s d for normally distributed data, 
and Cliff’s Delta for non-parametric analyzed data [377].  The established convention rates 
were used.  A Cohen’s d effect size of 0 < 0.50 is small, a size of 0.50 to < 0.80 is moderate, 
and > 0.80 is large [378].  The corresponding effect sizes for Cliff’s Delta are: < 0.147 is 
small; between 0.148 and 0.33 is moderate, and > 0.33 is large [379].  Effect size was 
calculated utilizing t(4), being the primary end point of this study; and t(2), the time period 
immediately prior to receiving RFN.  
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5.1.5 Results 
5.1.6 Participants 
Fifty-eight individuals had a successful response to the cervical facet joint double 
blockade (intra-articular block followed by MBB) and agreed to participate in the study.  Four 
individuals subsequently withdrew before undergoing RFN (three individuals declined to 
proceed with RFN, and one individual sustained other traumatic injuries from a skiing 
accident).  Thus, 54 individuals underwent RFN.   
At the one month review period following RFN (t(3)), one individual sustained 
neuritis (this was the only side effect noted for the duration of the study); and thus was unable 
to attend for further analysis.  Thus, 53 individuals (36 female, 17 male; mean age = 44.7 +/- 
10.9 (SD) years) were included in the study.  Three individuals were unable to attend the three 
month review (one pregnancy, two lost to follow up), although all data until that point was 
included in the analysis (Table 5.1).   
The collision vectors reported were: rear-end impacts (51%), frontal impacts (23%), 
side impacts (21%) and combined (6%) vectors.  Twenty-eight participants (53%) were 
involved in ongoing compensation claims; 30 (57%) reported the presence of other 
musculoskeletal symptoms (i.e. headaches (44%), low back pain (34%), thoracic spine pain 
(21%), shoulder/arm pain (21%) and jaw pain (8%)); 27 (51%) were university educated; 41 
(77%) were fully employed throughout the course of the study, and 39 (74%) reported that 
they were married or in a long-term supportive relationship.   
 The median [range] duration of symptoms post whiplash injury was 43 [9 – 195] 
months (Table 5.1).  Following the initial cervical facet double blockade procedure, there was 
a mean (+/-SD) wait of 10.4 (+/-4.5) months until RFN was performed.  All participants 
received treatment following the MVC.  Thirty-one participants (58%) were receiving 
conservative treatment at the time of participation in the study.  Twenty-six participants 
(49%) had previously attended the local health authority multi-disciplinary chronic pain 
centre.  
The most common facet joint involved was C2/3 (41%), followed by C6/7 (28%) and 
C5/6 (24%).  C3/4 (11%) and C4/5 (4%) were less often involved.  Bilateral facet joint 
involvement was present in 31% of individuals, whilst 36% of individuals had involvement of 
both an upper cervical (C2-4) and lower cervical intervertebral segment (C4-7).   
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Following RFN, medication usage decreased as follows: anti-inflammatory medication 
(from 45% of individuals to 36%); simple over-the-counter analgesics (34% to 23%); various 
narcotic medications (26% to 19%); anti-convulsants (19% to 13%); selective serotonin 
reuptake inhibitors (13% to 8%), tri-cyclic antidepressants (13% to 6%), with slight increase 
in usage of selective norepinephrine reuptake inhibitors (8% to 13%).  
Gender 
(F/M) 
Age 
yrs (+/- SD) 
Duration of 
symptoms 
Mths 
median 
[25,75] 
VAS 
(+/- SD) 
(0-100mm) 
NDI 
(+/- SD) 
(%) 
WAD: 
36/17 
HC: 
21/9 
WAD: 
44.7 (10.9) 
HC: 
44.2 (9.7) 
43 
[30,69] 
t(1): 58 (19)
¥
 
t(2): 55 (19) 
t(3): 25 (20)†* 
t(4): 25 (21)†*¥ 
t(1): 42 (15)
 ¥
 
t(2): 43 (16) 
t(3): 29 (16)†* 
t(4): 27 (16)†*¥ 
 
Table 5.1: Demographics of participants and changes in pain and disability over time in the WAD 
participants 
Legend: WAD =Whiplash and Associated Disorder; HC = Healthy Controls; VAS = Visual Analogue Scale; 
NDI = Neck Disability Index; t(1) = time-point 1 (admission to study following cervical facet joint injection 
double blockade); t(2) = time-point 2 (immediately prior to receiving radiofrequency neurotomy); t(3) = time-
point 3 (one month following radiofrequency neurotomy); t(4) = time-point 4 (three months following 
radiofrequency neurotomy); † p<0.0001 (between t(1) and t(x)); * p<0.0001 (between t(2) and t(x)); ¥ p=1.00 
(between t(1 and 2), or t(3 and 4), or post-RFN) 
5.1.7 Pain and Disability 
Repeated measures ANOVA revealed a significant main effect of time for VAS (Table 
5.1).  Post-hoc tests of simple effects showed that there was no significant difference in pain 
scores before receiving RFN (t(1) and t(2)); with early (t(3): one month following RFN) and 
sustained (t(4): three months after receiving RFN) reductions in pain measured after receiving 
RFN.  There were no significant differences in pain scores in the time periods following RFN.  
Similarly, there was a main effect of time for NDI scores (Table 5.1).  Post-hoc tests mirrored 
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the results for VAS scores, with reduction in self-reported disability measured following 
RFN, with no significant differences in disability measured in the time periods prior to 
receiving RFN or following RFN respectively.  
The effect sizes were large for both pain (Cohen’s d: 1.34 (95%CI: 1.13,1.55)) and 
disability measures (Cohen’s d: 1.00 (95%CI: 0.79,1.21)).  
5.1.8 Pressure Pain Thresholds (PPT) 
Repeated measure ANOVA revealed a significant main effect of time for PPT at all 
sites (Table 5.2).   Post-hoc tests of simple effects for the tibialis anterior and median nerve 
sites demonstrated early and sustained increases in PPTs following RFN; with no difference 
in PPTs observed prior to receiving RFN or following RFN.  Similar results were 
demonstrated in the cervical spine site, with one slight difference, that being no significant 
difference measured between t(2) and t(3) (p=0.27).  The effect sizes were moderate for all 
sites measured (Table 5.2).  
  In comparison to the HC group, the independent samples t-test revealed that PPTs at 
all sites were lower in the whiplash group prior to undergoing RFN compared to controls (81 
d.f., p<0.0001).  Following RFN (t(4)), there was no differences between the WAD group and 
controls at the median nerve and tibialis anterior sites (78 d.f., p>0.18), but PPT at the 
cervical spine remained lower in the WAD group (t78=2.26, p=0.013).     
5.1.9 Nociceptive Flexion Reflex (NFR) 
There was a significant main effect of time for NFR threshold (Table 5.2).  Post-hoc 
tests showed that there was no significant difference in NFR thresholds before receiving RFN.  
However, a significant difference was measured between the time periods prior to RFN, and 
following RFN, with increases in NFR threshold resulting following RFN.  There were no 
significant differences in NFR thresholds between t(2) and t(4), and following RFN.  The 
effect size was small: Cohen’s d = 0.40 (Table 5.2).  
There was no significant difference between the healthy control group and the 
whiplash group at t(4): t78 = 0.67, p=0.51.  This compares to the significant difference in NFR 
threshold that existed prior to RFN being performed at t(2): t81 = 2.97, p=0.004. 
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5.1.10 Brachial Plexus Pain Provocation Test (BPPT) 
There was a significant main effect of time for elbow extension ROM with the BPPT 
(Table 5.2).  Post-hoc analysis revealed that there were no significant differences measured 
prior to RFN being performed.  Increases in elbow extension ROM were measured following 
RFN.  There were no significant differences in elbow extension motion measured following 
RFN.  The effect size was large: Cohen’s d: 1.21 (Table 5.2).  
The WAD group showed less elbow extension ROM compared to controls both prior 
(t81 = -9.2, p<0.0001) to and following RFN (t67 = -2.61, p=0.011; Table 5.2). 
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Time 
(n) 
 
 
t(1) 
(53) 
 
t(2) 
(53) 
 
t(3) 
(53) 
 
t(4) 
(50) 
 
Healthy 
Controls 
Effect 
Size 
Cohen’s d 
(95%CI) 
 
 
 
 
 
 
 
 
 
PPT 
(kPa) 
Median 
[IQR] 
Cervical 
 
186 
[142,228] 
199 
[139,253] 
236 
[178,304] 
293 
[191,352] 
344 
[285,415] 
 
 
0.74 
(0.54,0.94) 
 <----p=1.00----->    
P values <-------------p=0.037------------------>   
  <----------------p<0.005-------------->  
 <---------------------------p<0.001-------------------------->   
   <---p=0.76---->   
Median 
N 
242 
[183,286] 
253 
[179,312] 
307 
[242,379] 
338 
[252,426] 
371 
[297,428] 
 
 <---p=1.00----->    
 <---------------p<0.01---------------->   0.73 
P values  ---p=0.023---->   (0.53,0.93) 
  <--------------p<0.001---------------->   
 <--------------------------p<0.001--------------------------->   
   <----p=1.00--->   
Tib Ant 328 
[282,398] 
350 
[285,436] 
428 
[363,549] 
511 
[360,657] 
563 
[462,728] 
 
 <----p=1.00----->     
 <-----------p<0.005---------------->   0.73 
P values  <---p=0.019--->   (0.53,0.93) 
  <--------------p<0.001------------>   
  <------------------------p<0.001------------------------->   
    --p=0.58-->   
 
 
NFR (mA) 
Median 
[IQR] 
 
12 
[6,18] 
12 
[6,20] 
18 
[10,30] 
16 
[8,38] 
21 
[10,38] 
 
 
0.40 
(0.20,0.60) 
<------p=1.00------>   
<--------------p=0.013-------------->  
 <---p=0.035--->  
 <-------------p=0.056--------------> 
<-----------------------p=0.022---------------------------> 
  <---p=1.00---> 
 
 
BPPT 
(°elb ext ROM) 
Median 
[IQR] 
29 
[18,39] 
31 
[20,37] 
12 
[5,20] 
10 
[3,19] 
3 
[0,9] 
 
 
1.21 
(0.98,1.44) 
<----p=1.00---->   
<--------------p<0.001------------->  
 <--p<0.001-->  
 <--------------p<0.001------------> 
<-------------------------p<0.001------------------------> 
  <--p=1.00-> 
 
Table 5.2: Summary of sensory measures over time in WAD participants vs. healthy controls 
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Legend: WAD = Whiplash and Associated Disorders; kPa = kilopascal; IQR = Interquartile Range; Median N = 
Median Nerve; Tib Ant = Tibialis Anterior; NFR = Nociceptor Flexion Reflex; mA = milliamperes; BPPT = 
Brachial Plexus Provocation Test; °elb ext ROM = degrees of elbow extension Range of Motion; CI = 
Confidence Interval; Bolded P values denote statistical significance 
5.1.11 Cold Pain Thresholds (CPT) 
There was a significant effect of time for CPT (Table 5.3).  Post-hoc analyses revealed 
that significant reductions in cold hyperalgesia (lower CPTs) were measured post-RFN.  
There were no significant differences in CPTs measured before receiving RFN or following 
RFN.  Effect sizes were large: Cliff’s Delta = 0.38.   
Prior to undergoing RFN, the WAD group demonstrated a significantly elevated CPT 
(20.8°C) compared to the HC group (3.5°C, Table 5.3; Mann–Whitney U = -4.89, nWAD = 53, 
nHC = 30, p<0.0001).  At t(4), three months following RFN (in the WAD group), median 
CPTs in the whiplash group were significantly higher than those of controls (p=0.003; Table 
5.3).   
5.1.12 Heat Pain Thresholds (HPT) 
 There was a significant time effect for HPT (Table 5.3).  Post-hoc analysis revealed 
that significant increased HPTs resulted following RFN.  There were no significant 
differences in HPTs measured in the time periods prior to receiving RFN, or following RFN.  
The effect sizes were large: Cliff’s Delta = 0.41 (Table 5.3). 
Prior to undergoing RFN, the WAD group showed lower HPT compare to controls 
(Mann–Whitney U = 4.43, nWAD = 53, nHC = 30, p<0.0001; Table 5.3) but there was no 
difference between the groups following RFN (p=0.17; Table 5.3) being performed. 
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Time 
(n) 
t(1) 
(53) 
t(2) 
(53) 
t(3) 
(53) 
t(4) 
(50) 
Healthy 
Controls 
Effect 
Size 
Cliff’s 
Delta 
CPT 
(°C) 
19.6 
[11.3,25.3] 
20.8 
[11.0,24.7] 
12.6 
[4.9,17.8] 
9.7 
[3.6,17.0] 
3.5 
[0,8.1] 
 
 
0.38 Median <-----p=0.51------>    
[IQR] <--------------p<0.0001--------------->   
  <---p<0.0001--->  
 
 
P values  <--------------p<0.0001------------>  
 <-------------------------p<0.001------------------------->   
   ---p=0.12---->   
HPT 
(°C) 
42.6 
[40.3,45.0] 
43.5 
[41.8,45.9] 
46.7 
[43.7,48.1] 
46.6 
[44.0,48.4] 
47.5 
[46.1,48.6] 
 
Median <------p=0.04------>     
[IQR] <--------------p<0.0001-------------->   0.41 
  <---p<0.0001--->    
P values  <--------------p<0.0001------------>   
 <--------------------------p<0.001-------------------------->   
   <---p=0.48---->   
Table 5.3: Summary of thermal pain thresholds over time in WAD participants vs. healthy controls 
Legend: WAD = Whiplash and Associated Disorders; CPT = Cold Pain Threshold; HPT = Heat Pain Threshold; 
°C = degrees Celsius; IQR = Interquartile Range; Bolded P values denote statistical significance 
5.1.13 Range of Motion (ROM) 
There were significant differences over time for ROM (F3,153=104.4, p<0.0001).  Post-
hoc analysis showed no changes in ROM between t(1) and t(2) (p=1.00); however significant 
improvements in ROM were measured following RFN (both early: t(3) (p<0.0001), and three 
months later: t(4); p<0.0001).  No significant differences in ROM were measured between 
t(3) and t(4) (p=1.00).  A large effect size was present: Cohen’s d: 1.78 (95%CI: 1.52,2.04).  
Both prior to and following RFN, the WAD group showed less ROM compared to the 
HC group (p<0.0001). 
5.1.14 Cranio-cervical Flexion Test (CCFT) 
There was a significant main effect of time for surface EMG at 24mmHg, 26mmHg 
and 28mmHg levels of the CCFT (Table 5.4).  No significant effect of time was found for the 
22mmHg and 30mmHg levels of the CCFT.  Post-hoc tests of simple effects were not 
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significant.  Thus, a general trend for reduced EMG was evident at the 24mmHg, 26mmHg 
and 28mmHg levels of the CCFT.   
Prior to RFN, the WAD group demonstrated increased EMG levels compared to the 
controls at all levels of the CCFT (p<0.05), except for 30mmHg (p=0.053).  Following RFN, 
there was no significant difference between the WAD and HC groups for any level of the 
CCFT (p>0.084). 
 
Time 
 
t(1) t(2) t(3) t(4) ANOVA 
P value 
Healthy 
Controls 
22mmHg 
 
0.08 
[0.03,0.26] 
0.07 
[0.04,0.15] 
0.07 
[0.03,0.16] 
0.06 
[0.02,0.15] 
0.057 0.04 
[0.02,0.08] 
24mmHg 
 
0.13 
[0.05,0.31] 
0.16 
[0.07,0.31] 
0.10 
[0.05,0.21] 
0.12 
[0.04,0.21] 
0.044 0.08 
[0.03,0.19] 
26mmHg 
 
0.16 
[0.07,0.42] 
0.26 
[0.14,0.66] 
0.15 
[0.06,0.39] 
0.18 
[0.05,0.28] 
0.013 0.16 
[0.06,0.23] 
28mmHg 0.30 
[0.15,0.52] 
0.34
 
[0.16,0.72] 
0.29 
[0.12,0.53] 
0.27 
[0.09,0.50] 
0.015 0.21 
[0.10,0.30] 
30mmHg 0.53 
[0.17,0.82] 
0.55 
[0.21,0.86] 
0.37 
[0.16,0.69] 
0.35 
[0.10,0.71] 
0.067 0.29 
[0.10,0.46] 
 
Table 5.4: CCFT RMS values (medians [IQR]) over time for WAD Participants vs. healthy controls 
Legend: mmHg = millimetres mercury; RMS = Root Mean Square; Bolded P values note statistical 
significance 
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5.1.15 Discussion  
The results of this study demonstrated that individuals with chronic WAD who 
underwent successful cervical RFN show significant and sustained reductions in sensory 
hypersensitivity (mechanical and thermal), spinal cord hyperexcitability, improved responses 
to the BPPT and cervical ROM with trends towards improved cervical muscle control.  
Attenuation of widespread sensory hypersensitivity, spinal cord hyperexcitability and 
measures of motor function after RFN suggests that nociception from the cervical facet joint 
contributes to augmented central nociceptive processing and movement dysfunction in 
patients with chronic WAD. 
Post-mortem studies have previously demonstrated that cervical facet joints are injured in 
MVCs [23-25,380], with clinical studies confirming the facet joint as a candidate for ongoing 
nociception  in patients with chronic WAD [26,28].  Biomechanical studies of cadavers and 
human volunteers have demonstrated how these injuries may occur [14-21].  Animal studies have 
shown that facet joint capsule stretch resulting from whiplash loading [294] has the potential 
to initiate physiological and behavioural responses including nociceptive afferent activation 
and after-discharge [278,281,282,294,381,382]; release of inflammatory mediators resulting 
in peripheral sensitization [374]; and alterations in neuronal excitability in the spinal cord 
[297,299,381,383,384].  The results of our study, where hyperalgesic responses were 
effectively modulated following the reduction of facet joint nociception, would support the 
results of these animal studies demonstrating a relationship between the facet joint and 
ongoing hyperalgesic responses in WAD.    
Other studies in humans with chronic musculoskeletal pain have attempted to 
elucidate the relationship between peripheral mechanisms (persistent nociception) and 
augmented central processes.  In studies of painful osteoarthritis, participants demonstrated 
central nervous system hyperexcitability prior to undergoing arthroplasty of the hip or knee 
which was reversed after arthroplastic surgery and subsequent pain relief [275,371], 
implicating the role of ongoing afferent nociception in augmentation of central pain processes.  
The influence of peripheral mechanisms driving central mechanisms was also demonstrated in 
a recent study involving individuals with chronic low back pain [385].  Following successful 
reduction in pain with surgery or facet joint injections; functional MRI scans demonstrated a 
reversal of functional and structural brain abnormalities, which did not occur in those who did 
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not respond to treatment [385].  Thus, it appears that successfully reducing nociception, 
results in changes in central pain processing mechanisms.   
Previous studies have investigated the effects of RFN on sensory measures in patients 
with WAD to some extent.  Consistent with our findings, Prushansky et al. [340] and Chua et 
al. [375], demonstrated that PPTs measured over the cervical spine increased following RFN 
and this may reflect local hypoalgesia related to the anaesthetic procedure to the neck and 
decreased focal sensitization of peripheral structures.  Our finding of decreased heat 
hyperalgesia may also support this proposal, as heat hyperalgesia is thought to reflect 
nociceptor sensitization, and also be an indicator of peripheral sensitization [362,386].  Chua 
et al. [375] found no change in PPTs at remote sites.  In contrast, we found that PPTs at sites 
remote to the neck also increased, indicating that RFN has the capacity to modulate central as 
well as peripheral nociceptive processing.  This discrepancy in study findings could be 
explained by the low sample size (n=9) of Chua’s study [375], in view of large variance in 
distal PPT measurements [62,387].  We previously demonstrated immediate (within hours) 
increases in PPTs at sites away from the site of injury (neck) in patients with chronic WAD 
Given that conservative treatment has not reduced transition to chronicity for the WAD 
population [273] or reduced pain and disability in those with chronic WAD [319]; cervical 
RFN may be an option to assist with reduction of the global burden of WAD.  The current 
study replicated these findings but demonstrated that these effects were sustained to at least 
three months post procedure and exceeded published minimal detectable changes (MDC) 
[338].  The current study findings also differed from those of our previous study.  In the 
former study, PPT measures of the whiplash group remained lower than that of controls post-
MBB, whilst in the current study, measures largely returned to those of the HC group.  This 
may be due to the duration of pain relief in this study (3 months compared to 1-2 hours), or 
possibly due to participant variability in their health characteristics.  
In addition to changes in PPT, we found sustained increases in NFR threshold 
following RFN, indicating reduced excitability of the spinal cord reflexes; reduced 
hyperalgesic response to the BPTT, together with decreased cold and heat hyperalgesia. Cold 
sensitivity has been postulated to occur as a result of sensitized afferent fibres or dorsal horn 
neurons, with possible underlying insular cortex dysfunction [388,389].  Dorsal horn 
sensitization has also been suggested as an underlying mechanism of heat hyperalgesia [275], 
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whilst BPPT reactivity has been interpreted to reflect hyperalgesic motor and sensory 
responses as a consequence of central sensitization [155,390].  Thus, reduction of cold 
hyperalgesia, concomitant improvements in PPT at distal sites of uninjured tissues (tibialis 
anterior and median nerves), especially when combined with reduction of spinal cord 
hyperexcitability (increased NFR threshold) and improvement in BPPT hyperalgesia, would 
suggest that peripheral nociception contributes to these processes.  Most of the sensory 
measures of the WAD group were no longer different from control data following RFN.  The 
exceptions to this were CPT and BBPT responses, which remained more sensitive than the 
healthy controls at the follow-up time points, although the values for these two measures were 
within 95% confidence intervals of published normative data [35,391].   
Individuals with chronic WAD consistently demonstrate the presence of persistent 
motor dysfunction [38,40,41,64,211,341], most noticeable in those with increased levels of 
pain and disability [38,64].  In longitudinal studies, motor dysfunction has remained 
unchanged over time [64,392], with only modest improvements in ROM, pain and disability 
demonstrated following a course of multimodal physiotherapy [186].  The changes measured 
were not significantly different to a self-management group (advice booklet and exercise) 
[186].  In contrast, our study demonstrated a large and significant improvement in ROM 
following RFN with concurrent large reductions in pain and disability.  There was also a trend 
toward improvement in performance of the CCFT, with changes not quite reaching statistical 
significance.  However, following RFN, no significant difference in test performance was 
measured between the HC and WAD groups, indicating that the improvements measured were 
relevant.  Hence, the reduction of nociception resulted in certain CCFT improvements 
occurring.  Given that individuals continued to report ongoing mild levels of pain, further 
improvement could be postulated to occur if further pain reduction was possible.  However, 
these results are also consistent with findings in previous research, where, despite resolution 
of pain and disability in some participants, deficits in performance of the CCFT remained 
[64].  Thus, the remaining motor impairment in this group with chronic neck pain probably 
reflects both local changes in muscle properties as well as changes in central neuromotor 
control [176,177,179,372].   
Individuals in our study continued to present with mild to moderate levels of pain and 
disability (as measured by VAS and NDI), one- to three-months following RFN.  These 
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results are not inconsistent with other studies, when comparing similar time periods post-RFN 
[326,340].  At first glance, these results may not seem as promising as Lord et al. [61], where 
complete relief of pain was reported in the days following the procedure.  In our study, 4 
patients reported complete relief of pain 1-month following RFN and an additional 10 
reported ≤ 1/10 pain.  However, when comparing results at 3-months post-RFN, they are 
similar, with both studies finding that approximately 60% of participants reported relief of 
pain of at least 50% [61].   Pain reported at one and three months may be as a result of 
ongoing nociception from structures other than the facet joints influenced by RFN [27].  
Additionally, ongoing disability found in our study could be related to factors such as 
persistent motor dysfunction (ongoing reduced ROM when compared to the healthy control 
participants and impaired motor control demonstrated via the CCFT) and persistent 
psychological distress [67].    
There are some limitations in this study.  We investigated 54 consecutive individuals 
undergoing RFN after successful response to facet joint double blockade.  Selection of 
patients for, and performance of RFN differed slightly from the stringent guidelines 
established by the International Spine Intervention Society [393,394].  Another limitation of 
the study was that it was not possible to blind the assessor to the status of the patient or the 
aims of the study.  This may have introduced bias, thus indicating some caution with 
interpretation of study findings.   
5.1.16 Conclusions. 
Cervical RFN resulted in increased NFR thresholds, increases in local (mechanical 
and thermal) and remote (mechanical) pain thresholds as well as improvement in cervical 
ROM.  These results indicate that augmented central nociceptive processes and movement 
loss are maintained by peripheral nociception arising from the cervical facet joints.   
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5.2 Study 3 
Cervical Radiofrequency Neurotomy Reduces Psychological Features in Individuals 
with Chronic WAD 
5.2.1 Abstract 
Objectives:   
To determine if reducing pain in the cervical spine (following cervical medial branch 
radiofrequency neurotomy - RFN) significantly reduces psychological features (distress, pain 
catastrophizing and posttraumatic stress symptoms) in individuals with chronic whiplash 
associated disorders (WAD). 
Methods: 
This prospective cohort study investigated 53 individuals with chronic WAD who 
underwent cervical RFN following successful response to cervical facet joint blockade.  
Measures were made at four time points: two prior to RFN, and one- and three-months post-
RFN.  Psychological measures included the General Health Questionnaire (GHQ-28); Pain 
Catastrophizing Scale (PCS) and the Post Traumatic Stress Diagnostic Scale (PDS).  Self-
reported pain (VAS) and disability (NDI) measures were also collected.    
Results: 
Pain, disability, psychological distress and pain catastrophization significantly 
decreased at both one and three months following RFN. There was no significant change in 
posttraumatic stress symptom severity (p = 0.39). 
Conclusions:  
Reducing pain via cervical RFN was associated with significant improvement in 
psychological distress and pain catastrophizing, but not posttraumatic stress symptoms.  
Effective pain relief would seem a crucial element in the management of psychological 
features associated with chronic WAD.   
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5.2.2 Introduction 
Chronic WAD following a motor vehicle collision (MVC) are a significant public 
health problem that incur substantial personal and economic costs [2,82,83].  Psychological 
distress is common in many chronic pain conditions, [67,395,396] and chronic WAD is no 
exception.  Psychological features which may be evident include: anxiety, distress, depression 
and posttraumatic stress disorder (PTSD) [48,216-219].   
Relationships have been demonstrated between pain and psychological distress in 
individuals with WAD.  Initial distress in those who recover will abate in parallel with 
resolving pain and disability [67,221,224].  In contrast, psychological distress remains 
elevated in those with poor recovery and ongoing pain and disability [51,52].  It has been 
demonstrated in patients with chronic WAD that pain relief following successful cervical 
radiofrequency neurotomy (RFN) resolves psychological distress and anxiety [225].  
Relationships have not been examined between pain and a broader spectrum of psychological 
substrates now commonly identified in chronic WAD, such as PTSD and pain 
catastrophizing. 
Chronic pain and PTSD often co-exist [240-243], with increasing recognition of 
potentially shared aetiological pathways of WAD and PTSD [244].  A recent study explored 
directional relationships between PTSD and chronic pain in 323 survivors of accidents (not 
whiplash) [397].  A mutual relationship was found between pain intensity and posttraumatic 
stress symptoms at five days post-injury; but by six months post-injury (chronic stage), PTSD 
symptoms impacted significantly on pain but not vice versa [397].  Further, a recent 
preliminary randomized controlled trial demonstrated that decreasing PTSD symptoms with a 
trauma-focused cognitive behavioral intervention resulted in decreased levels of pain related 
disability; with no changes in pain intensity or sensory pain thresholds demonstrated [234], 
thus providing partial support for the possibility that PTSD symptoms impact pain related 
factors.  One way to further explore these relationships would be to modulate pain and 
evaluate effects on PTSD symptoms.  To our knowledge such an investigation has not yet 
been undertaken.      
Catastrophization refers to an exaggerated negative orientation toward noxious stimuli 
[245].  Catastrophizing is associated with enhanced pain reports, disability [247,248], poor 
prognosis [398], and lower pain threshold/tolerance levels [63] in individuals with WAD.  
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Treatment addressing catastrophization in individuals with WAD has demonstrated reductions 
in catastrophic thinking, however only modest improvements in pain and disability measured 
[250,399].  In contrast, reduced catastrophic thinking was demonstrated following successful 
knee joint arthroplasty, suggesting that catastrophizing is modulated by pain intensity [252].  
We are not aware of studies in chronic WAD investigating the influence of modulating pain 
and its effect on pain catastrophizing. 
Cervical RFN is a neuroablative technique that denatures the sensory nerves of the 
cervical facet joints, resulting in reduction of nociception and related pain [61,328].  We have 
reported on a cohort of individuals with chronic WAD for whom RFN led to significant, and 
clinically relevant reductions in pain, disability, and sensory hypersensitivity and improved 
neck movement [400]. 
The aim of this study was to determine if psychological distress, pain catastrophizing 
and PTSD symptoms were modulated with the reduction in pain following RFN.  We 
hypothesized that following pain reduction with RFN there would be concomitant reductions 
in psychological distress, pain catastrophizing and post-traumatic stress symptoms. 
5.2.3 Materials and Methods 
5.2.3.1 Design: 
A prospective cohort study design was employed at a tertiary spinal intervention 
centre in Calgary, Alberta, Canada.  Participants were assessed and completed questionnaires 
at the following time points: (t1) at a time period when their familiar baseline neck pain was 
present (when symptoms returned following successful cervical facet joint blockade) [376]; 
(t2): immediately prior to receiving RFN [400]; t(3)one month following RFN and t(4): 3 
months following RFN.   
5.2.3.2 Participants: 
Inclusion Criteria:   
Consecutive participants were recruited from: individuals aged 18-65 years; with 
WAD Grade II [2] of a duration greater than six months post motor vehicle collision (MVC); 
who had had a successful response (greater than 50% of neck pain relief) to cervical facet 
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joint blockade (intra-articular block followed by confirmatory MBB) [376]; and who 
subsequently underwent RFN.    
Exclusion Criteria:  
Individuals were excluded from the study if they were classifiable as WAD Grade III 
(neurological deficit) or IV(fracture or dislocation) [2]; sustained a concussion or loss of 
consciousness as a result of the trauma; if they were not fluent in spoken or written English, 
had a major psychiatric history (e.g. psychosis, schizophrenia, bipolar disorder, etc) or 
previously treated for depression/anxiety.    
All the participants were unpaid volunteers.  Ethical clearance for this study was 
granted from the institutional medical research ethics committees.  All participants provided 
informed consent. 
5.2.3.3 Outcome Measures: 
Questionnaires: 
As previously reported [376], a general intake questionnaire was provided to capture 
the details of collision related factors, symptoms and demographics of the participants.  
Measures of pain (visual analogue scale – VAS) and disability (Neck Disability Index – NDI, 
[353]) were also collected as reported [376,400].   
All participants completed the General Health Questionnaire-28 (GHQ-28) [355] as a 
measure of general psychological distress.  The GHQ-28 consists of 4 subscales, measuring 
28 items of emotional distress in medical settings: somatic symptoms (items 1 to 7), 
anxiety/insomnia (items 8 to 14), social dysfunction (items 15 to 21), and severe depression 
(items 22 to 28).  Each item has a 4-point rating scale ranging from (0) to (3).  The total score 
provides a measure of psychological distress, with greater distress indicated by a higher score.  
The GHQ-28 has been used in previous research of WAD [67,221].  
The Posttraumatic Diagnostic Scale (PDS) [356] was used to assess the presence of 
posttraumatic stress symptoms according to the Diagnostic and Statistical Manual of Mental 
Disorders (fourth edition, text revision; DSM– IV–TR [401]) diagnostic criteria for PTSD.  
Participants completed the questionnaire in relation to the MVC which resulted in their WAD 
injury.  Using a Likert four-point scale, participants rated 17 items representing the cardinal 
symptoms of PTSD experienced in the past month.  Finally, participants rated the level of 
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impairment caused by their symptoms across nine areas of life functioning.  A probable 
diagnosis of PTSD is made only when a specified number of DSM IV criteria are met across 
symptom clusters.  The PDS also includes a symptoms severity score which ranges from 0 to 
51, obtained by adding up the individual's responses of the 17 symptom items.  The cut-offs 
for symptom severity rating are 0 no rating, 1–10 mild, 11–20 moderate, 21–35 moderate to 
severe and >36 severe.  The PDS has demonstrated high internal consistency and good 
stability and is a valid instrument for the assessment of PTSD in survivors of various 
traumatic events including MVC [402,403]. 
Pain catastrophizing was evaluated using the Pain Catastrophizing Scale (PCS) [245].  
This 13-item questionnaire describes various thoughts and feelings that individuals experience 
when in pain, and indicates the degree to which each of the items applies to them, when 
reflecting on their past pain experiences.  Each item has a 5-point rating scale ranging from 
(0) not at all to (4) all the time, with addition of these scores providing a total for the PCS.  
The PCS measures 3 distinct components: rumination, magnification, and helplessness [245].  
Research indicates that the PCS is associated with heightened pain severity and has high 
internal consistency [404]. 
5.2.4 Data Analysis 
Stata 9.0 statistical software was used to analyze data.  To detect meaningful 
differences over time, power analyses were conducted to determine the number of participants 
required.  Given the lack of previous research on these specific co-morbidities with utilization 
of these outcome measures, effect sizes were estimated from relevant previous research on 
catastrophization [250] and psychological distress [225].  Moderate-to-large effect sizes were 
estimated.  On the basis of the previous research and in accordance with guidelines set out by 
Cohen [405], power was set at 0.80 and the significance level at 0.05.  Following collation of 
these results, it was determined that a minimum of 17 participants would be required to allow 
enough power to detect meaningful differences over time.   
Assumptions of normality, residual normality and sphericity were tested through 
examination of histograms, box plot graphs, and plots of predicted to residual values 
respectively.  Normality was not demonstrated in the following questionnaire measures – 
GHQ-28, PCS and PDS.   
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For GHQ-28, PCS and PDS results (and their respective sub-components), non-
parametric Friedman repeated measure tests were utilized to analyze differences over time.  
Significance level was set at 0.05.  Where there was a significant group difference 
demonstrated (over time), Mann-Whitney U tests were performed between each and every 
time point (six comparisons) to evaluate where the differences occurred.  Bonferroni 
adjustment was used, such that the significance level was set at 0.008.   
Chi-squared analysis was utilized to determine if there was a difference in proportions 
of individuals over time with ‘above threshold’ scores for GHQ-28 (> 23) [355], PCS (>24) 
[399], and probable diagnosis of PTSD as determined by the PDS questionnaire [406]. 
The data were assessed for effect size using Cohen’s d for normally distributed data, 
and Cliff’s Delta for non-parametric analyzed data [377].  The established convention rates 
were used.  A Cohen’s d effect size of 0 <0.50 is small, a size of 0.50 to <0.80 is moderate, 
and >0.80 is large [378].  The corresponding effect sizes for Cliff’s Delta are: <0.147 is small; 
between 0.148 and 0.33 is moderate, and >0.33 is large [379].  Effect size was calculated 
utilizing t(4), being the primary end point of this study; and t(2), the time period immediately 
prior to receiving RFN. 
5.2.5 Results 
5.2.6 Participants 
Figure 5.1 demonstrates the flow of participants through the study.  This study 
investigated 53 individuals (36 female, 17 male; mean age = 44.7 +/- 10.9 (SD) years) who 
underwent cervical RFN.  Three individuals failed to complete the study (one pregnancy; two 
lost to follow up).  The median [range] duration of symptoms post whiplash was 43 [9 – 195] 
months.  All participants received initial treatment following the MVC [376].  As previously 
reported, pain scores (VAS 0-100: mean +/- SD) were stable between t(1) (58 +/- 19) and t(2) 
(55 +/- 19) prior to the RFN but reduced significantly as measured at the two time points post-
RFN t(3) (25 +/- 20) and t(4) value (25 +/- 21) [400].  Similarly, disability scores (NDI%: 
mean +/- SD) remained stable between t(1) (42 +/- 15) and t(2) (43 +/- 16), with significant 
improvement measured following RFN at t(3) (29 +/- 16) and t(4) (27 +/- 16) [400].    
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Figure 5.1: Flow of participants through the study 
Legend: RFN = radiofrequency neurotomy 
5.2.7 General Health Questionnaire (GHQ-28) 
The median scores, interquartile ranges and proportion of participants exceeding the 
threshold score (≥23) for GHQ-28 are presented in Table 5.5.  The threshold score is 
indicative of presence of generalized psychological distress [355]. 
There was a significant effect of time, both in terms of proportion of individuals over 
the threshold score of 23/24 (2 = 14.8, 3 d.f., p=0.002), and their respective total scores (2 = 
13.5,3 d.f., p=0.0012).  Post-hoc analysis revealed a significant decrease in GHQ-28 total 
scores between t(1) and t(3) (p=0.0025); t(1) and t(4) (p=0.0002); t(2) and t(3) (p<0.0001); 
and t(2) and t(4) (p=0.0001), with no significant differences measured prior to undergoing 
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RFN (p=0.64), or following RFN (p=0.92).  A large effect size was demonstrated (Cliff’s 
Delta: 0.68). 
Immediately prior to undergoing RFN (t(2)), approximately two-thirds (64%) of the 
individuals had a total threshold score >23/24 (presence of generalized psychological 
distress), whilst three months following RFN (t(4)), only one-third (34%) of individuals 
recorded a score above this threshold; with the median group score reducing from 25 to 19 
(below threshold) over the intervening period.  
Time 
Period 
GHQ-28 
% 
≥23 
 
Score 
[IQR] 
PCS 
% 
>24 
 
Score 
[IQR] 
PDS 
% met criteria 
probable 
PTSD 
 
                       
Severity 
Score 
[IQR] 
t(1) 64% 24
 
[19,32] 
19% 15 
[9,22] 
30% 7 
[2,13] 
t(2) 62% 25
 
[17,37] 
23% 17 
[7,23] 
34% 8 
[2,14] 
t(3) 40% 17 
[12,31] 
13% 10 
[4,17] 
26% 5 
[0,14] 
t(4) 34% 19 
[12,26] 
10% 8 
[1,15] 
16% 6 
[2,11] 
Table 5.5: Median [Interquartile Range] scores for psychological measures over time 
Legend: GHQ = General Health Questionnaire; PCS = Pain Catastrophization Scale; PDS = Post Traumatic 
Stress Diagnostic Scale; t(1) = time-point 1 (admission to study following cervical facet joint injection double 
blockade); t(2) = time-point 2 (immediately prior to receiving radiofrequency neurotomy); t(3) = time-point 3 
(one month following radiofrequency neurotomy); t(4) = time-point 4 (three months following radiofrequency 
neurotomy) 
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The median scores for the sub-component categories of the GHQ-28 are presented in 
Table 5.6 (somatic symptoms, anxiety/sleeplessness, social dysfunction and severe 
depression).  In respect to the sub-component scores of the GHQ-28, there was a significant 
effect of time demonstrated in three of the four sub-components. Somatic symptoms (2 = 
11.7,3 d.f., p=0.0029), anxiety/sleeplessness (2 = 7.99,3 d.f., p=0.018) and social dysfunction 
(2 = 14.5,3 d.f., p=0.0007) all demonstrated significant improvement following RFN.  There 
was no significant effect of time for the depression subscale (2 = 3.8,3 d.f., p=0.14).   
 
GHQ-28 
Subscale 
Somatic 
 
Median 
[IQR] 
Anxiety/Sleeplessness 
 
Median 
[IQR] 
Social 
Dysfunction 
Median 
[IQR] 
Severe Depression 
 
Median 
[IQR] 
t(1) 8 
[5,10] 
6 
[4,10] 
8 
[7,10] 
1 
[0,3] 
t(2) 9 
[7,11] 
7 
[4,10] 
8 
[7,12] 
1 
[0,3] 
t(3) 5 
[3,9] 
6 
[2,8] 
7 
[6,11] 
0 
[0,2] 
t(4) 6 
[4,9] 
5 
[3,7] 
7 
[5,9] 
0 
[0,1] 
Table 5.6: Median [Interquartile Range] scores for each sub-component of the GHQ-28 
Legend: GHQ = General Health Questionnaire; t(1) = time-point 1 (admission to study following cervical facet 
joint injection double blockade); t(2) = time-point 2 (immediately prior to receiving radiofrequency neurotomy); 
t(3) = time-point 3 (one month following radiofrequency neurotomy); t(4) = time-point 4 (three months 
following radiofrequency neurotomy) 
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5.2.8 Pain Catastrophization (PCS) 
The median scores, interquartile ranges and proportion of participants exceeding the 
threshold score (>24) for PCS [399], are presented in Table 5.5.   
There was a significant effect of time for PCS scores (2 = 20.9,3 d.f., p<0.0001).  
Post-hoc analysis revealed a significant decrease in PCS scores between t(1) and t(3) 
(p=0.0001); t(1) and t(4) (p<0.0001); t(2) and t(3) (p<0.0005); t(2) and t(4) (p=0.0001); with 
no significant differences measured prior to receiving RFN (p=0.78) or following RFN 
(p=0.012).  The demonstrated effect size was large (Cliff’s Delta: 0.72).   
There was no significant difference in proportion of individuals over the threshold 
score of 24 (2 = 3.65,3 d.f., p=0.30).  Immediately prior to RFN (t(2)), 23% of individuals 
had a total threshold score >24, whilst three months following RFN (t(4)), 10% of individuals 
scored above this schedule; with the median group score reducing from 17 to 8 during this 
time period.   
5.2.9 Posttraumatic Stress (PDS) 
The median scores, interquartile ranges and proportion of participants meeting the 
criteria for a probable diagnosis of PTSD [406], are presented in Table 5.5.  
There was no significant difference demonstrated over time, in regard to proportion of 
individuals with a probable diagnosis of PTSD as measured on the PDS (2 = 4.68,3 d.f., 
p=0.20).  There was also no difference in severity of posttraumatic stress symptoms for the 
group over time (2 = 1.90,3 d.f., p=0.39).  There was no difference over time in regard to the 
number of posttraumatic stress symptoms demonstrated by individuals (2 = 2.24,3 d.f., 
p=0.33).    
At entry into the study (t(1)), 30% of individuals met criteria for a probable diagnosis 
of PTSD based on the scoring criteria of the PDS, which was essentially unchanged (26%) 
one month after receiving RFN.  At three months following RFN, 16% of individuals fulfilled 
the PDS criteria for probable diagnosis of PTSD.  In so far as the severity of symptoms were 
concerned, the group median score of 7 (at entry to the study) and 6 (three months post-RFN) 
equate to a mild level of stress symptoms being present [406].  
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5.2.10 Discussion  
Participants presented with initial moderate to severe levels of pain and disability and 
clinical levels of psychological distress, similar to previous studies of individuals with WAD 
[35,69], and individuals undergoing cervical RFN [61,326,340,342,407].  We have previously 
shown that cervical RFN led to significant, and clinically relevant, early and sustained 
reductions in their pain and disability; together with improved sensory and motor function 
[400].  In parallel, this study demonstrated reductions in psychological distress and pain 
catastrophizing post-RFN.  No significant changes in posttraumatic stress symptoms were 
found post-RFN although there were trends towards reduced severity and number of 
symptoms, as well as a reduced proportion of individuals meeting criteria for a probable 
PTSD diagnosis.  
Our results are consistent with prior studies where reductions in psychological distress 
[225,340], anxiety [225], depression [340] and somatic symptoms [340] were demonstrated 
following RFN for patients with chronic WAD.  In contrast, prospective data from non-
interventional studies indicate that levels of psychological distress remain relatively consistent 
over time, with little evidence of fluctuation or resolution [48,51,52,221,224].  This differs 
from those with a resolving acute condition, who exhibit decreasing levels of distress that 
parallel decreases in pain and disability [67,221,224].  Results of the current study support the 
hypothesis that ongoing distress is associated with higher levels of pain.  Levels of depression 
did not change significantly in the current study and this may reflect the instrument used, 
given that other studies have documented that depressive symptomatology after whiplash 
injuries is common [263], and predictive of poor prognosis [3].  The depression sub-scale of 
the GHQ-28 measures severe depression which was not a characteristic of our group.  Our 
participants scored very low on this sub-scale at baseline, leaving little room for improvement 
and possibly resulting in a floor effect.  Further research is needed using a more sensitive 
measure to evaluate the effects of pain relief with RFN on depression. 
Prior to RFN, 30-34% of our participants had a probable diagnosis of PTSD, based on 
the criteria of the PDS [408].  This is consistent with previous research indicating the 
prevalence of PTSD in chronic WAD to be similar to more major traumatic injuries requiring 
hospital admission [239].  The proportion of patients with a probable PTSD diagnosis 
decreased from 34% to 16% following RFN, although this was not statistically significant. 
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Similarly, a small and non-significant decrease in PTSD symptom levels was found.  This 
may also be due to a floor effect, given that participants reported only mild PTSD symptoms 
at baseline and post-RFN; but also may be a reflection of the sample size of the study; or 
indicate that PTSD symptoms are not as dependent upon pain levels as the other 
psychological substrates measured. In a prospective, longitudinal study following traumatic 
injury, Jenewein et al. [397] showed that in the chronic stage, PTSD symptoms impacted pain, 
but not vice versa.  Our results support these findings as significant reductions in pain 
following RFN were not associated with significant reductions in posttraumatic symptoms.  In 
addition, in chronic WAD, decreasing PTSD symptoms with trauma-focused cognitive 
behavioural therapy resulted in decreased pain related disability but not pain intensity or pain 
thresholds [234].  Thus, our non-significant results for PTSD when pain was targeted, and the 
inconsistent results on pain outcomes in Dunne’s study [234], when PTSD symptoms were 
targeted, indicate that the nature of the relationship between pain and PTSD remains 
unresolved.  Both our study and that of Dunne’s are likely hampered by low sample size and 
future studies with larger samples are required.  Taken together, these results may indicate 
that both pain and PTSD should be targeted in the management of chronic WAD.  Treatment 
of underlying nociception to reduce pain (e.g. RFN), combined with treatment of PTSD (e.g. 
cognitive behavioural therapy) may be an option in the management of chronic WAD with 
identified facet joint involvement.    
There is debate on whether catastrophization is a stable (enduring) [246], or dynamic 
trait, related to particular constructs such as pain [251].  Individuals with chronic WAD 
presenting with pain catastrophizing demonstrate poor physical outcomes [63], concurrent 
disability [247,248] and poor prognosis [398].  When catastrophic thinking has been 
addressed (in work-disabled individuals with sub-acute WAD) through multidisciplinary 
rehabilitation [399]; physical therapy, or multi-faceted psychosocial risk factor-targeted 
interventions [250], reductions in catastrophizing have resulted, however with only modest 
improvements in pain and disability [250,399].  Approximately 20% of our participants 
presented with clinically significant catastrophic thinking.  In contrast to the modest 
improvements in pain in other studies, our study demonstrated concurrent reductions in both 
pain and catastrophizing scores, with large effect sizes.  It is also notable that the scores for 
catastrophizing following RFN (median score = 8) were substantially less than the post-
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treatment scores following physiotherapy (score = 14.0) or a 10-week program of 
physiotherapy combined with a multi-pronged strategy aimed at reducing psycho-social risk 
factors (score = 20.6) [250].  The significant reduction in pain following RFN was associated 
with substantial improvement in pain catastrophizing, similar to findings of a recent study of 
individuals undergoing total knee arthroplasty [252].  In combination, these findings support 
the proposal by Buitenhuis et al. [247], who argue that catastrophization likely results from 
high levels of pain and disability 
Thirty-four percent of individuals continued to report ongoing generalized 
psychological distress (GHQ-28) three months after receiving RFN.  Whilst levels of pain 
related disability decreased significantly, the mean NDI score of the group indicated the 
presence of persistent mild to moderate levels in some individuals.  This may be a reason for 
ongoing levels of distress.  Alternatively the ongoing distress may be related to the ‘other’ 
symptoms reported by over 50% of individuals in this study including headaches, 
shoulder/arm pain, thoracic spine pain and lumbar spine pain [376].  The reverse relationship 
may also exist, whereby ongoing psychological distress leads to persistent pain and disability 
[409].  Additional management addressing psychological distress may be required to further 
decrease pain and disability in this patient group.        
 There are additional limitations of the current study that warrant discussion. Review of 
patients was limited to three-months post-RFN to allow investigation regarding the role of 
reduced pain on symptom presentation.  Thus, the longer term effects of RFN on 
psychological manifestations cannot be established with this study.  While patients completed 
the questionnaires independently, they were administered by the researcher who was aware of 
the aims of the study.  Additionally, in order to minimise patient burden, we did not 
investigate other psychological factors shown to be present in WAD, such as self efficacy [8], 
fear of movement [258,259], coping styles [260,262,410,411], and beliefs and attitudes 
regarding expected recovery [247,267,268].  Investigation of these factors following RFN is 
warranted.    
Individuals in this study were also free to pursue treatment following RFN.  Fifteen 
individuals attended treatment following RFN.  One individual continued to attend the 
regional multidisciplinary chronic pain centre.  Thus, the psychological improvements noted 
in this study cannot categorically be all attributed to RFN.   However, given that these 
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individuals were receiving, and had received lengthy doses of treatment prior to RFN, without 
improvement in any measures documented between t(1) and t(2), we are confident that the 
results demonstrated can be attributed to the effects of cervical RFN.   
In summary, our results support the hypothesis that pain reduction following cervical 
RFN is associated with reductions in psychological distress and pain catastrophizing.  Further 
research on the relationship between pain and post traumatic stress symptoms is warranted. 
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CHAPTER 6 
 In the previous chapter, we demonstrated that the physical and psychological features 
of the clinical manifestations of individuals with chronic WAD could largely be successfully 
modulated following successful RFN of the cervical facet joints.  This chapter reports on the 
results of a study investigating whether these same features ‘recur’ upon resumption of pain, 
after the effects of the RFN abate and the pain returns. 
The main aim for this study was: 
1. To determine if the physical and psychological features of individuals with chronic 
WAD change following the return of pain when the effects of cervical RFN have 
dissipated. 
Publication: 
Smith AD, Jull GA, Schneider GM, Frizzell B, Hooper RA, Sterling M.  Modulation of 
cervical facet joint nociception and pain attenuates physical and psychological features of 
chronic whiplash: a prospective study (Submitted for Publication Aug 15, 2014) 
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6.1 Study 4 
Modulation of cervical facet joint nociception and pain attenuates physical and 
psychological features of chronic whiplash: a prospective study 
6.1.1 Abstract 
Objectives:   
We have previously demonstrated improvements in physical and psychological 
manifestations in individuals with chronic whiplash associated disorder (WAD) following 
cervical radiofrequency neurotomy (RFN).  This study investigated changes in these features 
when the effects of RFN had dissipated and pain returned.     
Methods: 
A prospective cohort study of 53 individuals with chronic WAD who underwent RFN 
and were assessed prior and at one and three months post procedure.  Measures included: 
quantitative sensory tests (pressure; thermal pain thresholds; brachial plexus provocation test 
– BPPT); nociceptive flexor reflex (NFR), and motor function (cervical range of movement - 
ROM; cranio-cervical flexion test - CCFT).  Self-reported disability (NDI), psychological 
distress (GHQ-28), pain catastrophization (PCS) and posttraumatic stress disorder symptoms 
(PDS) were also measured.    
Results: 
Within one month of the return of pain following RFN, levels of disability increased 
(p<0.0001) and were no different to those prior to RFN (p=1.00).  There was also a significant 
reduction in NFR threshold, increased cold hyperalgesia, increased responses to the BPPT, 
and reduced cervical ROM following the return of pain (all p<0.05) and all approached values 
recorded prior to RFN (p>0.22).  There were no significant changes in local and remote 
hyperalgesia to pressure (p>0.054) or CCFT performance (p>0.07), following the return of 
pain.  Psychological distress and pain catastrophization increased significantly following the 
return of pain (p<0.01) and again were no different than measures taken prior to RFN 
(p>0.13).  However, there was no difference in number or severity of post-traumatic stress 
symptoms following the return of pain (p>0.30).   
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Conclusions:  
Physical and psychological features of chronic WAD are dynamically modulated with 
cervical RFN.  These findings indicate that peripheral nociception is involved in the 
manifestations of chronic WAD. 
  
- 132 - 
6.1.2 Introduction  
Many individuals transition to chronic pain and disability following whiplash injury 
from a motor vehicle crash (MVC) [3,51,69].  Chronic whiplash associated disorders (WAD) 
are characterised by psychophysical indictors of augmented central nervous system 
nociceptive processing [63,154], motor and sensori-motor dysfunction [180,189,200] and 
psychological features including posttraumatic stress symptoms, affective disturbances, 
anxiety and depression [8,67,226].  The mechanisms underlying these manifestations remain 
unclear.  
There is much debate about whether or not a ‘patho-anatomical’ lesion is present in 
patients with WAD, as in the majority of cases such a lesion cannot be demonstrated with 
imaging.  However evidence from biomechanical, basic science and clinical research indicates 
that there is likely to be an injury of some kind [87], with most evidence supporting cervical 
facet joint involvement [412].  We recently demonstrated that modulating peripheral 
nociception from the cervical facet joint via radio frequency neurotomy (RFN) attenuated 
measures of central hyperexcitability, improved neck range of movement and decreased 
psychological distress for up to three months [400,413].  These findings suggest that 
peripheral nociception from the cervical facet joints and/or associated pain contributes to the 
physical and psychological presentation of chronic WAD. 
When testing any model and implying the effects of such, the inverse should also 
apply.  Pain relief following RFN is finite [283], with pain returning in the majority of cases 
over a period of 7 to 14 months [283,326,328,407].  The rationale for the return of neck pain 
relates to regeneration of the previously denatured nerve (medial branch of the dorsal ramus) 
[332,414], resulting in the ability to again transmit nociception, and henceforth the perception 
of pain.  If central hyperexcitability, motor deficits and psychological distress of chronic 
WAD are indeed related to ongoing facet joint nociception, deterioration in the physical and 
psychological features would be expected to coincide with the return of pain.  This study 
sought to determine, if there was: a) increased central nervous system hyperexcitability; b) 
reduced motor function, and c) increased psychological manifestations following return of 
pain after successful RFN.  
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6.1.3 Materials and Methods 
6.1.3.1 Design: 
A prospective cohort study design was employed at a tertiary spinal intervention 
centre in Calgary, Alberta, Canada.  Participants included individuals with chronic WAD who 
successfully responded to cervical facet joint double blockade [376], before proceeding to 
RFN [400].     
Participants were assessed on all outcome measures at the following time points: (1) 
when familiar baseline neck pain returned following successful cervical facet joint double 
blockade [376]; (2): immediately prior to receiving RFN; (3): one month following RFN, (4): 
3 months following RFN, and (5) when neck pain returned.  Participants were contacted on a 
monthly basis following the three month review appointment and a structured interview was 
performed.  When the participants determined that their familiar neck pain had returned to the 
same pain intensity as ‘prior to receiving RFN’ (for a minimum period of low-fluctuating pain 
intensity of one week duration), they re-attended the research laboratory to complete the study 
(t5).  We have previously reported the results of time periods 1 to 4 [400,413].  As there were 
no significant differences in measures for the two time periods prior to receiving RFN (i.e. 1 
and 2) or the two time periods following RFN (i.e. 3 and 4), the results for periods one and 
two were averaged, as were the results for time periods three and four.  Thus, this study is 
reporting the results following the return of pain t3 in relation to the following time periods: 
t1: prior to RFN and t2: post-RFN. 
6.1.3.2 Participants: 
Inclusion and Exclusion Criteria:   
These criteria did not differ from studies 2 and 3 and are documented under sections 
5.1.3.2 and 5.2.3.2 on pages 96 and 114 respectively. 
6.1.3.3 Instrumentation: 
            Individuals underwent laboratory testing, including quantitative sensory testing (TPTs, 
PPTs, BPPT and NFR) and measures of their motor performance (range of motion (ROM) 
and CCFT).  A full description of these tests is provided in Appendix 1. 
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Questionnaires: 
Participants completed standard intake examination forms, which collected 
information regarding demographics, MVC collision dynamics, symptom presentation and 
treatment history.  These results have been previously reported [376]. 
Measures of disability (Neck Disability Index – NDI, [353]) were also collected as 
reported [376,400].   
Psychological distress was measured using the total score of the General Health 
Questionnaire-28 (GHQ-28) [355], as has been previously been reported [376,413].    
The Posttraumatic Diagnostic Scale (PDS) [356] assessed the presence of post-
traumatic stress symptoms (in relation to the MVC that resulted in their WAD injury) 
according to the Diagnostic and Statistical Manual of Mental Disorders (fourth edition, text 
revision; DSM– IV–TR) diagnostic criteria for post-traumatic stress disorders (PTSD).  
Participants rated the level of impairment caused by their symptoms across nine areas of life 
functioning.  When a specified number of DSM IV criteria are met, a probable diagnosis of 
PTSD is made.  The symptoms severity score was also calculated.  We have utilized this scale 
before [376,413].   
The total score of the Pain Catastrophizing Scale (PCS) [245] was used to measure 
pain catastrophization, as previously reported [376,413].   
For a fuller description of these questionnaires, including detailed scoring criteria and 
appropriate clinimetrics, please refer to Appendix 1. 
6.1.3.4 Procedure: 
The initial diagnostic work-up (Chapter 4.1.4), RFN procedure (Appendix 2) and 
study procedure (Chapter 5.1.3.4) has been reported [376,400].   
6.1.4 Data Analysis 
Data were analyzed with Stata 9.0 statistical software.  Based on our previous research 
[62], utilizing the standard deviation of changes observed (in distal PPT pre/post 
interventional procedure), our statistical calculations indicated that this study required 26 
participants (with 80% power at 5% level of significance) to adequately detect a minimally 
clinically important difference for the primary outcome measures (change in PPT in Tibialis 
Anterior, change in CPT, or change in NFR threshold).   
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ANOVA assumptions were tested through examination of histograms, box plot 
graphs, correlation matrices, and plots of predicted to residual values, respectively.  PPT, 
BPPT, NFR threshold and CCFT data required log transformation to achieve normality.  The 
data from each side (PPT, CPT, HPT, BPPT) were averaged, with the mean data used for 
analysis.  
All assumptions for repeated measures ANOVA were satisfied, except for GHQ-28, 
PCS and PDS measures.  One-way repeated measures analysis of variance (ANOVA) was 
performed to investigate the main effect of time (three measures: prior to receiving RFN; one 
to three months following RFN, and one month following the return of pain when the effects 
of RFN had ‘worn off’) on the following log-transformed measures: PPT, BPPT, NFR, and 
CCFT, and normally distributed CPT, HPT, ROM, VAS and NDI.  Non-parametric 
Friedman’s repeated measures test was used to analyze the effects of time on GHQ-28, PCS 
and PDS.  Age, gender and the baseline data for each dependent measure was entered into 
each ANOVA (but not Friedman’s) analysis as a covariate.     
For ease of interpretation, results are presented using non-transformed data for 
medians and interquartile ranges, with probability estimates taken from analyses using 
transformed data.  Where there was a significant difference over time, post hoc tests of simple 
effects were performed to determine where these differences occurred.  When the Friedman 
test was significant, multiple Wilcoxon matched-pairs signed-rank tests were performed.  
Significance levels for all tests were set at 0.05 with Bonferroni adjustments used 
where appropriate.   
6.1.5 Results 
6.1.6 Participants 
This study investigated 53 consecutive individuals (36 female, 17 male; mean age = 
44.7 +/- 10.9 (SD) years) who underwent cervical RFN.  The median [range] duration of 
symptoms post whiplash at entry to the study was 43 [9 – 195] months.  Seven individuals 
failed to complete the study (one pregnancy; one with subsequent traumatic injuries and five 
lost to follow up).  Four individuals continued to have ongoing pain relief (of greater than 2 
years following RFN) and did not attend t3 and were excluded from the study.  The median 
time for relief [interquartile range] of pain was 10 [7,15] months.   
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At the final assessment, following the return of pain, the following medication usage 
was reported: anti-inflammatory medication (36%); simple over-the-counter analgesics 
(26%); narcotic medications (29%); anti-convulsants (12%); selective serotonin reuptake 
inhibitors (10%); various tri-cyclic antidepressants (7%), and selective norepinephrine 
reuptake inhibitors (7%).   
6.1.7 Disability 
 Repeated measures ANOVA revealed a significant difference over time for NDI 
scores (F2,144=42.7, p<0.0001; table 6.1).  Post-hoc tests demonstrated an increase in self-
reported disability measured following the return of pain (from t2 to t3; p<0.0001); with no 
differences measured when comparing NDI scores at the return of pain to the time period 
prior to receiving RFN (from t1 to t3; p=1.00). 
Time Period NDI 
(%) 
Mean (SD) 
GHQ-28 
Score 
[IQR] 
PCS 
Score 
[IQR] 
PDS 
% met criteria  
probable PTSD 
 
Severity Score 
[IQR] 
t1 43 
(15) 
25
 
[20,34] 
16 
[7,22] 
34% 9 
[2,12] 
t2 27 
(15) 
19 
[14,24] 
9
 
[3,16] 
16% 6 
[2,12] 
t3 41 
(16) 
24 
[16,32] 
12 
[5,28] 
28% 5 
[2,12] 
Table 6.1: Disability and Psychological Scores over time 
Legend: NDI = Neck Disability Index; GHQ = General Health Questionnaire; PCS = Pain Catastrophization 
Scale; PDS = Post Traumatic Stress Diagnostic Scale; t1 = time-point 1 (prior to receiving radiofrequency 
neurotomy); t2 = (one to three months post-radiofrequency neurotomy); t3 = time-point 3 (within one-month of 
pain returning) 
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6.1.8 Questionnaires 
6.1.8.1 General Health Questionnaire (GHQ-28): 
The median GHQ-28 scores [interquartile ranges] are presented in Table 6.1.  There 
was a significant effect over time for GHQ-28 scores (2 = 23.2,2 d.f., p<0.0001).  GHQ-28 
scores increased following the return of pain (t3) (Z = -3.15, p=0.0017); with no difference 
between t3 and t1 (Z = 1.50, p=0.13).  At t3 (return of pain), the median GHQ-28 score 
increased from 19 (t2) to 24, indicating generalized psychological distress.  
6.1.8.2 Pain Catastrophization (PCS): 
The median scores [interquartile ranges] for PCS, are presented in Table 6.1.  There 
was a significant effect over time for PCS scores (2 = 13.8,2 d.f., p=0.001; Table 6.1).  PCS 
scores were higher at t3 (return of pain) when compared to t2 (following RFN) (Z = -2.60, 
p=0.0094).  Scores at t3 were no different from those at t1 (prior to RFN: p=0.61).   
6.1.8.3 Post Traumatic Stress (PDS): 
The median scores, interquartile ranges and proportion of participants exceeding the 
threshold score for probable diagnosis of Post-Traumatic Stress Disorder [406], are presented 
in Table 6.1.  
There was no difference in the proportion of individuals with a probable diagnosis of 
post traumatic stress disorder (2 = 4.42,2 d.f., p=0.11; Table 6.1); severity of post traumatic 
stress symptoms (2 = 2.39,2 d.f., p=0.30; Table 6.1); or number of post traumatic stress 
symptoms reported by the participants (2 = 0.73,2 d.f., p=0.70) at any time point.   
6.1.9 Physical Measures 
6.1.9.1 Nociceptive Flexion Reflex (NFR): 
There was a significant effect of time for NFR thresholds (F2,143=17.8, p<0.0001).  
NFR threshold (Median, [Interquartile Range]) was decreased at the return of pain (t3: 8 
[4,16]) compared to post-RFN (t2: 19 [13,31]; p<0.0001).  At t3, the NFR threshold was 
lower when compared to t1 (12 [8,16]; p=0.021).  
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6.1.9.2 Thermal Pain Thresholds (TPTs): 
Repeated measures ANOVA revealed a significant difference over time for both CPT 
and HPT (both p<0.0001; Figure 6.1).  Cold pain thresholds decreased between t2 and t3 
(p=0.031).  There was no difference in HPT between t2 and t3 (p=0.11) but an increase in 
HPT between t1 and t2, following RFN (p=0.002).  No differences in any thermal pain 
thresholds were measured between t1 and t3 (p>0.24).  The mean CPT following return of 
pain was 17.9°C, compared to 11.7°C following RFN.  HPT reduced from 46.2°C (post-RFN) 
to 45.2°C (upon return of pain). 
 
Fig. 6.1: Thermal pain thresholds (means and SEM) over time 
Legend: °C = degrees Celsius; HPT = Heat Pain Threshold; CPT = Cold Pain Threshold; SEM = Standard Error 
of the Mean; t(1) = time-point 1 (prior to receiving radiofrequency neurotomy); t(2) = (one to three months post-
radiofrequency neurotomy); t(3) = time-point 3 (within one-month of pain returning) 
6.1.9.3 Pressure Pain Thresholds (PPTs): 
There was a significant difference over time for PPTs at all test sites (all p<0.0001; 
Figure 6.2).  PPTs increased at all sites between t1 and t2 (p≤0.005).  There were no 
differences between t2 and t3 (return of pain: p>0.054), although there was a trend for 
increased PPT over the median nerve (p=0.054) between the t2 and t3 time points. There were 
no differences in PPTs prior to undergoing RFN (t1) and return of pain (t3: p>0.22). 
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Fig. 6.2: Pressure pain thresholds (means and SEM) over time 
Legend: kPa = kilopascals; M.N. = Median Nerve; Cx = Cervical Spine; Tib. Ant. = Tibialis Anterior; SEM = 
Standard Error of the Mean; t(1) = time-point 1 (prior to receiving radiofrequency neurotomy); t(2) = (one to 
three months post-radiofrequency neurotomy); t(3) = time-point 3 (within one-month of pain returning) 
6.1.9.4 Brachial Plexus Provocation Test (BPPT): 
There were significant differences over time for elbow extension ROM with the BPPT 
(F2,135=56.4, p<0.0001).  There was a reduction in elbow ROM (median [interquartile range]) 
between t2 (11 [6,19]) and t3 (28 [30,35]; p<0.0001), but no difference between t1 (30 
[21,38]) and t3 (p=1.00).   
6.1.9.5 Range of Motion (ROM): 
Repeated measures ANOVA revealed a significant effect of time for ROM (F2,144= 
90.8, p<0.0001; Figure 6.3).  Cervical ROM decreased between t2 (post RFN) and t3 (return 
of pain) (p<0.0001).  There was no difference between t1 (prior to RFN) and t3 (p=0.11). 
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Figure 6.3: Total (Flexion, Extension and Rotation) ROM (means and SE) over time 
Legend: °ROM = Degrees of Cervical Range of Motion; RFN = radiofrequency neurotomy; t1 = time-point 1 
(prior to receiving radiofrequency neurotomy); t2 = (one to three months post-radiofrequency neurotomy); t3 = 
time-point 3 (within one-month of pain returning) 
6.1.9.6 Cranio-cervical Flexion Test (CCFT): 
There was a significant main effect of time for EMG at 22mmHg 
(F2,144=3.29;p=0.042), 26mmHg (F2,144=5.86;p=0.0041) and 28mmHg (F2,144=4.84;p=0.01) 
levels of the CCFT but not at 24mmHg and 30mmHg levels of the CCFT (p>0.08).  Post-hoc 
tests of simple effects were not significant at any level (all p>0.07).  Thus, a general trend for 
reduced EMG was evident at the 22mmHg, 26mmHg and 28mmHg levels of the CCFT 
following RFN (t2), with another trend evident for increased EMG following the return of 
pain (Figure 6.4).  
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Figure 6.4: Cranio-Cervical Flexion Test RMS values (medians) over time 
Legend: mmHg = millimetres mercury; RMS = Root Mean Square 
6.1.10 Discussion 
This study demonstrated that the majority of physical and psychological features of 
chronic WAD deteriorate within one month of the return of pain following RFN to the 
cervical facet joints.  The measures returned to levels that were no different to those 
demonstrated prior to RFN being performed.  As we have previously shown that these factors 
improve following pain relief with RFN [400,413]; the deterioration of results with the return 
of pain indicates dynamic modulation of the processes underlying these measures with 
manipulation of cervical facet joint nociception.  To our knowledge, apart from one study that 
demonstrated increased psychological distress [225]; no previous study has investigated 
changes in a wider range of physical and psychological manifestations of chronic WAD after 
the effects of RFN have dissipated and pain has returned.  
Participants reported significant reduction of their neck pain for approximately 10 
months following the cervical RFN.  This is consistent with other cohorts undergoing cervical 
RFN [61,283,326,328,407] and thus we are confident that our sample is representative of 
patients receiving this form of intervention.  The eventual return of pain following RFN is 
generally thought to be as a result of the return of nociception following regeneration of the 
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medial branch of the dorsal ramus [332], and is supported by data demonstrating that 
successful pain reduction occurs with repeat RFN [283].  However, we cannot be completely 
certain that return of pain in individuals in our study reflects the return of nociception, given 
that transduction of nociception is not necessary to result in the perception of pain [36].   
Participants reported similar levels of disability within one month of the return of pain 
to those prior to undergoing RFN.  Reported medication intake increased and was similar to 
pre-RFN levels [376].  Psychophysical measures of central hyperexcitability (cold pain 
thresholds, NFR threshold and responses to the BPPT) deteriorated within one month of the 
return of pain indicating a plasticity of central nociceptive processing based on modulation of 
peripheral nociception.  We previously demonstrated an immediate and sustained 
improvement in CPT, BPPT and NFR threshold, of moderate to large effects following RFN 
[400].  The proposal that the central hyperexcitability arises as a result of ongoing peripheral 
nociception is further supported by, amongst others, the significant deterioration in these 
thresholds observed within one month of ‘return of pain’.  This role of peripheral nociception 
has also been proposed from results of other studies in individuals with persistent WAD 
[32,274,339].   
There was a different temporal relationship for PPT measures compared to the CPTs 
and NFR thresholds.  Whereas the CPTs and NFR showed a significant increase in sensitivity 
following the return of pain, PPTs did not decrease significantly, although there was a trend in 
this direction.  This may suggest that different mechanisms underlie NFR excitability and cold 
hyperalgesia compared to widespread mechanical hyperalgesia [161].  Pressure pain 
thresholds have been shown to be a sensitive measure to detect endogenous pain inhibitory 
mechanisms [415], and as such, changes in PPT may be more reflective of inhibitory 
processes [415].  Spinal cord hyperexcitability measured with the NFR and cold hyperalgesia 
may reflect excitatory processes arising from the increased peripheral nociception [416].  
Thus, these results may indicate that appropriate inhibitory processes have not developed 
within this time period following the return of pain, in comparison to the excitatory measures 
evident.  It is also possible that widespread hypersensitivity to pressure may take longer to 
deteriorate following return of pain, than the one month period that was utilized in our study.  
Findings of a recent study suggested that deficiencies in conditioned pain modulation (CPM) 
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relate more to the duration of pain than the presence of pain itself [417].  It would seem that 
the inclusion of measures of CPM may shed more light on these proposals. 
Thermal hyperalgesia was also evident within one month of the return of pain, 
although HPTs were not significantly different to those during pain relief (although HPT 
findings are generally found to be variable [35,146,168]).  Cold pain thresholds improved 
following RFN and worsened upon return of pain suggesting that peripheral mechanisms 
contribute to the presence of cold hyperalgesia.  There is data indicating that cold 
hyperalgesia may reflect sensitized afferent fibres [388] and/or insular cortex dysfunction 
[389].  In WAD, cold hyperalgesia has also been shown to be  associated with psychological 
factors including posttraumatic stress symptoms [65] and pain catastrophizing [63].  In our 
study, both heat and cold hyperalgesia worsened upon return of pain.  Thus, it may be that the 
increase in thermal hyperalgesia following return of pain is suggestive of deterioration in 
underlying central mechanisms.   
Ongoing restriction in cervical ROM is common in patients with chronic WAD 
[38,64].  We previously demonstrated that ROM improved immediately following cervical 
RFN, indicating that peripheral nociceptive input from the cervical facet joints may contribute 
to this movement loss [400].  The results of this study would support this proposal, as ROM 
significantly decreased again following the return of pain.  An alternative explanation could 
include heightened fear of movement  upon the return of pain, which has previously been 
documented [418].  Future studies may wish to investigate the role of fear in conjunction with 
peripheral nociception to clarify this relationship further.  Cervical motor control as measured 
with the CCFT  did not significantly improve following RFN [400], or worsen after return of 
pain.  There was a trend towards improvement following RFN and upon return of pain, at 
certain levels of this test (22, 26 and 28mmHg).  These results suggest that pain has little 
effect on cervical motor control.  Previous research has also shown that motor control deficits 
remain even after the resolution of pain [64].  Consequently, this led some authors to advocate 
re-training for restoration of effective cervical neuromotor control and perhaps the prevention 
of pain recurrence [175,318], although the benefits of this approach remain unknown.     
The return of pain was also associated with increased psychological distress and pain 
catastrophization.  Return of distress following return of pain has previously been reported 
[225].  In conjunction, these findings indicate that modulation of pain also modulates levels of 
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distress and pain catastrophizing.  However there was no temporal relationship between pain 
and PTSD symptoms.  This may be a result of the study sample size, or that PTSD symptoms 
are not as dependent on pain as other psychological substrates.  Jenewein [397] demonstrated 
that chronic PTSD symptoms impact pain levels, but not vice versa.  Otis et al. [240] 
reviewed models explaining the relationship between chronic pain and PTSD, with many 
models demonstrating that  factors, such as fear, avoidance, anxiety sensitivity, and 
catastrophizing, co-exist for the maintenance of both conditions.  Hence, factors other than, or 
in addition to pain, may be required for PTSD symptoms to be triggered or alleviated.   
The study has limitations.  Due to its clinical context, measurements were performed 
by an unblinded assessor.  However, the study aims were not conveyed to participants until 
after study completion.  The results apply to individuals with a localized peripheral source of 
nociception who undergo RFN after successful comparative blockade and may not be 
applicable to the wider WAD population.  Additionally, individuals returned for laboratory 
evaluation within one month return of pain, and we cannot be sure that this reflects return of 
peripheral nociception or that pain is due to other unknown reasons that developed.     
Nevertheless, we can be fairly confident that peripheral mechanisms contribute to the 
experience of pain and clinical manifestations of patients with chronic WAD.  Our initial 
study demonstrated that after a stable baseline 12 month period, all physical measures (except 
muscle activity with CCFT) improved following reduction of nociception and concurrent 
reduction in pain and disability [400].  In addition, apart from PTSD, psychological 
manifestations demonstrated improvement following RFN [413].  This present study 
demonstrates complementary findings.  Upon return of pain there is a worsening in both 
physical and psychological manifestations, with these measures no longer being any different 
to baseline (prior to RFN).  Thus, in individuals with chronic WAD, consideration should be 
given to investigate peripheral sources of nociception where possible.   
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CHAPTER 7 
The previous studies have demonstrated that individuals with chronic WAD 
presenting with nociception arising from the cervical facet joint(s) have a complex array of 
clinical manifestations that are successfully modulated with RFN (apart from posttraumatic 
stress symptoms) .  We have also demonstrated that the clinical features deteriorate upon the 
dissipation of the effects of the RFN.  However, what is still uncertain is whether any of these 
features predict success of RFN? 
The aim of this final study was as follows: 
1. To determine if clinical features (pain, disability, psychophysical sensory measures 
and psychological measures) predict a successful response (Global Rate of Change 
measure ≥ 4) to cervical RFN. 
Publication: 
Smith AD, Jull GA, Schneider GM, Frizzell B, Hooper RA, Sterling M. Low Pain 
Catastrophization and Disability Predicts Successful Outcome to Radiofrequency 
Neurotomy in Individuals with Chronic Whiplash (Accepted for Publication: Pain Practice. 
Nov 2, 2014)  
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7.1 Study 5 
Low Pain Catastrophization and Disability Predicts Successful Outcome to 
Radiofrequency Neurotomy in Individuals with Chronic Whiplash 
7.1.1 Abstract 
Objectives:   
Physical and psychological symptoms of individuals with chronic whiplash associated 
disorders (WAD) are modulated by successful treatment with cervical radiofrequency 
neurotomy (RFN).  However, not all individuals respond to cervical RFN and it is unknown 
which clinical features predict successful response to cervical RFN.   
Methods: 
This prospective cohort study investigated 53 individuals with chronic WAD (36 
female, 17 male; mean age = 44.7 +/- 10.9 (SD) years) who underwent cervical RFN.  
Predictor variables measured at baseline (Prior to RFN) included self-reported pain (VAS), 
disability (NDI), posttraumatic stress symptoms (PDS), pain catastrophizing (PCS) and 
measures of sensory hypersensitivity (pressure and cold pain thresholds).  The outcome 
measure was perceived Global Rating of Change (where scores ≥ 4 were classified as a 
successful response) 3-months post-cervical RFN.       
Results: 
Univariate logistic regression demonstrated that disability and pain castrophizing were 
associated with successful response of cervical RFN (both p < 0.05).  Multivariable logistic 
regression demonstrated that low levels of pain catastrophizing and disability remained 
significant predictors of a successful response to cervical RFN (both p < 0.05). 
Conclusions:  
Low levels of pain catastrophizing and disability independently predicted a successful 
response to cervical RFN in patients with chronic WAD.    
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7.1.2 Introduction 
Individuals with chronic whiplash associated disorders (WAD) present with complex 
clinical manifestations, characterized by central nervous system hyperexcitability [63,154], 
motor [180] and sensori-motor system dysfunction [189,200], together with psychological 
features including posttraumatic stress symptoms, distress, anxiety and depression [8].   
Various conservative treatments have been trialled for chronic WAD, incorporating 
physical (such as exercise), psychological (e.g. cognitive behavioural therapy) or combined 
approaches.  Unfortunately, conservative treatment has failed to substantially reduce pain and 
disability in patients with chronic WAD [186,187,319].  Cervical radiofrequency neurotomy 
(cRFN) is the only treatment for chronic WAD shown to demonstrate clinically relevant 
reductions in pain in patients with pain arising from the facet joints [61,225,340].  However, 
not all individuals respond to this procedure [27].  One study investigated various features 
(including demographics, radiological, pharmacological and physical examination findings) 
that may influence success of cervical RFN [303].  The only clinical variable associated with 
success was paraspinal tenderness [303].  However in this study, determination for proceeding 
to cervical RFN was based on positive response (at least 50% pain relief) to a single 
diagnostic medial branch block (MBB) for the putative facet joint.  As single blocks have 
been associated with high false positive rates of cervical facet joint pain [58,419,420], there is 
a possibility of low response or failure of cervical RFN when performed using this selection 
criteria [358] and this may have influenced the results.  Thus it is not clear who will or will 
not respond to cervical RFN, but in view of the myriad of physical and psychological factors 
present in patients with chronic WAD, it would be logical to explore their potential to predict 
responsiveness to this procedure.     
It is feasible that some of the physical and psychological manifestations of chronic 
WAD may predict responsiveness to cervical RFN, but this is yet to be investigated [376].  
For example, individuals with features indicative of central sensitization demonstrate poor 
response to surgery [350], whilst the absence of central sensitization predicted an improved 
response to physiotherapy in individuals with carpal tunnel symptoms [349].  The presence of 
both mechanical (reduced pressure pain thresholds) and cold hyperalgesia (elevated cold pain 
thresholds) in individuals with chronic WAD (which is thought to be indicative of the 
presence of central sensitization [362]) has been shown to be associated with poor response to 
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conservative physiotherapy [186].  Pain catastrophizing is associated with enhanced pain 
reports, disability [247,248], poor prognosis [398], lower pain threshold/tolerance levels [63] 
and with poor response to diagnostic facet joint injections [376] in individuals with WAD; 
whilst posttraumatic stress symptoms (present in approximately 20-30% of individuals with 
chronic WAD) also predict poor health outcomes in chronic WAD [228,230,231,421].  High 
levels of pre-procedural pain have also been associated with poor responsiveness to 
neurotomy involving the sacro-iliac joint [422]. 
  The aim of this study was to determine if pain, disability, psychophysical sensory 
measures and psychological features predicted response to cervical RFN in individuals with 
chronic WAD. 
7.1.3 Materials and Methods 
7.1.3.1 Design: 
A prospective cohort study design was employed and conducted at a tertiary spinal 
intervention centre in Calgary, Alberta, Canada.  Participants were assessed at the following 
time points: one month prior to receiving cervical RFN, and 1 and 3 months post-cervical 
RFN.  The primary end point was 3 months.   
7.1.3.2 Participants: 
Inclusion and Exclusion Criteria:   
These criteria did not differ from studies 2 and 3 and are documented under sections 
5.1.3.2 and 5.2.3.2 on pages 96 and 114 respectively. 
7.1.3.3 Instrumentation: 
Pressure Pain Thresholds 
Pressure pain thresholds (PPTs) were measured using a pressure algometer (Somedic 
AB, Farsta, Sweden), bilaterally over two pairs of homologous anatomical sites (putative facet 
joint pillars (as a measure of local hyperalgesia) and upper one third of the muscle belly of 
tibialis anterior (as a measure of remote sensory hypersensitivity)) [376].  Triplicate 
recordings were taken at each site and the mean value for each site used in the analysis.   
Cold Pain Thresholds 
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Cold pain thresholds were measured bilaterally over the cervical spine using the TSA 
II Neurosensory Analyzer (Medoc Advanced Medical Systems; Minneapolis, MN, USA) 
[376].  Three recordings were taken at each site and the mean value for each site used in the 
analyses. 
A full description of these tests is provided in Appendix 1. 
Questionnaires: 
Individuals completed a standard intake questionnaire (as previously reported) which 
provided standard demographic, crash-related information, symptom profile and 
pharmacological intake [376]. 
Following cervical RFN, individuals were asked to rate the “success” of the procedure 
via a 15-point Global Rating of Change (GROC) scale.  The GROC is a 15-point global rating 
scale ranging from -7 (“a very great deal worse”) to 0 (“about the same”) to +7 (“a very great 
deal better”) [423].  Intermittent descriptors of worsening and improving are assigned values 
from -1 to -6 and from +1 to +6, respectively [424,425].  Scores of +4 and +5 are indicative of 
moderate changes in a person’s status and that scores of +6 and +7 indicate large changes in a 
person’s status [423].  Participants who rated their perceived recovery on the GROC as “a 
very great deal better,” “a great deal better,” “a good deal better,” or “moderately better” (i.e. 
a score of +4 or greater) would be considered to have experienced a “successful” outcome. 
Measures of pain (visual analogue scale – VAS) and disability (Neck Disability Index 
– NDI, [353]) were also collected as per Appendix 1.  Pain and disability measures were 
chosen as predictors of poor response to cervical RFN, as they are robust predictors of poor 
prognosis in individuals with WAD [6], together with knowledge that pre-procedural pain has 
previously predicted failure of sacro-iliac joint radiofrequency denervation [422].   
The Posttraumatic Diagnostic Scale (PDS) [356] assessed the severity of post-
traumatic stress symptoms (in relation to the MVC that resulted in their WAD injury).  The 
symptom severity score was calculated by summing the participant’s responses to the 17 
symptom items.  The cut-offs for symptom severity rating are 0 no rating, 1–10 mild, 11–20 
moderate, 21–35 moderate to severe and >36 severe.  This measure was chosen, as a recent 
study suggested subgrouping was recommended based on presence of such features [228].   
The Pain Catastrophizing Scale (PCS) [245] was used to measure pain 
catastrophization [376,413].  Pain catastrophizing (utilizing the PCS [245]) has been 
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associated with a poor response to diagnostic facet joint injections [376].  A total score was 
calculated by summing the responses to the 13 individual items, with a 5-point rating scale 
ranging from (0) not at all to (4) all the time. 
Participants first completed all questionnaires, after which a standard protocol was 
used for the order of tests [184].  The same examiner performed all physical tests.   
  For a full description of these questionnaires, including detailed scoring criteria and 
appropriate clinimetrics, please refer to Appendix 1. 
7.1.3.4 Procedure: 
The initial diagnostic work-up (Chapter 4.1.4), RFN procedure (Appendix 2) and 
study procedure (Chapter 5.1.3.4) has been reported [376,400].   
7.1.4 Data Analysis 
Descriptive statistics were utilised for baseline group (SUCCESS vs. less SUCCESS) 
characteristics (including demographics – age, gender and duration of symptoms) prior to and 
following cervical RFN.  The distribution of categorical variables (gender) in each group was 
compared using Pearson’s 2.  Continuous variables were compared with independent t-tests, 
and Mann-Whitney U test was used for non-parametric data (duration of symptoms, PCS and 
PDS).   
The clinical measures were analyzed for their association with the dependent outcome 
variable (SUCCESS = GROC ≥ 4) at the three-month assessment following cervical RFN via 
univariate and multivariate logistic regression.  In univariate logistic regression, the 
independent variables were pressure pain thresholds (local and remote), cold pain thresholds, 
PCS scores and PDS symptom severity scores.  Univariate analyses were performed to 
determine which predictor variables to include in the multivariable model.  The level of 
significance for inclusion in the multivariable model was p ≤ 0.2.  Variables retained in the 
multivariable model were screened for collinearity by calculating bivariable Spearman 
correlation coefficients.  Variables with a significant relationship (p < 0.05) were not used 
together in the regression model.  For multivariable logistic regression, a stepwise forward 
approach was utilized.  A Receiver Operating Curve (ROC) analysis to determine the 
discriminative ability of the model was performed.  The sensitivity and specificity of this 
  
- 151 - 
model in predicting SUCCESS was also calculated via the ROC analysis.  Assumptions of 
normality, nonmulticollinearity, and homoscedasticity were tested through examination of 
histograms, correlation matrices, and a plot of predicted to residual regression values, 
respectively.  Data were log transformed, where required to ensure normality.  All data were 
analyzed with Stata 9.0 statistical software.   
7.1.5 Results 
7.1.5.1 Participants:  
Fifty-four individuals received cervical RFN.  As previously reported [400] the most 
common facet joint involvement was C2/3 (41%), with C5/6 and C6/7 implicated in 25-30% 
of participants.  Approximately 30% of participants had bilateral injections.  One individual 
sustained neuritis (this was the only side effect noted for the duration of the study), and was 
excluded from the study.  Thus, 53 individuals (36 female, 17 male; mean age = 44.7 +/- 10.9 
(SD) years) formed the study group.  Two individuals attended follow-up 1 month following 
cervical RFN, and then were lost to follow-up.  Both individuals reported that they had not 
perceived any benefit from cervical RFN with no relief of pain reported (GROC = 0).  One 
individual attended at the 3-month period reporting that she was pregnant.  The duration of 
her relief of pain was documented to be 3-months.  All other individuals attended review 
appointments, both at 1- and 3-months post-cervical RFN.  Apart from the 3 individuals lost 
to follow-up (whose 1-month GROC data was carried forward), all data was used from the 3-
month primary end point of the study.   
As has been previously reported, at the time of receiving the initial cervical facet joint 
diagnostic injection, the median [range] duration of symptoms post whiplash injury was 43 [9 
– 195] months [376].  Following the initial diagnostic facet joint blockade, there was a mean 
(+/-SD) wait of 10.4 (+/-4.5) months until cervical RFN was performed [400].  All 
participants reported receiving initial conservative treatment following the MVC consisting of 
any of the following: physiotherapy, chiropractic and/or massage therapy [376].  Thirty-one 
participants were receiving conservative treatment at time of participation in the study.  
Twenty-six participants had previously attended the local health authority multi-disciplinary 
chronic pain centre.   
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Fifty three percent were involved in ongoing compensation claims; other regional 
musculoskeletal symptoms were noted in 57% of individuals (i.e. headaches (44%); low back 
pain (34%), thoracic spine pain (21%), shoulder/arm pain (21%) and jaw (8%)); 51% were 
university educated; 77% had full employment for the duration of the study, and 74% reported 
that they were in a co-habitative relationship.   
Participants Classification at 3 months Post-Cervical RFN 
Forty individuals (75%) reported a successful (GROC ≥ 4) outcome at the 3-month 
period following cervical RFN.  Nine individuals (17%) reported a GROC score of between 0 
to 3 (almost the same, a little bit better or somewhat better); whilst 4 individuals (8%) 
reported a score of 0 (no change), which included the two individuals lost to follow up (whose 
GROC scores were carried forward from the 1-month time period). 
Pre-Cervical RFN Group Differences at Baseline 
There was no significant difference in age or gender distributions, pain (VAS) or 
duration of symptoms between the SUCCESS (GROC ≥ 4) and ‘less SUCCESSFUL’ groups 
at baseline prior to cervical RFN being performed (Table 7.1).  There was also no significant 
difference between groups for compensation status, education levels, employment status, 
marriage status, or utilization of prior treatment status (all p>0.22).  Individuals in the 
SUCCESS group reported less disability (NDI) and pain catastrophizing (PCS) prior to 
receiving cervical RFN.  Table 7.2 demonstrates the changes in outcome measures over time 
for both groups.      
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Group SUCCESS 
(n=40) 
Less SUCCESS 
(n=13) 
P value 
 Mean (+/- SD) or Median [IQR]  
Gender 
(F/M) 
28/12 8/5 0.57
 
Age 
(yrs) 
45.4 (11.1) 42.7 (10.1) 0.45 
Duration of Symptoms 
(mths) 
41 [30,65] 44 [42,178] 0.25 
Pain 
(VAS) 
54 (21) 61 (15) 0.26 
Disability 
(NDI) 
40 (14) 51 (18) 0.03 
Pain Catastrophizing 
(PCS) 
13 [6,22] 19 [17,31] 0.02 
Posttraumatic Stress 
Symptom Severity 
(PDS) 
7 [2,14] 14 [3,14] 0.39 
Cervical PPT 
(kPa) 
203 [153, 250] 157 [118, 264] 0.32 
Tib Ant PPT 
(kPa) 
360 [312,426]  329 [252,520] 0.91 
Cold Pain Threshold 
(°C) 
16.6 (9.2) 19.7 (2.7) 0.30 
Table 7.1: Patient characteristics by group status prior to cervical RFN 
Legend: VAS = Visual Analogue Scale; NDI = Neck Disability Index; PCS = Pain Catastrophizing Scale; PDS 
= Posttraumatic Stress Diagnostic Scale; PPT = Pressure Pain Threshold; kPa = kilopascal; Cx = Cervical Spine; 
Tib Ant = Tibialis Anterior; t2 = one-month prior to RFN; SD = Standard Deviation; IQR = Interquartile Range; 
Bolded = p < 0.05 
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 Pre-cRFN 1 Month Post-cRFN 3 Months Post-cRFN 
Pain (VAS /100mm)    
SUCCESS 54 (21) 19 (16) 19 (19) 
Less Success 61 (15) 45 (21) 44 (18) 
Disability (NDI %)    
SUCCESS 40 (14) 25 (14) 23 (15) 
Less Success 51 (18) 41 (18) 41 (13) 
PCS (/52)    
SUCCESS 13 [6,22] 8 [3,15] 4 [0,11] 
Less Success 19 [17,31] 18 [14,33] 16 [14,33] 
PDS (/51)    
SUCCESS 7 [2,14] 5 [0,12] 4 [2,10] 
Less Success 14 [3,14] 9 [6,18] 6 [2,29] 
PPT – Cx (kPa)    
SUCCESS 203 [153,250] 258 [198,319] 299 [230,370] 
Less Success 157 [118,264] 190 [148, 239] 203 [169,308] 
PPT – Tib Ant (kPa)    
SUCCESS 360 [312,426] 429 [366,551] 524 [397,657] 
Less Success 329 [252,520] 396 [301,492] 369 [333,736] 
CPT (°C)    
SUCCESS 19.7 (9.9) 14.1 (9.9) 13.7 (9.0) 
Less Success 16.6 (9.2) 11.7 (8.6) 10.2 (8.6) 
Table 7.2: Group differences vs. time prior to and following cervical radiofrequency neurotomy (RFN) 
Legend: cRFN: Cervical Radiofrequency Neurotomy; VAS: Visual Analogue Scale; NDI: Neck Disability 
Index; PCS: Pain Catastrophization Scale; PDS: Posttraumatic Diagnostic Scale; PPT: Pressure Pain Threshold; 
Cx: Cervical; Tib Ant: Tibialis Anterior; CPT: Cold Pain Threshold 
Success: GROC (Global Rating of Change) ≥ 4 at 3-months post-RFN; Less Success: GROC<4 
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7.1.5.2 Prediction of Cervical RFN SUCCESS 3 Months Post-Cervical RFN: 
Table 7.3 presents the results of the univariate logistic regression analyses.  In 
predicting SUCCESS of cervical RFN, the following variables were statistically significant: 
disability (NDI) and pain catastrophizing (PCS).  The other four variables under investigation 
demonstrated wide 95% confidence intervals and were not significant predictors of 
SUCCESS. 
Clinical Variable Odds Ratio  
(95% CI) 
Standard Error Probability 
Pain 0.82 
(0.58 – 1.15) 
0.14 0.25 
Disability 0.91 
(0.84 – 0.99) 
0.04 0.037 
PCS 0.94 
(0.89 – 0.99) 
0.03 0.018 
 
PDS symptom 
severity 
0.96 
(0.91 – 1.01) 
0.03 0.20 
LogPPTCx 1.99 
(0.52 – 7.52) 
1.01 0.31 
LogPPTtibant 1.10 
(0.21 – 5.84) 
0.94 0.91 
Cold Hyperalgesia 0.96 
(0.89 – 1.04) 
0.04 0.30 
Table 7.3: Odds ratios of the clinical variables in univariate logistic regression for predicting cervical RFN 
SUCCESS 
Legend: CI = Confidence Interval; PCS = Pain Catastrophizing Scale; PDS = Posttraumatic Stress 
Diagnostic Scale; PPTCx = Pressure Pain Threshold in the Cervical Spine; PPTtibant = Pressure Pain Threshold 
over Tibialis Anterior; Bolded = p < 0.05 
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7.1.5.3 Correlation between Predictor Variables: 
To ascertain whether the variables that demonstrated significance in univariate 
regression were related, a correlational analysis was conducted between predictors that 
demonstrated a relationship (p ≤ 0.2) with cervical RFN SUCCESS (PCS, PDS Severity and 
NDI).  Other variables (VAS, LogPPTCx, LogPPTtibant and Cold Pain Thresholds) were 
discarded from analysis.  There was a significant correlation between disability and pain 
catastrophization or post traumatic stress severity (r = 0.56, p < 0.0001), albeit moderate in 
strength, with a strong and significant correlation between pain catastrophization and post 
traumatic stress severity (r = 0.77, p < 0.0001). 
Due to the correlation between predictor variables, multivariable analyses were 
performed.  Multivariable logistic regression models were constructed utilizing the predictor 
variable NDI.  A second model utilized PCS as the predictor variable.  Models utilizing PDS 
Severity were also constructed, but did not reach significance.  Following a forwards stepwise 
approach, two models reached statistical significance in predicting SUCCESS of cervical 
RFN at 3 months (Table 7.4).  The first model included the single variable: NDI (LR chi2(1) 
= 4.80, p=0.029).   The second model included the single variable: PCS (LR chi2(1) = 6.36, 
p=0.010).  
For model 1, ROC analysis resulted in an AUC of 0.68 and correctly predicted 98% of 
those with a successful outcome (sensitivity), but only 23% of those with a less successful 
outcome (specificity) with an overall success rate of 79% (Table 7.4).   
For model 2, ROC analysis resulted in an AUC of 0.73 and correctly predicted 95% of 
those with a successful outcome (sensitivity), and 23% of those with a less successful 
outcome (specificity) with an overall success rate of 77% (Table 7.4).   
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Model 
Predictor 
Variable 
Odds Ratio 
(95% CI) 
Standard 
Error 
Probability Sensitivity Specificity 
#1 
NDI 
0.91 
(0.83 – 0.99)  
0.04 0.037 0.975 0.231 
#2 
PCS 
0.94 
(0.89 – 0.99) 
0.03 0.018 0.95 0.231 
Table 7.4: Accuracy statistics with 95% confidence intervals for the two models predicting success of 
cervical RFN at 3 months 
Legend: NDI = Neck Disability Index; PCS = Pain Catastrophizing Scale; CI = Confidence Interval  
7.1.6 Discussion  
The results of this study were in agreement with previous research investigating 
cervical RFN, whereby approximately 75% of individuals successfully responded and 
reported ongoing success 3-months following the procedure [61,326,328,340].  Low levels of 
pain catastrophization and disability were found to predict success of cervical RFN, whereas 
various physical (pain levels, local and remote pressure pain thresholds and cold pain 
thresholds) and psychological features (pain catastrophization and posttraumatic stress 
symptoms) did not predict a successful (or less successful) response to cervical RFN.   
We have previously demonstrated that cervical RFN improves physical (decreases 
central hyperexcitability and increases neck movement) and psychological manifestations 
(psychological distress and pain catastrophizing) of chronic WAD [400,413].  However, as 
not all individuals respond to cervical RFN, our previous study results may not have 
highlighted differential inter-individual treatment responses [323].  We hypothesised that 
individuals with less complex clinical features would respond better to cervical RFN.  This 
was not the case.   
Our findings contrast with those of Cohen and colleagues [303] as we found that 
midline tenderness (local cervical PPTs) was not associated with a successful response to 
cervical RFN.  However there are differences between the studies. Cohen and colleagues used 
a dichotomised measure of neck ‘midline tenderness’ (pain overlying the facet joints with an 
estimated 4 kg of manually applied force), whereas we used a continuous variable of rate-
controlled algometry measuring pain thresholds over the neck.  They also used a retrospective 
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study design and this may have influenced the selection criteria of individuals investigated 
and possibly resulted in differential bias of results [303].  Additionally the selection criteria to 
determine suitability to undergo cervical RFN were different between the studies, with Cohen 
et al using a positive response to single medial branch block compared to our comparative 
double facet joint injection procedure.  This may have resulted in a less successful response to 
cervical RFN in Cohen’ et al’s study due to the high rate of false positives encountered with a 
single block procedure prior to RFN [58].  Additionally, the outcome used by Cohen et al was 
6 months post injury, and ours was 3 months and this may also contribute to the different 
results between the two studies.     
Our study demonstrated that two models predicted a successful response to cervical 
RFN.  Our finding that lower disability levels are a predictor of success for cervical RFN is 
not surprising.  The presence of higher disability levels (NDI > 28%) in the acute stage of 
WAD has frequently been shown to predict poor long-term health outcomes following the 
injury [6,231,421,426,427], with our study demonstrating the complementary finding that 
lower disability is a predictor of responsiveness to cervical RFN.  Our previous results also 
demonstrated that individuals who did not respond to initial facet joint block injections (prior 
to undergoing cervical RFN) presented with higher levels of pain catastrophizing [413].  
Thus, the current study result is not surprising, especially when taken with other studies 
showing that pain catastrophizing is associated with poor prognosis [398] and enhanced pain 
reports with concurrent disability [247,248].  The specificity of both predictive variables (NDI 
and PCS) was low, indicating that there was a 77% probability of a false positive ‘diagnosis’ 
of “success” being achieved with higher PCS or NDI scores.  The sensitivity was high (0.95), 
indicating that individuals with low pain catastrophizing or disability could be predicted to 
have a successful response to cervical RFN.  Hence, some clinical utility is evident for 
individuals with lower measures of pain catastrophizing (PCS < 24, [428]) and disability 
(NDI < 28%), with limited utility for individuals with higher scores on these measures.  Thus, 
higher levels of pain catastrophizing or disability should not prevent an individual from 
benefitting from cervical RFN.  We have previously demonstrated that individuals with high 
pain catastrophizing and disability benefit from cervical RFN [400,413].  Pain catastrophizing 
and disability scores were better predictors of “success”, in comparison to various other 
physical and psychological measures utilized in this study.  Individuals with various other 
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clinical features (e.g. widespread pressure hyperalgesia, cold hyperalgesia or higher levels of 
post-traumatic stress symptoms) still demonstrated benefit from undergoing cervical RFN, 
and these features did not predict “success” or “failure”.  Overall, apart from pain 
catastrophizing and disability, there was no significant clinical feature, either alone or in 
combination that successfully predicted “success” of cervical RFN, indicating that response to 
the initial facet joint diagnostic blockade continues to be the most suitable indicator for 
cervical RFN success [393].   
Certain study limitations need to be mentioned.  Thirty-one patients were receiving 
concurrent conservative treatment at the commencement of this study, and this may have 
confounded the results.  However, given that these individuals did not report any 
improvement over time in the twelve months before undergoing RFN [376], this does not 
appear to be highly likely.  A definition of recovery is challenging for individuals with 
chronic WAD [429].  The GROC score chosen  for “success” in this study has been reported 
to be indicative of moderate to large changes in a person’s status [423].  As this study 
contained both physical and psychological measures, it was decided that this outcome was 
satisfactory for the purposes of evaluation of patient’s overall outcome, as it likely 
incorporated a combination of pain and disability relief and possibly reflected reduction of 
psychological manifestations – all of which are important outcomes for individuals with 
chronic pain after a whiplash injury [430].  However, the outcome measure chosen (GROC) 
may have under reported the “success” of cervical RFN, as every individual in this study 
subsequently underwent repeat cervical RFN upon return of their symptoms.  Another 
consideration with this outcome measure, is the possible lack of clear delineation between 
individuals with ‘moderate success’ when compared to individuals who had a ‘less 
successful’ response.  This may have prevented certain predictor variables from reaching 
significance and would warrant evaluation in a larger study.  The outcome measures also 
included self-report measures that may have limited diagnostic accuracy and subsequent 
utility within the models investigated.   
One must also note that the model predicting “success” of cervical RFN is only as 
good as the variables measured.  Given the broad range of physical and psychological 
measures evident in the clinical presentation of individuals with chronic WAD [2,66], not all 
measures can be entered into logistic regression models, and thus, the results of this study 
  
- 160 - 
require replication in future research.  Intuitively, models are also more likely to reach 
significance if the variable under investigation is included as a predictor.  Thus, it may be that 
the outcome measure chosen (GROC) is closely associated with catastrophizing and 
disability, and if a different outcome was chosen (e.g. pain or ‘stress’), different predictors 
may have been significant in predicting “success”.  Thus, the results of this study 
investigating associations between multiple variables are a first step in identification of 
candidate variables for a prognostic model that need to be repeated in future studies in the 
context of a randomized controlled trial to determine the robustness, generalizability and 
validity of these measures as predictors of success for cervical RFN. 
In summary, this study demonstrated that individuals with chronic WAD respond to 
cervical RFN, irrespective of their clinical presentation.  Low levels of catastrophizing and 
disability predicted a successful response to cervical RFN. 
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CHAPTER 8 
Discussion and Conclusions 
8.1 Overview 
Individuals with chronic whiplash associated disorders (WAD) present with a complex 
array of physical and psychological features including central hyperexcitability, motor 
dysfunction, psychological distress, pain catastrophization and posttraumatic stress symptoms 
[30].  Research demonstrating the ability of particular treatment regimes to successfully 
reduce these features in the chronic state is limited [61,186,187,431] and certain clinical 
features (combination mechanical and cold hyperalgesia) seem resistant to conservative care 
[186].  Thus, treatments or strategies that can alleviate these features and successfully reduce 
pain and disability would be of significant benefit for all involved.  It is challenging to 
determine the reason(s) for the persistence of these symptoms, and in particular, if a patho-
anatomical lesion is responsible for some or all of these symptoms [87].  It is made even more 
challenging by the inability of current diagnostic imaging to detect lesions in the cervical 
spine after whiplash trauma [25,432].  Even when lesions have been detected, their relevance 
has been questioned [123,433].  Thus, it is unclear in individuals with chronic WAD whether 
tissue lesions are responsible for the persistence of the various clinical features.  There is also 
much debate as to whether the clinical manifestations are driven by an ongoing peripheral 
nociceptive source (the anatomical lesion) [53-55] or are self-maintaining due to neuroplastic 
changes in the central nervous system [36].   
The cervical facet joint has been implicated in clinical research as one of the  
anatomical structures responsible for neck pain in individuals following whiplash injury [28].  
Basic science research has also established an association between nociception in the cervical 
facet joints and some of the clinical features of WAD, and in particular behavioural 
hypersensitivity [374]. Cervical radiofrequency neurotomy (RFN) is a neuroablative 
technique that can be utilized to successfully treat individuals with facet joint nociception, 
identified via comparative medial branch blocks (MBBs) [345].  However, there has been no 
detailed study of the relationship between cervical facet joint nociception and the variety of 
clinical features demonstrated in individuals with chronic WAD.  It was also unknown 
whether persistent cervical facet joint nociception contributes to the physical and 
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psychological features evident in individuals with chronic WAD.  Likewise it was unknown 
whether effective modulation of this nociception through RFN improves these features.  It 
was important to determine whether modulation of these features was possible through 
effective treatment of underlying nociception, as this would assist in providing validated 
treatment options for these individuals.     
These deficits in knowledge prompted this body of research. The primary aim of this 
thesis was to determine if the physical and psychological manifestations of chronic WAD 
could be effectively modulated through successful response to RFN.  This, and subsidiary 
research questions to meet current deficits in knowledge, were answered through a series of 
studies. 
8.2 Determination of Clinical Features of Individuals with Cervical Facet 
Mediated Pain 
Generally, inception cohorts in studies investigating clinical features in individuals 
with chronic WAD, utilize the Quebec Task Force grading system [2], which results in a 
heterogeneous whiplash patient cohort.  It was important in the first instance to determine if 
individuals with neck pain attributed to cervical facet joint nociception were representative of 
the individuals classified as WAD II in these studies and whether they presented with similar 
clinical manifestations.  Thus, two groups of individuals classified as WAD II were examined, 
together with a group of healthy control individuals.  One WAD group had successfully 
responded to diagnostic facet joint injections (intra-articular facet joint injection followed by 
MBB) and thus were determined to have neck pain arising from cervical facet joint 
nociception; one group did not respond to cervical facet joint injections (non-responders) 
[376].  The only difference in physical and psychological clinical manifestations 
demonstrated between the two WAD groups involved pain catastrophization which was 
elevated in the ‘non responder’ group [376].  Increased medication intake was also 
documented in the ‘non responder’ group.  Both WAD groups demonstrated increased central 
hyperexcitability, reduced neck motion and increased upper quadrant electromyography 
(EMG) when performing the CCFT, together with psychological distress and elevated post 
traumatic stress symptoms when compared to the healthy cohort of individuals [376].  It was 
postulated that the higher levels of pain catastrophization may have been a factor of study 
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methodology as this measure was recorded after the completion of the double facet block 
procedure.  Individuals who did not respond may be more likely to have negative thoughts 
about their pain related disability.  Alternatively, the presence of pain catastrophization might 
have been evident prior to the procedures and in itself been responsible for the poor outcomes 
[245,351].  Future studies need to prospectively investigate any relationship between pain 
catastrophization and interventional outcomes.  In summary, this study demonstrated that the 
individuals proceeding to RFN presented with similar clinical manifestations to those 
previously documented in the literature.  In particular, the cohort had features that were 
associated with poor prognosis [6,231] and resistant to improvement with various 
conservative treatment regimes [186,187].  
8.3 Physical Manifestations of Chronic WAD Are Modulated by Cervical 
RFN 
 Study 2 investigated the group of individuals who proceeded to cervical RFN 
following their successful response to the double facet block procedures [400].  There was a 
significant wait time between completing the facet blocks and receiving the cervical RFN. 
Thus it was possible to investigate whether the physical features (central hyperexcitability, 
neck motion and CCFT performance) were stable or changed with time.  It was found that no 
features significantly improved or worsened over the 10 month time period, indicating the 
stability of this group’s chronic condition in the pre-intervention period [400].  Following the 
cervical RFN, individuals were followed-up on two occasions – one, and three-months post-
cervical RFN.  Importantly, it was found that following cervical RFN, pain and disability 
reduced and, with the exception of muscle function (CCFT), measures of central 
hyperexcitability (pressure pain thresholds (PPTs), heat and cold hyperalgesia, nociceptive 
flexion reflex (NFR) thresholds and elbow extension range of motion (ROM) during the 
brachial plexus provocation test (BPPT)) all improved and were no different from those of a 
healthy cohort of individuals [400].  The improvements were maintained at the 3-month 
follow-up.  These findings suggested that peripheral nociception was responsible for 
modulating the physical features of this cohort with chronic WAD, and that these 
improvements occur within a short time period post-cervical RFN.  Of particular interest, was 
the finding that peripheral nociception modulated central hyperexcitability.  It seems that the 
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presence of a peripheral lesion may be ‘driving’ the persistent hyperexcitability of the central 
nervous system (CNS), and modulation of central mechanisms is possible, and occurs in a 
short time period.  This contrasts with alternative views which contend that initial 
neuroplastic changes in the CNS are independent of peripheral involvement, are possibly 
‘self-generating’ and are likely to require ‘central’ input to produce change [36].  Thus the 
research in this thesis has produced a key finding namely, the importance of effectively 
treating peripheral tissue lesions in individuals in chronic WAD to improve physical 
manifestations.  
8.4 Psychological Manifestations of Chronic WAD Are Modulated by 
Cervical RFN 
 In study 3, investigations focussed on whether the psychological manifestations 
(psychological distress, pain catastrophization and posttraumatic stress symptoms) of chronic 
WAD could be effectively modulated with cervical RFN.  In tandem with the physical 
measures, there was no change in psychological manifestations during the 11 months between 
diagnostic facet blocks and cervical RFN.  Following cervical RFN, individuals reported 
statistically significant and clinically relevant (large effect sizes) improvement in 
psychological distress and pain catastrophizing, but not in posttraumatic stress symptoms.  
The improvements in pain catastrophizing and psychological distress were apparent within 
one month of the cervical RFN and were sustained at the three month follow up, which 
mirrored the improvements in pain and disability measures.  These results indicate the likely 
association between psychological measures and pain levels.  In contrast, the lack of 
significant improvement in posttraumatic stress symptoms suggests that these symptoms are 
independent of pain levels, but may explain the residual psychological distress (33%) 
demonstrated post-RFN.  This supports previous research by Jenewein [397], who found that 
posttraumatic stress symptoms influenced pain measures in the chronic stage of recovery 
following trauma, but the converse did not apply.  Given that ‘some’ improvement in 
symptomatology was noted in this group, a lack of power may have also contributed to this 
finding.  Of particular note, there was substantially greater improvements in the psychological 
measures following cervical RFN than achieved when these psychological manifestations 
were targeted with psychosocial interventions [250]. 
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8.5 Physical and Psychological Manifestations Deteriorate On Return of Pain 
 Studies 2 and 3 made apparent that reduced nociception (and associated pain) 
following cervical RFN resulted in improvements in physical and psychological 
manifestations of chronic WAD.  However, pain reduction associated with cervical RFN is 
finite [283] and individuals reported that their pain returned approximately 10 months post-
cervical RFN, which is consistent with literature reports.  As predicted, upon return of pain, 
participants demonstrated a deterioration of both physical and psychological features.  There 
was an increase in central hyperexcitability (cold hyperalgesia, reduced NFR threshold, 
reduced elbow extension ROM during the BPPT) and reduced neck motion, in conjunction 
with increased psychological distress and pain catastrophization.  These measures returned to 
levels demonstrated prior to receiving cervical RFN.  There was a trend for local and distal 
PPT measures to deteriorate following the return of pain (although not reaching significance), 
such that they were not significantly different to original measures at commencement of the 
study.  There was no change in EMG measures during performance of the CCFT, supporting 
other literature indicating that impaired neuromuscular control is not solely related to pain 
[64].  Worsening psychological distress and pain catastrophization on return of pain again 
demonstrated their interaction with pain.  This contrasted with posttraumatic stress measures.  
Posttraumatic stress measures did not improve following reduction of pain, or worsen 
significantly following the return of pain, suggesting that chronic posttraumatic stress 
symptoms in the individuals in this study with chronic WAD were independent of pain. 
8.6 Low Disability or Low Pain Catatastrophization Predicts Success of 
Cervical RFN 
Individuals undergoing cervical RFN demonstrated significant improvements in 
physical and psychological manifestations of chronic WAD.  However, not all individuals 
improved, which is consistent with the literature, which reports that approximately 70% of 
individuals have successful reduction of pain post-cervical RFN [61,328].  Information is 
sparse regarding features which may determine success of cervical RFN.  The only variable 
documented is midline tenderness [303].  Some of the physical and psychological features 
evident in chronic WAD are associated with poor prognosis [6,35,230,231] and it was 
questioned whether these features predicted outcomes following cervical RFN.  Of the 54 
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individuals undergoing cervical RFN, 13 reported a less than successful outcome (Global 
Rating of Change (GROC) < 4).  To determine which variables independently predicted 
‘success’ of cervical RFN, various measures (pain, disability, widespread sensory 
hypersensitivity (combination cold and pressure hyperalgesia), local tenderness (cervical 
pressure pain thresholds), pain catastrophizing and posttraumatic stress severity) were entered 
into logistic regression models.  One model including the variable low pain catastrophization 
and another model with the variable low disability (Neck Disability Index) independently 
predicted ‘success’ of cervical RFN.  However, the low specificity of these measures 
indicated that individuals with high pain catastrophization and high disability were still likely 
to benefit from cervical RFN.  The presence of local hyperalgesia, widespread sensory 
hypersensitivity or elevated posttraumatic stress symptoms symptoms did not preclude these 
individuals from reporting success following cervical RFN.  It still appears that the best 
determination of success post-cervical RFN is the initial response to the diagnostic cervical 
facet joint blocks [345].   
8.7 Overall Significance of Findings 
  The body of research in this thesis demonstrated for the first time that cervical RFN 
resulted in successful reduction of disability, reductions in central hyperexcitability, pain 
catastrophization and improvement in neck ROM.  The results also supported prior studies 
demonstrating a significant reduction of pain and psychological distress.  Notably, those 
measures returned to values comparable to a healthy cohort.  The changes were not only 
statistically significant, but effect sizes were large, indicating the clinical relevance of 
successful treatment with cervical RFN.  Thus successful treatment of peripheral nociception 
with cervical RFN can provide improvements in clinical manifestations that have been 
previously resistant to conservative care [186].  Another unique finding was that treatment 
(RFN) directed at peripheral mechanisms (cervical facet joints) reduced clinical features 
associated with central hyperexcitability and psychological manifestations.  This indicates that 
the peripheral mechanisms were ‘driving’ the central mechanisms.  This has important clinical 
ramifications and provides the basis for administering treatment of peripheral nociception for 
individuals with persistent central mechanisms to improve clinical outcomes.  Of note, the 
clinical features demonstrated by individuals in this study undergoing cervical RFN did not 
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predict an adverse outcome to treatment.  For individuals fulfilling the appropriate diagnostic 
criteria, low pain catastrophization and low levels of disability as measured with the NDI 
predicted a successful response to cervical RFN.   
8.8 Implications of Research 
 Effective management of chronic WAD poses significant challenges, as up to 50% of 
whiplash-injured individuals continue to report symptoms 12 months following the trauma 
[3].  In fact, 20 to 30% of individuals continue to report moderate to severe pain and disability 
two to three years post-injury [51,69].  The outcomes of this research help to further explain 
the relationship between cervical facet joint nociception and persistent symptoms.  It has been 
demonstrated previously that cervical RFN is successful in reducing pain and psychological 
distress in individuals with chronic WAD [61,225].  Until now, changes in other clinical 
manifestations had not been demonstrated in individuals undergoing cervical RFN.  The 
reasons for the persistence of many of these clinical features have been speculative, including 
ineffective treatment [186,434], presence of central hyperexcitability [35,154], presence of 
posttraumatic stress symptoms [230], hypothalamic-pituitary-adrenal gland (HPA) axis 
dysfunction [435], and even perceived injustice [264].  Thus, the body of studies within this 
thesis investigated one aspect of a very complex picture.  However, it is clear, that effective 
treatment of nociception is responsible for not only a reduction in neck pain, but also for 
improvement in other impairments’ underlying mechanisms contributing to persistence of 
symptoms in chronic WAD.  Thus, clinically, in individuals with features of chronic WAD 
that have not responded to conservative care, consideration for cervical RFN would seem 
appropriate; whilst for those presenting with symptoms suggestive of PTSD, other treatment 
options would seem to be indicated.  Given that conservative treatment has not reduced 
transition to chronicity for the WAD population [273] or reduced pain and disability in those 
with chronic WAD [319]; cervical RFN may be an option to assist with reduction of the 
global burden of WAD.     
8.9 Limitations of Research 
 There are limitations to this research that warrant discussion.  The predominant 
limitation in a longitudinal cohort study is the lack of employment of an appropriate placebo 
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control, especially when not controlled by randomization.  As such, it is possible that the 
results observed following RFN resulted for reasons other than being due to the effects of the 
intervention performed.  This is countered by the previous non-response to various 
conservative therapies, lack of long-term response to the double cervical facet diagnostic 
blockade procedure, and response to RFN that matched other clinical cohorts studied, thus 
providing some certainty that the results obtained were due to the intervention studied.  
Although the studies were powered appropriately to demonstrate the primary aims of the 
thesis, further participants would have allowed further investigation of different relationships.  
For example, the non-significant findings in changes in PDS may be as a result of low power 
of the study.  Similarly, increased study participants would have allowed for other predictor 
variables to be considered for inclusion in the models constructed to investigate which 
features predicted the success of RFN.  
 During the conduct of this thesis, other research has been completed that may have 
shaped the measures used in this study if it was undertaken today.  In particular, research 
regarding conditioned pain modulation [149], would have been of assistance in determination 
of the role of ‘excitation’ versus ‘inhibition’ following reduction of nociception that resulted 
from cervical RFN.  Furthermore, brain studies have emerged, which have investigated the 
underlying mechanisms apparent with individuals with chronic musculoskeletal pain 
[385,436].  These measures could possibly render some of the measures used in the studies 
within this body of research obsolete.   
 Finally, the data collection was performed entirely by the author in a clinical 
environment.  As such, the author was not blinded during collection of measures or analyses, 
and this has the potential to introduce bias.  To counteract this potential bias, study aims were 
not conveyed to participants. However acknowledgement of this limitation is necessary, with 
hope that in the future, study budgets would allow an independent assessor to collect data. 
8.10 Future Research 
Completion of any scientific endeavor prompts further questions.  One of the 
challenges of prospective cohort studies is the lack of ability to explain how or why specific 
treatments work [437].  For example, in the series of studies in this thesis, it was observed that 
physical features, and in particular central hyperexcitability; in conjunction with 
  
- 169 - 
psychological manifestations improved following reduction of pain with successful cervical 
RFN, and then deteriorated upon the return of pain.  It seems likely that successful reduction 
of nociception improved pain and central hyperexcitability. However the possibility remains 
that reduction of psychological distress with pain relief may have been responsible for the 
change in hyperexcitability.  Similarly, disentangling the role of peripheral nociception and 
impairments underlying central mechanisms is challenging.  The results of these studies 
implicate the role of peripheral mechanisms in central mechanisms, as evidenced by 
improvements in NFR thresholds, BPPT, PPT and thermal pain thresholds.  However, not all 
of these measures deteriorated (PPT and heat pain thresholds) upon the return of pain, 
indicating that there are likely different underlying mechanisms apparent for the return of pain 
for these respective measures.  Thus, the clinical measures utilized in this study and others 
remain as proxies for underlying impairments of mechanisms that have yet to be fully 
elucidated.  Future research will likely require the use of brain imaging studies.   
Seminowicz and colleagues investigated individuals with chronic low back pain (LBP) 
[385].  They investigated changes in cortical thickness through the use of structural magnetic 
resonance imaging (fMRI).  In their study, individuals underwent surgery or facet joint 
interventions in an attempt to reduce pain and disability.  They found that those individuals 
who improved as a result of these treatments demonstrated a reversible change in cortical 
thickness in the varying brain regions associated with pain experience (left dorsolateral 
prefrontal cortex, primary motor cortex and left anterior insula), together with improved 
cognitive performance.  Thus, improvement in pain and disability was associated with both 
functional and structural brain changes, with increases in cortical thickness associated with 
clinical outcomes.  This may explain the changes observed in the body of work contained 
within this thesis.     
 Similarly, in chronic post-traumatic headaches following whiplash injury, individuals 
who improved in the subsequent 12 months following their injuries, demonstrated reversible 
changes in voxel-based morphometry in grey matter in various brain regions (anterior 
cingulate and dorsolateral prefrontal cortex) involved in an individual’s pain experience 
[436].  These changes did not reverse in individuals who did not improve, although an 
increase in grey matter in antinociceptive brainstem centres, thalamus and cerebellum 
developed in all individuals developing chronic headaches revealing a biological plausibility 
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for persistent symptoms [436].  Again, the changes in central mechanisms demonstrated here 
may explain the changes observed in our studies, whereby improvements in central 
mechanisms were demonstrated.  
 Thus, it would seem important in future research to determine if individuals 
undergoing diagnostic cervical facet joint injections and cervical RFN demonstrate similar 
findings.  Apkarian and colleagues have produced a series of studies demonstrating that 
different chronic pain conditions exhibit unique anatomical ‘brain signatures’ when 
investigated with fMRI [438].  As an example, an individual with chronic LBP will 
demonstrate different findings on fMRI than an individual with chronic pelvic pain or knee 
osteoarthritis.  The author is not aware of any studies that have reported changes in fMRI 
following whiplash injury (apart from Obermann et. al’s [436] posttraumatic headache 
findings as reported above).  Apkarian’s laboratory also produced a prospective study 
investigating individuals with LBP.  They determined that transition into chronicity 
corresponded to a functional connection between the medial prefrontal cortex and the nucleus 
accumbens, suggesting that this ‘pre-existing’ brain structural connection predisposed 
individuals to chronic LBP [439].  This has subsequently been confirmed in a validation study 
[440].  No interventions were applied in Apkarian’s trial.  Given Apkarian’s results, it would 
seem that a unique ‘brain signature’ for chronic neck pain following whiplash injury may be 
possible.  Research in this field is warranted as it holds promise for directing future treatment.  
If individuals with this ‘brain signature’ underwent successful cervical RFN, then further 
fMRIs could determine if this ‘brain signature’ could be ‘improved’, when compared to that 
of a healthy individual.  Obviously, it would be of interest to determine if any ‘residual’ ‘brain 
signature’ remained.  Subsequent research could then study the ‘brain signatures’ of 
individuals with presence of neck pain post-whiplash injury with other co-morbid conditions, 
such as PTSD [441].  The remaining ‘brain signature’ post-cervical RFN in these individuals 
may lead to a residual ‘brain signature’ that could lead to a further understanding of 
underlying mechanisms present in the co-morbid conditions and thereby assist with 
appropriately targeting these mechanisms (and hence conditions) with other interventions 
[442].  In the example of PTSD, the influence of cognitive behavioural therapy could be 
evaluated.  Combination treatment of cervical RFN and PTSD could also be evaluated with 
such assessment methods.   
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Recently, repetitive transcranial magnetic stimulation (rTMS) has demonstrated 
promise in treating impairments of underlying central mechanisms [443].  Repetitive TMS has 
been successful in reducing depression symptoms in individuals who have failed 
pharmacological management [444].  As chronic pain and co-morbid depression share similar 
overlapping findings in central mechanisms, rTMS shows promise as a future treatment for 
individuals with chronic WAD.  Again, if it was possible to determine an appropriate ‘brain 
signature’ of underlying impaired central mechanisms, appropriate treatment with rTMS 
could be delivered to brain regions associated with impaired mechanisms that did not resolve 
with conservative therapy or cervical RFN.  A variation of rTMS, transcranial direct current 
stimulation has been trialled in chronic low back pain, albeit without success [445]. 
There are other questions of a mechanistic nature that remain which could possibly 
affect treatment options in the future.  Following cervical RFN, there was a reduction in 
central hyperexcitability but this improvement deteriorated following the return of pain.  
However, PPT measures did not alter significantly on return of pain.  Thus, future research is 
required to determine if cervical RFN reduces hyperexcitability at the dorsal horn (as 
indicated by the changes in NFR threshold measures) by reducing inflammation locally within 
the facet capsule (i.e. reduce peripheral sensitization); or whether these are changes related to 
change in central inhibitory processes, as suggested by the lack of change in PPT measures 
upon the return of pain.  Measurement of conditioned pain modulation may assist in this 
regard [149].  Within the basic science realm, many of these mechanisms have been observed 
in a ‘whiplash’ model.  Local facet capsular inflammation and spinal cord inflammation have 
been demonstrated [446,447], together with increased glutamatergic response in the dorsal 
horn [381,384] following a cervical facet joint distraction model.  Teasing out these 
mechanisms remains a challenge, but also holds great promise moving forwards.  Researchers 
in other recalcitrant pain conditions advocate a treatment-based system directed at 
impairments of the underlying mechanisms [36,448].  If it could be possible to elucidate the 
mechanisms underlying the presentation of these clinical manifestations in whiplash 
associated disorders, treatments could hopefully be directed at such.   
 Individuals who reported that cervical RFN was ‘successful’ continued to report the 
presence of some ongoing pain and disability.  It could be questioned whether further 
improvement could be gained with successful treatment of features that did not improve.  
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Levels of posttraumatic stress symptoms, as measured by the PDS, did not vary either post-
cervical RFN or upon the return of pain.  The number of symptoms, severity of symptoms or 
individuals obtaining a diagnosis of posttraumatic stress disorder (PTSD) did not significantly 
change through the series of studies.  The sensitivity or specificity of the PDS to predict a 
diagnosis of posttraumatic stress disorder is unknown.  Thus it is possible that the study was 
under-powered to demonstrate significant improvements in posttraumatic stress measures.  
Nevertheless, posttraumatic stress symptoms were not affected by pain, as were the other 
psychological measures (psychological distress and pain catastrophizing).  Future research is 
indicated to determine if concurrent treatment of posttraumatic stress symptoms and cervical 
RFN might result in greater improvements in neck pain than either treatment alone.  
8.11 Other Research Considerations 
One of the challenges with cervical RFN is the finite effectiveness it provides.  
Although effective, individuals consistently report improvement over a 7-14 month period 
[283].  As such, it would be advantageous to find ways to provide long-lasting relief.  One 
trial investigated pragmatic multi-professional management, including pharmacological 
treatment [273].  Unfortunately, no reduction in transition to chronicity was measured for 
individuals receiving this multi-professional management.  However, no individuals 
reportedly received cervical RFN as part of the multi-professional management.  It would be 
of benefit to investigate whether multi-professional management including cervical RFN may 
hold promise in reducing these clinical manifestations and assist with improved treatment 
outcomes and reduction of chronicity if introduced earlier to individuals post-whiplash injury.  
It was approximately three to four years following the initial injury when individuals 
underwent cervical RFN in this research.  Thus, by this time, complex physical and 
psychological clinical manifestations had developed.  If nociception was able to be modulated 
earlier with effective cervical RFN and associated pain reduced, development of some of the 
clinical features associated with poor prognosis (e.g. cold hyperalgesia) might be prevented.  
The research would be challenging. Individuals presenting with indictors of a very poor 
prognosis [231], with likely facet joint involvement [302] would be the target.  Of note, 
prospective studies have demonstrated that these features develop very early (within one 
month) [35].  Thus ideally, if such a study is medically feasible, cervical RFN would need to 
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be performed within 2-3 weeks post-injury.  A more feasible study in the first instance, might 
be to investigate the responses to the non-destructive MBB, using a long lasting medication; 
or alternatively, intra-articular regenerative medicine techniques (e.g. platelet rich plasma) 
that may assist in capsular repair that has been demonstrated in basic science and cadaveric 
WAD models [20,21]. 
 Other biomarkers in chronic WAD have also been demonstrated.  Recently, 
biomarkers suggestive of ongoing inflammation were demonstrated in blood tests [449].  The 
presence of these biomarkers was indicative of ongoing moderate to severe symptoms and 
also correlated with presence of mechanical hyperalgesia [449].  Previous authors 
demonstrated persistent inflammatory changes in individuals with chronic WAD utilizing 
PET scans [274].  Similarly, other authors have demonstrated increased interstitial 
concentrations of interleukin-6 and serotonin in micro-dialysis studies in upper fibres of 
trapezius that corresponded with the presence of local mechanical hyperalgesia in individuals 
with chronic whiplash symptoms [170].  Similarly, fibrous fatty infiltrate has been 
demonstrated in the cervical flexor and extensor musculature [44,168] and is associated with 
similar clinical manifestations.  It is possible that the inflammatory, biochemical and 
morphometric alterations are resulting from persistent cervical facet joint nociception.  
Further research could investigate whether successful cervical RFN treatment could change 
these biomarkers and thus constitute a treatment of such. 
 Stress system dysregulation and HPA axis dysfunction (cortisol production) have also 
been postulated as reasons for persistence of symptoms in chronic WAD [366,450].  Stress 
system dysregulation could result from genetic variations in the Catechol O-
Methyltransferease (COMT) gene, indicating a possible genetic predisposition to persistent 
symptoms [451].  Again, investigation of individuals who do and do not respond to cervical 
RFN (or even diagnostic facet joint injections) should consider this possibility.  Of interest, 
would be whether effective treatment of nociception via RFN could result in improvements in 
stress system dysregulation, or whether improvements in pain and disability and other clinical 
manifestations are independent of such measures, which would indicate that treatment 
directed specifically to these symptoms is warranted in individuals with chronic WAD.   
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8.12 Conclusion. 
 Individuals receiving cervical RFN demonstrated improvements in most physical and 
psychological manifestations of chronic WAD, with deterioration of these measures resulting 
upon return of pain. These findings indicate that peripheral nociception dynamically 
modulates these clinical manifestations and needs to be targeted to provide effective 
management of individuals with chronic WAD with cervical facet joint lesions. 
The relief gained with cervical RFN is temporary and as shown in this research, 
physical and psychological measures deteriorate upon return of pain. This research has 
enhanced understanding of the key role of peripheral nociception in the production of the 
potentially complex physical and psychological clinical manifestations in whiplash associated 
disorders. Future research is strongly indicated to determine ways to suppress or eliminate this 
peripheral nociception through conservative or interventional means or a combination of both.  
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Appendix 1: Instrumentation 
Quantitative Sensory Tests:  
Pressure Pain Thresholds (PPTs) 
Pressure pain thresholds (PPTs) were measured using a pressure algometer (Somedic 
AB, Farsta, Sweden). The probe size was 1 cm
2
 and the rate of application was set at 40 
kPa/sec. PPTs were measured over the articular pillars of C5/6 bilaterally (which is the most 
common facet joint involved in neck pain, (not involving headaches) following whiplash 
trauma); over the median nerve trunks anterior to the elbow bilaterally, and at a bilateral 
remote site (upper one third of the muscle belly of tibialis anterior) as previously described in 
investigations of chronic WAD [35].  The participants were requested to push a button when 
the sensation first became painful.  Triplicate recordings were taken at each site and the mean 
value for each site used in the analysis. 
Thermal Pain Thresholds 
Thermal pain thresholds were measured bilaterally over the cervical spine using the 
TSA II Neurosensory Analyzer (Medoc Advanced Medical Systems; Minneapolis, MN, 
USA).  The thermode was placed over the skin of the mid cervical region and preset to 32°C, 
with the rate of temperature change being 1°C per second. To identify cold pain thresholds 
(CPT) and heat pain thresholds (HPT), participants were asked to push a switch when the cold 
or warm sensation first became painful [452].  Triplicate recordings were taken at each site 
and the mean value for each site used in the analysis. 
Nociceptive Flexion Reflex 
The nociceptive flexion reflex (NFR) is a polysynaptic spinal withdrawal reflex that is 
elicited following activation of nociceptive A-delta afferents [453].  It was performed via 
electrical stimulation through bipolar surface Ag/AgCl-electrodes (inter electrode distance 
approximately 2 cm), which were placed just distal to the left lateral malleolus of the ankle 
(innervation area of the sural nerve).  EMG reflex responses to electrical stimulation were 
recorded from the middle of the biceps femoris and the (Ag/AgCl-electrodes).  The 
participant lay prone and a wedge was placed under the ankle to obtain 30 degrees knee 
flexion.  The EMG signal was amplified and low-pass filtered 0-500Hz by a Multichannel 
  
- 215 - 
EMG (Noraxon, Scottsdale AZ). Stimulation and recording was controlled and analyzed with 
custom software developed specifically for this test.  A 25ms, train-of-five, 1ms, square-wave 
impulse (perceived as a single stimulus), was delivered by a computer-controlled constant 
current stimulator (Digitimer DS7A, England).  
The current intensity was increased from 2mA in steps of 2mA until a reflex was 
elicited.  The program delivered the impulses at random time intervals, so that the participants 
were not aware of when the stimulus was going to be applied.  In this way, voluntary muscle 
contraction due to stimulus anticipation was avoided.  A reflex response was defined using the 
standardized peak (NFR interval peak z score) EMG activity from biceps femoris as 
recommended [454].  The NFR Interval Peak z score is the NFR interval peak (EMG activity 
90 to 150ms post-stimulation interval)—baseline mean (60ms before stimulation)/baseline 
SD. Rhudy and France [455],  suggest a NFR interval peak z score of greater that 10.32 be 
used to define a reflex response.  The 90 to 150ms interval was chosen as it avoids possible 
contamination by low threshold cutaneous flexion reflex, startle reactions, and voluntary 
movements [455].  The current intensity required to elicit a reflex response was defined as the 
NFR threshold. 
Brachial Plexus Provocation Test (BPPT) 
The brachial plexus provocation test (BPPT) was performed as described previously 
and in the following sequence: gentle shoulder girdle depression, glenohumeral abduction and 
external rotation in the coronal plane, forearm supination, wrist and finger extension, and 
elbow extension [456].  The range of elbow extension was measured at the participants’ pain 
threshold using a standard goniometer aligned along the mid humeral shaft, medial 
epicondyle, and ulnar styloid [457].  If the participant did not experience pain, the test was 
continued until end of available range.  
Motor Measures: 
Range of Motion 
Active cervical range of motion (ROM) was measured using electromagnetic motion 
sensors (Fastrak, Polhemus, USA) [38].  One sensor was placed over the C7 spinous process 
and the other was attached to the top of a light skull cup, which was fitted to the participant’s 
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head and firmly tightened, such that the second sensor sat on the vertex of the head.  Three 
trials were performed in each direction (flexion, extension, left and right rotation) and the 
means of the three trials were used in analysis.  A computer program was developed to 
convert the Euler angles into degrees of freedom of motion for the motion of the head (vertex) 
relative to the neck (C7 spinous process).  The Fastrak has previously been used in trials of 
neck pain and whiplash participants [64] and has shown to be accurate within +/- 0.2 degrees 
[458].         
Cranio-cervical Flexion Test (CCFT) 
Surface EMG (Noraxon Tele Myo 900) was used to measure the activity of superficial 
neck flexor muscles (sternocleidomastoid - SCM) during the five incremental stages of the 
CCFT as described by Jull [180].  The test was performed in supine and used a pressure 
biofeedback device (Stabilizer, Chattanooga, USA) placed sub-occipitally behind the neck to 
guide performance.  It was inflated to a baseline of 20mmHg and participants perform cranio-
cervical flexion to increase the pressure by five progressive increments of 2mmHg (22mmHg-
30mmHg). Each pressure level was maintained for 10s and participants rested for 15s 
between each stage.  Myoelectric signals were collected from the SCM muscles using Ag–
AgCl electrodes (Noraxon, USA) in a bipolar configuration.    
Electrodes were positioned along the lower one-third of the muscle bellies of the SCM 
[459].  Signals were amplified and filtered by a 500Hz low pass filter (Noraxon TeleMyo 900, 
Scottsdale AZ) and sampled at 2000Hz (National Instruments DAQ PCI-6221).  EMG data 
were analyzed as follows: The maximum root mean squared (RMS) value was identified for 
each trace using a 1s sliding window, incremented in 100ms steps.  RMS values were 
normalized for each participant, by dividing the 1s maximum RMS from each level of the 
CCFT by the 1s maximum RMS during a standardized head lift.  The baseline EMG data 
(RMS value) obtained at rest (20mmHg) was subtracted from the measured EMG at each 
level of this test.  The normalized RMS data for the left and right SCMs were averaged for 
analysis [64,180]. 
Questionnaires: 
Baseline measures included a description of symptoms, symptom dominance 
(unilateral or bilateral) and severity, collision parameters, treatments since the collision, 
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compensation status, list of medications and demographic variables including gender, age, 
marital status, employment status, education level and duration of neck pain as per a standard 
clinical examination. 
A single item visual analogue scale (VAS: 0-100mm) was used to measure the 
participants’ pain intensity in the cervical spine with (0) described as ‘No Pain’ and (100) as 
‘Worst Pain Imaginable’. 
Self-reported pain and disability was measured in whiplash participants with the Neck 
Disability Index (NDI) [353].  The NDI consists of 10 items addressing functional activities 
such as personal care, lifting, reading, work, driving, sleeping, and recreational activities and 
also pain intensity, concentration, and headache which are rated from no disability (0) to total 
disability (5). The overall score (out of 100) is calculated by totalling the responses of each 
individual item and multiplying by 2. A higher score indicates greater pain and disability. It is 
the questionnaire most utilized in WAD research [460]. 
The s-LANSS is a validated self-report version of the Leeds Assessment of 
Neuropathic Symptoms and Signs pain scale [354].  It consists of seven items and includes 
two self-examination items. A score of 12 or greater indicates pain of a predominantly 
neuropathic nature.  It has been used in previous WAD research [461].  
All participants completed the General Health Questionnaire 28 (GHQ-28) [355] as a 
measure of general psychological distress.  The General Health Questionnaire-28 (GHQ-28) 
is a 28-item measure of emotional distress in medical settings that is divided into 4 subscales: 
somatic symptoms (items 1 to 7), anxiety/insomnia (items 8 to 14), social dysfunction (items 
15 to 21), and severe depression (items 22 to 28).  Each item has a 4-point rating scale 
ranging from (0) to (3).  The total scores can be used as a measure of psychological distress, 
with a higher score (>23/24) indicating greater distress. The GHQ-28 has been used in 
previous research of WAD [67,221].  
The Posttraumatic Diagnostic Scale (PDS) [356] was included to assess the presence 
of symptoms according to the Diagnostic and Statistical Manual of Mental Disorders (fourth 
edition, text revision; DSM– IV–TR) diagnostic criteria for posttraumatic stress disorders 
(PTSD).  For every item, the frequency of the 17 PTSD symptoms within 1 week is assessed 
on a 4-point Likert scale, ranging from 0 (never) to 3 (daily).  The items referred to a 1-month 
period prior to the study period.  A total symptom severity score (ranging from 0 to 51) is 
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derived with larger scores indicating greater symptom severity.  The original PDS 
demonstrated high internal consistency and good stability and appeared to be a valid 
instrument for the assessment of PTSD in survivors of various traumatic events inclusive of 
motor vehicle collisions [402,403]. 
Pain catastrophizing was evaluated using the Pain Catastrophizing Scale (PCS) [245].  
This is a 13-item questionnaire that describes various thoughts and feelings that individuals 
can experience when they are in pain, and requires participants to reflect on past pain 
experiences and to indicate the degree to which each of the items applied to them.  Each item 
has a 5-point rating scale ranging from (0) not at all to (4) all the time and scores provide a 
total for the PCS.  A total “cut-off score” of 30 reflects that an individual has clinically 
relevant pain catastrophization [357]. 
In both WAD groups, the following measures were completed: VAS, NDI, s-LANSS, 
GHQ-28, PDS and PCS.  In the HC group, only the GHQ-28 questionnaire was completed.   
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Appendix 2: RFN Procedure 
Local anesthetic, fluoroscopic guidance and sterile technique were utilized for placing 
the 21 gauge RF cannulae to the expected location of the medial branches of the dorsal rami at 
the appropriate sites. A grounding pad was placed on the patient and connected to the 
RF lesion generator.  Once the RF cannulae were in proper position based on the AP, oblique, 
and lateral fluoroscopic imaging, an RF probe was inserted into each cannula for 
determination of the tissue impedance and then motor stimulation. When it was determined 
that there was no motor nerve stimulation and the cannulae were considered in proper 
position, 2% lidocaine was injected through each cannula.  After anesthetizing with lidocaine, 
RF thermocoagulation lesions were made at each site using an RF probe with a 5 mm active 
tip, heating to the tissue at the tip of the probe to 80 degrees centigrade for 75 seconds.  For 
the C2–3 joint the third occipital nerve was the target.  For joints below C2–3 both medial 
branches that innervated the joint were targeted.  A small amount (2 mg) of Celestone 
Soluspan was injected at each neurotomy site at the conclusion of the procedure to reduce the 
chance of a post-procedure neuritis.  The patient was given post-procedure written 
instructions and phone numbers to reach the radiologist if necessary.  
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Appendix 3: 
Ethical Clearance 
Whiplash Associated Disorders: A Prospective Study of the Time Course of Effects of 
Cervical Medial Branch Neurotomies on Sensory, Motor and Psychological Features of the 
Disorder was granted ethical approval by the Conjoint Health Ethics Board of the Faculties of 
Medicine, Nursing and Kinesiology, University of Calgary, and the Affiliated Teaching 
Institutions.  This approval was dated January 8, 2009.  Ethics ID: E -22082 
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On February 25, 2009, ethics approval was gained from the University of Queensland 
Medical Research Ethics Committee for Experiments on Humans including Behavioural 
Research.  Project Number: 2009000272 
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Healthy Controls Consent Form 
__________________________________________________________ 
Name of Researcher, Faculty, Department, Telephone & Email: 
 
R. Allen Hooper MD, CCFP – Faculty of Medicine; Department of Family Medicine 
T: 403 244 3700 (x: 3); E: ahooper@ucalgary.ca  
Ashley Smith PT, PhD(student); Michele Sterling PT, PhD; Gwen Jull PT, PhD; Geoff 
Schneider PT, DSc; Bevan Frizzell MD; R. Allen Hooper MD; Asad Khan PhD 
 
Title of Project: 
 
Whiplash Associated Disorders: A prospective study of the time course 
of effects of cervical medial branch Radiofrequency Neurotomies on 
sensory, motor and psychological features of the disorder.  
__________________________________________________________  
 
This consent form is only part of the process of informed consent.  It should give you the basic 
idea of what the research is about and what your participation will involve.  If you would like 
more detail about something mentioned here, or information not included here, please ask.  Take 
the time to read this carefully and to understand any accompanying information.  You will 
receive a copy of this form. 
  
Background: 
 
Longstanding neck pain following a motor vehicle accident affects many people.  One significant 
reason for neck pain that lasts a long time is the presence of injury to the facet joints in your 
neck.  The facet joints in your neck are positioned on the back of the spine and they are 
surrounded by muscles, ligaments, and a disc.  Ongoing neck pain can lead to a change in the 
way your brain and spinal cord process pain information.  This can lead to the sensation of pain 
in areas of the body that are typically healthy or not injured as a result of a car accident.  You 
may feel pain or discomfort with pressure, thermal or electrical stimulation that you did not feel 
prior to the car accident.  Your ability to accurately use the right neck muscles for postural 
support and your range of motion may also be affected. 
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RadioFrequency Neurotomy (burning of the small pain nerves coming from the facet joints) may 
help reduce the pain coming from that joint.  This may in turn help decrease the amount of pain 
that you may feel to stimulation in other areas of the body as well.   
 
Purpose of the Study: 
 
The purpose of this research is to determine if there is a change in sensory responses following 
RadioFrequency Neurotomy (burning the small pain generating nerves) that blocks the pain 
coming from the facet joint.  We also would like to compare the differences in these sensory 
responses between those who do and don’t respond to Medial Branch Blocks performed in the 
neck region.  These results will also be compared against a group of healthy control subjects. 
 
What Would I Have to Do? 
 
You will be requested to participate in the following procedures; 
 
1) Medical Information: You will be asked to complete a questionnaire requesting 
information about yourself, your motor vehicle collision, and your medical history.  This 
information will determine whether you are eligible for the study.  You will also be asked 
to complete another questionnaire concerning your general health status and your current 
level of distress.  This will take approximately 10-15 minutes to complete. 
 
2) Sensori-Motor Tests:  You will be asked to complete two tests involving movement of 
the neck.  One test measures neck range of motion and sensors will be placed on the back 
of your neck and you will wear a light skull cap to measure this movement. You will be 
asked to take your head forwards and backwards, to each side and turn your head to each 
side.  The other test will require you to gently nod your head while lying on your back.  
You will be guided in the test by viewing a dial which tells you how far to nod.  Whilst 
you are nodding your head, electrodes (placed on the skin at the front of your neck) will 
capture information regarding which muscles are performing this motion and how much 
they are working. 
 
3) Quantitative Sensory Tests:  You will be asked to complete the following tests.   
 
 Pressure Pain Thresholds: A small pressure sensor will be applied to your neck, arms 
and legs. As the pressure increases, you will be asked to press a button when you feel it 
becomes painful. The test will stop at this point. No tissue damage will occur at this low 
intensity.  Any local soreness should ease rapidly.  
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 Thermal Pain Thresholds. A small thermal sensor is placed on your neck. The 
temperature is gradually increased or decreased and you will be asked to press a button 
when you first feel a painful heat or cold, upon which you press a button and the test will 
stop. No tissue damage will occur as the maximum and minimum temperatures are preset 
to prevent this. 
 Brachial Plexus Provocation Test. Whilst lying on your back in a relaxed posture, your 
arm will gently be moved, progressively elongating nerve tissue in your arm.  When this 
becomes painful, the test is completed. 
 Nociceptive Flexion Withdrawal Response. Electrodes will be placed over your Sural 
Nerve, which is located near your ankle bone on the outside of your leg. The electrodes 
will send a small electrical current through your nerve, which may be slightly 
uncomfortable. This electrical stimulation will cause a “knee jerk reflex” that causes your 
hamstring muscle at the back of your thigh to contract automatically and quickly bend 
your knee slightly. Electrodes will also be placed over this muscle to measure its activity. 
You will not feel anything from these electrodes at the back of your thigh. After the 
electrical stimulation you will be asked to record the discomfort you felt on a scale. The 
scale will be anchored with 0=no pain at one end and 10=worst pain imaginable at the 
other end. If your score on this scale reaches 8 or higher, the test will be ceased.  
 
The one session of testing required will be performed at the Advanced Spinal Care Centre.  The 
tests will take 45-60 minutes to complete.  
 
What Type of Personal Information will be Collected? 
 
Should you agree to participate, you will be asked to provide your gender and age.  A review of 
your health status and history (including past treatment received) will also be collected to ensure 
that you are an appropriate candidate for this study.  No other personal identifying information 
will be collected in this study. 
 
What are the Risks? 
 
There are no significant risks associated with quantitative sensory or sensori-motor testing.  You 
may experience an increase in pain for a very brief period (following QST) as the testing 
procedure is assessing your pain threshold.  The brief increase in pain should only last for a few 
seconds, but may be mildly noticeable for a few minutes once testing is complete. 
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Are there any Reproductive Risks? 
 
There are no reproductive risks associated with the testing associated with this research and 
described above.   
 
Will I Benefit if I Take Part? 
 
If you agree to participate in this study there may not be a direct medical benefit to you.  Your 
participation in this study may benefit health care professionals focus their treatments more 
appropriately for their patients with chronic neck pain.   
 
Your participation in this study may help researchers develop future studies focused on the 
treatment of chronic neck pain. 
 
Do I Have to Participate? 
 
Participation is completely voluntary, anonymous and confidential.  Your ability to receive 
treatment at the Advanced Spinal Care Centre, EFW Radiology or Calgary Health Region is not 
affected by your participation in this study.  This research is not studying the effects of treatment, 
thus you are free to pursue any aspect of treatment as recommended by your health care team in 
conjunction with this study.   
 
You are free to discontinue participation at any time during the study without jeopardizing your 
health care.  You may notify us personally via telephone or email as per the details on this form.  
The researcher may also withdraw you from the study if your medical condition changes 
(including sustaining another injury) or if the study is completed sooner than currently 
anticipated.   
 
If new information becomes available that might affect your willingness to participate in this 
study, you will be informed as soon as possible. 
 
What Else Does my Participation Involve? 
 
There are no other unique features of this research that have not already been discussed in this 
research form and will affect you. 
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Will I Be Paid For Participating, Or Do I Have To Pay For Anything?  
 
There are no costs incurred as a condition of or because of participation in this study.  Your 
parking expenses will be covered.  No other financial remuneration is available for participation. 
  
Will My Records Be Kept Private? 
 
No one except the researcher and his supervisor will be allowed to see any of the answers to the 
questionnaires.  There are no names on the questionnaires.  Only group information will be 
summarized for any presentation or publication of results.  The questionnaires are kept in a 
locked cabinet only accessible by the researcher and his supervisor.   
 
The anonymous data will be stored for seven years on a computer disk, at which time, it will be 
permanently erased.  The University of Calgary Conjoint Health Research Ethics Board will 
have access to the records.   
 
If I Suffer A Research-Related Injury, Will I Be Compensated?   
 
In the event that you suffer injury as a result of participating in this research, no compensation 
will be provided to you by EFW Radiology, the Advanced Spinal Care Centre, the University of 
Calgary, the Calgary Health Region or the Researchers. You still have all your legal rights. 
Nothing said in this consent form alters your right to seek damages. 
 
What Happens if Something goes Wrong? 
 
If there was any incident during this testing, testing would be immediately interrupted, and the 
problem dealt with appropriately by the trained physiotherapist.  Your doctor and health-care 
team would be notified as to this occurrence by written documentation. 
 
Signatures (written consent) 
 
Your signature on this form indicates that you have understood to your satisfaction the 
information regarding your participation in the research project and agree to participate as a 
subject. In no way does this waive your legal rights nor release the investigators, or involved 
institutions from their legal and professional responsibilities. You are free to withdraw from the 
study at any time without jeopardizing your health care.  
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If you have further questions concerning matters related to this research, please contact: 
 
Mr. Ashley Smith (403) 244-3700 (ext: 2) 
 
Or 
 
Dr. Allen Hooper (403) 244-3700 (ext: 3) 
 
If you have any questions concerning your rights as a possible participant in this research, please 
contact Director, Office of Medical Bioethics, University of Calgary, at 403-210-9757. 
This study also adheres to the Guidelines of the ethical review process of The University of 
Queensland. Whilst you are free to discuss your participation in this study with project staff 
(contactable on 403-244-3700 ext. 2), if you would like to speak to an officer of the University 
not involved in the study, you may contact the Ethics Officer on + 1 61 3365 3924. 
 
 
Participant’s Name  Signature and Date 
   
Investigator/Delegate’s Name  Signature and Date 
   
Witness’ Name  Signature and Date 
   
The University of Calgary Conjoint Health Research Ethics Board and University of Queensland 
Medical Review Ethics Committee (Australia) has approved this research study.
Group: HC                    Subject ID#:______ 
  Date:______ 
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Healthy Control Demographics 
General Information: 
Name:           
Telephone: H)    C)    W) 
Email Address: 
Can we send study correspondence by e-mail to you?  Yes____No____ 
 
Date of Birth:____/____/____  Age:    Male____Female____ 
Family GP:________________________________________________ 
Occupation:______________________ 
Currently Employed?______________ 
Highest Level of Education Achieved?____________________________________________ 
 
Past medical history: 
Surgeries (dates): 
 
 
Fractures (dates): 
 
 
Serious illness (dates): 
 
 
Motor Vehicle Collision Injuries (dates): 
Did you require treatment following this MVC?   Yes   No   (Please circle) 
 
 
Sports or other injuries to head, neck, or back: 
 
 
Current Medical history: 
Current health problems:  
 
 
Current medications taken (inclusive of dose (‘size’) and frequency eg. Tylenol 100mg daily:  
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1) Please indicate what, if any, types of treatment you are presently receiving. 
a) Manipulation_______________________________________________ 
b) Massage___________________________________________________ 
c) IMS______Acupuncture______Trigger Point Injections_____________ 
d) Exercise___________________________________________________ 
e) Other (explain)______________________________________________ 
2) What type of practitioner has been providing the current treatment? 
a) Physical Therapist________________________________ 
b) Chiropractor_____________________________________ 
c) Massage Therapist________________________________ 
d) Acupuncturist____________________________________ 
e) Psychologist_____________________________________ 
f) Other (explain)___________________________________ 
How often are you attending this treatment (per month)?________ 
What is the name of your practitioner?_______________________ 
3) Prior to your current treatment program (if applicable), what other treatments have you 
had in the past? 
a) Physical Therapist 
b) Chiropractor 
c) Massage Therapist 
d) Acupuncturist 
e) Other (explain) 
 
Thank you for filling out this form. 
Please go on to complete the following questionnaires: 
GHQ-28 
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Whiplash Group (WAD_R or WAD_NR) Consent Form 
______________________________________________________ 
Name of Researcher, Faculty, Department, Telephone & Email: 
 
R. Allen Hooper MD, CCFP – Faculty of Medicine; Department of Family Medicine 
T: 403 244 3700 (x: 3); E: ahooper@ucalgary.ca  
Ashley Smith PT, PhD(student); Michele Sterling PT, PhD; Gwen Jull PT, PhD; Geoff 
Schneider PT, DSc; Bevan Frizzell MD; R. Allen Hooper MD; Asad Khan PhD 
 
Title of Project: 
 
Whiplash Associated Disorders: A prospective study of the time 
course of effects of cervical medial branch Radiofrequency 
Neurotomies on sensory, motor and psychological features of the 
disorder.  
______________________________________________________ 
 
This consent form is only part of the process of informed consent.  It should give you the 
basic idea of what the research is about and what your participation will involve.  If you 
would like more detail about something mentioned here, or information not included 
here, please ask.  Take the time to read this carefully and to understand any 
accompanying information.  You will receive a copy of this form. 
  
Background: 
 
Longstanding neck pain following a motor vehicle accident affects many people.  One 
significant reason for neck pain that lasts a long time is the presence of injury to the facet 
joints in your neck.  The facet joints in your neck are positioned on the back of the spine 
and they are surrounded by muscles, ligaments, and a disc.  Ongoing neck pain can lead 
to a change in the way your brain and spinal cord process pain information.  This can lead 
to the sensation of pain in areas of the body that are typically healthy or not injured as a 
result of a car accident.   
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You may feel pain or discomfort with pressure, thermal or electrical stimulation that you 
did not feel prior to the car accident.  Your ability to accurately use the right neck 
muscles for postural support and your range of motion may also be affected. 
 
RadioFrequency Neurotomy (burning of the small pain nerves coming from the facet 
joints) may help reduce the pain coming from that joint.  This may in turn help decrease 
the amount of pain that you may feel to stimulation in other areas of the body as well.   
 
Purpose of the Study: 
 
The purpose of this research is to determine if there is a change in sensory responses 
following RadioFrequency Neurotomy (burning the small pain generating nerves) that 
blocks the pain coming from the facet joint.  We also would like to compare the 
differences in these sensory responses between those who do and don’t respond to Medial 
Branch Blocks performed in the neck region.  These results will also be compared against 
a group of healthy control subjects. 
 
What would I Have to Do? 
 
You will be requested to participate in the following procedures; 
 
1) Medical Information: You will be asked to complete a questionnaire requesting 
information about yourself, your motor vehicle collision, and your medical 
history.  This information will determine whether you are eligible for the study.  
You will also be asked to complete five questionnaires concerning your pain and 
your ability to perform functional activities, as well as your current level of 
distress.  This will take approximately 45-60 minutes to complete. 
 
2) Sensori-Motor Tests:  You will be asked to complete two tests involving 
movement of the neck.  One test measures neck range of motion and sensors will 
be placed on the back of your neck and you will wear a light skull cap to measure 
this movement. You will be asked to take your head forwards and backwards, to 
each side and turn your head to each side.  The other test will require you to 
gently nod your head while lying on your back.  You will be guided in the test by 
viewing a dial which tells you how far to nod.  Whilst you are nodding your head, 
electrodes (placed on the skin at the front of your neck) will capture information 
regarding which muscles are performing this motion and how much they are 
working. 
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3) Quantitative Sensory Tests:  You will be asked to complete the following tests.   
 
 Pressure Pain Thresholds: A small pressure sensor will be applied to your neck, 
arms and legs. As the pressure increases, you will be asked to press a button when 
you feel it becomes painful. The test will stop at this point. No tissue damage will 
occur at this low intensity.  Any local soreness should ease rapidly.  
 Thermal Pain Thresholds. A small thermal sensor is placed on your neck. The 
temperature is gradually increased or decreased and you will be asked to press a 
button when you first feel a painful heat or cold, upon which you press a button 
and the test will stop. No tissue damage will occur as the maximum and minimum 
temperatures are preset to prevent this. 
 Brachial Plexus Provocation Test. Whilst lying on your back in a relaxed 
posture, your arm will gently be moved, progressively elongating nerve tissue in 
your arm.  When this becomes painful, the test is completed. 
 Nociceptive Flexion Withdrawal Response. Electrodes will be placed over your 
Sural Nerve, which is located near your ankle bone on the outside of your leg. The 
electrodes will send a small electrical current through your nerve, which may be 
slightly uncomfortable. This electrical stimulation will cause a “knee jerk reflex” 
that causes your hamstring muscle at the back of your thigh to contract 
automatically and quickly bend your knee slightly. Electrodes will also be placed 
over this muscle to measure its activity. You will not feel anything from these 
electrodes at the back of your thigh. After the electrical stimulation you will be 
asked to record the discomfort you felt on a scale. The scale will be anchored with 
0=no pain at one end and 10=worst pain imaginable at the other end. If your score 
on this scale reaches 8 or higher, the test will be ceased.  
 
The testing will be performed after the Medial Branch Blocks have been performed and 
again immediately preceding RadioFrequency Neurotomy (approximately 6 months later) 
if you are progressing to this procedure (WAD-RF group).  Further follow-up measures 
will be performed at the following time periods: 1 month, 3 months and at approximately 
7-12 months following RadioFrequency Neurotomy (i.e. when the pain returns to it’s 
original level).  We will call you to remind you of your appointments.   
 
If you do not proceed to RadioFrequency Neurotomy (WAD-C group), the testing will be 
completed one month after the Medial Branch Blocks have been completed.   
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Thus, you will be eligible for the study if you have Medial Branch Blocks performed to 
your neck region.   All testing will be performed at the Advanced Spinal Care Centre 
where you had your diagnostic Medial Branch Blocks performed.  The testing will take 
approximately 45-60 minutes to complete.   
 
What Type of Personal Information will be Collected? 
 
Should you agree to participate, you will be asked to provide your gender and age.  A 
review of your health status and history (including past treatment received) will also be 
collected to ensure that you are an appropriate candidate for this study.  No other personal 
identifying information will be collected in this study. 
 
What are the Risks? 
 
There are no significant risks associated with quantitative sensory or sensori-motor 
testing.  You may experience an increase in pain for a very brief period (following QST) 
as the testing procedure is assessing your pain threshold.  The brief increase in pain 
should only last for a few seconds, but may be mildly noticeable for a few minutes once 
testing is complete. 
 
You may experience a change in pain thresholds in the regions that are being tested 
following the RadioFrequency Neurotomy procedure.  The decrease in your pain in your 
neck following the Radiofrequency Neurotomy procedure is most often temporary 
(between 7-12 months), therefore the change in pain thresholds may only be temporary as 
well.   
 
There is no guarantee that you will experience a change in pain thresholds following the 
RadioFrequency Neurotomy procedure.   
 
Are there any Reproductive Risks? 
 
There are no reproductive risks associated with the testing associated with this research 
and described above.  You will not be a candidate for RadioFrequency Neurotomy if you 
are pregnant.   
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Will I Benefit if I Take Part? 
 
If you agree to participate in this study there may not be a direct medical benefit to you.  
Your participation in this study may benefit health care professionals focus their 
treatments more appropriately for their patients with chronic neck pain.   
 
Your participation in this study may help researchers develop future studies focused on 
the treatment of chronic neck pain. 
 
Do I Have to Participate? 
 
Participation is completely voluntary, anonymous and confidential.  Your ability to 
receive RadioFrequency Neurotomy is not affected by your participation in this study.  
This research is not studying the effects of treatment, thus you are free to pursue any 
aspect of treatment as recommended by your health care team in conjunction with this 
study.   
 
You are free to discontinue participation at any time during the study without 
jeopardizing your health care.  You may notify us personally via telephone or email as 
per the details on this form.  The researcher may also withdraw you from the study if 
your medical condition changes (including sustaining another injury) or if the study is 
completed sooner than currently anticipated.   
 
If new information becomes available that might affect your willingness to participate in 
this study, you will be informed as soon as possible. 
 
What Else Does my Participation Involve? 
 
There are no other unique features of this research that have not already been discussed in 
this research form and will affect you. 
 
Will I Be Paid For Participating, Or Do I Have To Pay For Anything?  
 
There are no costs incurred as a condition of or because of participation in this study.  
Your parking expenses will be covered.  No other financial remuneration is available for 
participation. 
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Will My Records Be Kept Private? 
 
No one except the researcher and his supervisor will be allowed to see any of the answers 
to the questionnaires.  There are no names on the questionnaires.  Only group information 
will be summarized for any presentation or publication of results.  The questionnaires are 
kept in a locked cabinet only accessible by the researcher and his supervisor.   
 
The anonymous data will be stored for seven years on a computer disk, at which time, it 
will be permanently erased.  Waiting list subject names within the Advanced Spinal Care 
Centre will be accessed via usual ancillary clinic staff.  The University of Calgary 
Conjoint Health Research Ethics Board will have access to the records.   
 
If I Suffer A Research-Related Injury, Will I Be Compensated?   
 
In the event that you suffer injury as a result of participating in this research, no 
compensation will be provided to you by EFW Radiology, the Advanced Spinal Care 
Centre, the University of Calgary, the Calgary Health Region or the Researchers. You 
still have all your legal rights. Nothing said in this consent form alters your right to seek 
damages. 
 
What Happens if Something goes Wrong? 
 
If there was any incident during this testing, testing would be immediately interrupted, 
and the problem dealt with appropriately by the trained physiotherapist.  Your doctor and 
health-care team would be notified as to this occurrence by written documentation. 
 
Signatures (written consent) 
 
Your signature on this form indicates that you have understood to your satisfaction the 
information regarding your participation in the research project and agree to participate as 
a subject. In no way does this waive your legal rights nor release the investigators, or 
involved institutions from their legal and professional responsibilities. You are free to 
withdraw from the study at any time without jeopardizing your health care.  
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If you have further questions concerning matters related to this research, please contact: 
 
Mr. Ashley Smith (403) 244-3700 (ext: 2) 
 
Or 
 
Dr. Allen Hooper (403) 244-3700 (ext: 3) 
 
If you have any questions concerning your rights as a possible participant in this research, 
please contact Director, Office of Medical Bioethics, University of Calgary, at 403-210-
9757. 
 
This study also adheres to the Guidelines of the ethical review process of The University 
of Queensland. Whilst you are free to discuss your participation in this study with project 
staff (contactable on 403-244-3700 ext. 2), if you would like to speak to an officer of the 
University not involved in the study, you may contact the Ethics Officer on + 1 61 3365 
3924. 
 
 
Participant’s Name  Signature and Date 
   
Investigator/Delegate’s Name  Signature and Date 
   
Witness’ Name  Signature and Date 
   
The University of Calgary Conjoint Health Research Ethics Board and University of 
Queensland Medical Review Ethics Committee (Australia) has approved this research 
study.
Group: WAD-RF, WAD-C, HC                    Subject ID#:______ 
Time Period:______  Date:______ 
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Whiplash Group (WAD_R or WAD_NR) Demographics 
General Information: 
Name:           
Telephone: H)    C)    W) 
Email Address: 
Can we send study correspondence by e-mail to you?  Yes____No____ 
 
Date of Birth:____/____/____  Age:    Male____Female____ 
Family GP:________________________________________________ 
Occupation:______________________ 
Currently Employed?______________Due to crash?  Yes   No   (Please circle) 
Highest Level of Education Achieved?____________________________________________ 
 
Past medical history: 
Surgeries (dates): 
 
 
Fractures (dates): 
 
 
Serious illness (dates): 
 
 
Sports or other injuries to head, neck, or back: 
 
 
Current Medical history: 
Current health problems:  
 
 
Current medications taken (inclusive of dose (‘size’) and frequency eg. Tylenol 100mg daily:  
 
 
Group: WAD-RF, WAD-C, HC                    Subject ID#:______ 
Time Period:______  Date:______ 
- 238 - 
NECK INFORMATION: (Please try to be as specific as possible) 
1) Why did you receive injections into the neck region? (Please tick those that apply) 
a) Neck pain?__________Right_________Left_________ 
b) Headaches?__________Right________Left_________ 
c) Neck pain & Headaches?_________________________ 
d) Shoulder pain?_______Right_________Left_________ 
e) Neck pain & Shoulder pain_______________________ 
f) Other________________________________________ 
PLEASE COMPLETE THE ATTACHED PAIN DRAWING (BODY DIAGRAM) TO 
INDICATE THE LOCATION OF YOUR PAIN. 
2) Approximately, how many weeks have you had the pain in question #1?_______ 
a) What was the date of your Motor Vehicle Collision Injury? 
______________________________________________________________ 
3) Have you been involved in previous Motor Vehicle Collisions?  Yes   No 
Approximate dates (year only) 
Did you require treatment for these injuries? 
4) Is litigation pending as a result of the Motor Vehicle Collision (please circle)? 
YES  NO 
5) Please indicate what, if any, types of treatment you are presently receiving. 
a) Manipulation_______________________________________________ 
b) Massage___________________________________________________ 
c) IMS______Acupuncture______Trigger Point Injections_____________ 
d) Exercise___________________________________________________ 
e) Other (explain)______________________________________________ 
6) What type of practitioner has been providing the current treatment? 
a) Physical Therapist________________________________ 
b) Chiropractor_____________________________________ 
c) Massage Therapist________________________________ 
d) Acupuncturist____________________________________ 
e) Psychologist_____________________________________ 
f) Other (explain)___________________________________ 
How often are you attending this treatment (per month)?________ 
What is the name of your practitioner?_______________________ 
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7) Prior to your current treatment program (if applicable), what other treatments have you 
had in the past? 
a) Physical Therapist 
b) Chiropractor 
c) Massage Therapist 
d) Acupuncturist 
e) Other (explain) 
 
Thank you for filling out this form. 
Please go on to complete the following questionnaires: 
NDI, GHQ-28, PDS, PCS & s-LANSS 
 
Please also complete the Motor Vehicle Collision Description form, so that we can 
understand more about this collision and it’s effect on you. 
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MOTOR VEHICLE COLLISION DESCRIPTION 
Collision Description 
Check all that apply to you: 
 Single-car crash  Two-vehicle crash  More than three vehicles 
 Rear-end crash  Side crash  Rollover 
 Head-on crash  Hit guardrail/tree  Ran off road 
 
You were the 
 Driver  Front passenger  Rear passenger 
 
Describe the vehicle you were in 
Model year and make: 
 Subcompact car  Compact car  Mid-sized car 
 Full-sized car  Pickup truck  Larger than 1 ton vehicle 
 
Describe the other vehicle 
Model year and make: 
 Subcompact car  Compact car  Mid-sized car 
 Full-sized car  Pickup truck  Larger than 1 ton vehicle 
 
Estimated crash speeds 
Estimate how fast your vehicle was moving at time of crash. _________ km 
Estimate how fast the other vehicle was moving at time of crash. _________ km 
 
At the time of impact your vehicle was 
 Slowing down  Stopped  Gaining speed  Moving at steady speed 
 
At the time of impact the other vehicle was 
 Slowing down  Stopped  Gaining speed  Moving at steady speed 
 
During and after the crash, your vehicle 
 Kept going straight, not hitting anything  Spun around, not hitting anything 
 Kept going straight, hitting car in front  Spun around, hitting another car 
 Was hit by another vehicle  Spun around, hitting object other than car 
 
Describe yourself during the crash 
Check only the areas that apply to you: 
 You were unaware of the impending collision. 
 You were aware of the impending crash and relaxed before the collision. 
 You were aware of the impending crash and braced yourself. 
 Your body, torso, and head were facing straight ahead. 
 You had your head, and/or torso turned at the time of collision: 
  Turned to left  Turned to right 
 You were intoxicated (alcohol) at the time of crash. 
 You were wearing a seat belt. 
 If yes, does you seat belt have a shoulder harness?  Yes  No 
 You were holding onto the steering wheel at the time of impact. 
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Indicate if your body hit something or was hit by any of the following 
Please draw lines and match the left side to the right side. 
Head Windshield 
Face Steering wheel 
Shoulder Side door 
Neck Dashboard 
Chest Car frame 
Hip Another occupant 
Knee Seat 
Foot Seat belt 
 
Check if any of the following vehicle parts broke, bent, or were damaged in your car 
 Windshield  Seat frame  Knee bolster 
 Steering wheel  Side/rear window  Other 
_______________________ 
 Dash  Mirror  Other 
_______________________ 
 
Rear-end collisions only 
Answer this section only if you were hit from the rear. 
Does your vehicle have 
 Movable head restraints 
 Fixed, nonmovable head restraints 
 No head restraints 
Please indicate how your head restraint was positioned at the time of crash.* 
 At the top of the back of your head 
 Midway height of the back of your head 
 Lower height of the back of your head 
 Located at the level of your neck 
 Located at the level of your shoulder blades (upper back) below neck 
*Estimate the distance between the back of your head and the front of the head restraint.  ______cm 
 
All types of collisions 
Answer this section regardless of the type of crash, indicating those relevant to your case. 
Yes No   
   Did any of the front or side structures, such as the side door, dashboard, or 
floorboard of your car, dent inward during the crash? 
   Did the side door touch your body during the crash? 
   Was your hand(s) on the steering wheel or dash during the crash? 
   Did your body slide under the seat belt? 
   Was the door(s) of your vehicle damaged to the point where you could not open 
the door? 
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Emergency department 
Yes No   
   Did you go to the emergency department after the accident? 
   What is the name of the emergency department?  _______________________________ 
   When did you go (date and time)?  __________________________________________ 
   Did you go to the emergency department in an ambulance? 
   Did you or another person drive you to the emergency department? 
   Were you hospitalized overnight? 
   Did the emergency department doctor take X-rays?  Check what was taken: 
    Skull      
    Neck 
    Low back 
    Arm or leg 
   Did the emergency department doctor give you pain medications? 
   Did the emergency department doctor give you muscle relaxants? 
   Did you have any cuts or lacerations? 
   Did you require any stitching for cuts? 
   Were you given a neck collar or back brace to wear? 
 
When did you first notice any pain after injury? 
 Immediately  ______ Hours after injury  ______ Days after injury 
 
If you did not see a doctor for the first time within the first week, indicate why 
Check all that apply 
 No pain was noticed  No appointment schedule available 
 No transportation  Work/home schedule conflicts 
 I thought pain would go away  I had no insurance or money 
 I self-treated with over-the-counter drugs  I took hot showers, used ice, heat 
 
Have you been unable to work since injury? 
 Yes  No If yes, you were off work    partially or   completely 
Please list dates off work:  ___________________ to ___________________ 
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PATIENT INSTRUCTIONS:  It is important for this section to be filled out in detail. 
CHECK if you have had any single or multiple symptom(s) listed below.  Leave row blank if the 
symptom listed does not apply to you. 
 
Symptom List Felt Right 
After 
Injury 
Felt 
24-48 
Hours 
Later 
Have 
Symptoms 
Now 
Had Similar 
Symptoms 
1-3 Months 
Before This 
Injury 
Headache     
Dizziness     
Tinnitus (ear ringing)     
Blurry vision     
Memory problems     
Poor concentration     
Irritability     
Balance problems     
Loss of coordination     
Sensitivity to sound     
Sensitivity to light     
Fatigue     
Anxiety     
Pain/difficulty swallowing     
Jaw pain     
Neck pain/soreness     
Neck stiffness     
Shoulder pain/stiffness     
Arm pain/tingling/numbness     
Wrist/hand/finger pain/numbness     
Weakness in arms/legs     
Upper/mid back pain     
Chest wall pain (rib)     
Low back pain/soreness     
Hip pain     
Leg pain     
Leg numbness/tingling     
Pain shoots down legs     
Knee pain     
Ankle/foot pain     
Other     
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APPENDIX 4: QUESTIONNAIRES 
VISUAL ANALOGUE SCALE (VAS) 
How severe is your pain today (in area that you received diagnostic facet blocks)?  
 
Place an ‘x’ on the line below to indicate how bad you feel your pain is today. 
No Pain________________________________________________Worst Pain Imaginable 
Please shade the following pain diagram as per instructions below: 
                                                                                                               
 
Can you please estimate what % of relief of your neck pain that you expect to receive if 
proceeding to RFN?
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NECK DISABILITY INDEX 
This questionnaire has been designed to give the physiotherapist information as to how your neck pain has affected your ability to manage in 
everyday life.   Please answer every section and mark in each section only the ONE box which applies to you.  We realize you may consider that two 
of the statements in any one section relate to you, but please just mark the box which most closely describes your problem over the last 24 hours. 
SECTION 1 – PAIN INTENSITY 
 I have no pain at the moment. 
 The pain is very mild at the moment. 
 The pain is moderate at the moment. 
 The pain is fairly severe at the moment. 
 The pain is very severe at the moment. 
 The pain is the worst imaginable at the moment. 
SECTION 6 – CONCENTRATION 
 I can concentrate fully when I want to with no difficulty. 
 I can concentrate fully when I want to with slight difficulty. 
 I have a fair degree of difficulty in concentrating when I want 
to. 
 I have a lot of difficulty in concentrating when I want to. 
 I have a great deal of difficulty in concentrating when I want 
to. 
 I cannot concentrate at all. 
SECTION 2 – PERSON CARE (Washing, Dressing, etc.) 
 I can look after myself normally without causing extra pain. 
 I can look after myself normally but it causes extra pain. 
 It is painful to look after myself and I am slow and careful. 
 I need some help but manage most of my personal care. 
 I need help every day in most aspects of self care. 
 I do not get dressed, I wash with difficulty and stay in bed. 
SECTION 7 – WORK 
 I can do as much work as I want to. 
 I can only do my usual work, but no more. 
 I can do most of my usual work, but no more. 
 I cannot do my usual work.  
 I can hardly do any work at all.  
 I can’t do any work at all. 
SECTION 3 – LIFTING 
 I can lift heavy weights without extra pain. 
 I can lift heavy weights but it gives extra pain. 
 Pain prevents me from lifting heavy weights off the floor, but I 
can manage if they are conveniently positioned, for example 
on a table. 
 Pain prevents me from lifting heavy weights, but I can manage 
light to medium weights if they are conveniently positioned. 
 I can lift very light weights. 
 I cannot lift or carry anything at all. 
SECTION 8 – DRIVING 
 I can drive my car without any neck pain. 
 I can drive my car as long as I want with slight pain in my 
neck. 
 I can drive my car as long as I want with moderate pain in my 
neck. 
 I can’t drive my car as long as I want because of moderate pain 
in my neck. 
 I can hardly drive at all because of severe pain in my neck. 
 I can’t drive my car at all. 
 
SECTION 4 – READING 
 I can read as much as I want to with no pain in my neck. 
 I can read as much as I want to with slight pain in my neck. 
 I can read as much as I want to with moderate pain in my neck. 
 I can’t read as much as I want to because of moderate pain in 
my neck. 
 I can hardly read at all because of severe pain in my neck. 
 I cannot read at all. 
SECTION 9 – SLEEPING 
 I have no trouble sleeping. 
 My sleep is slightly disturbed (less than 1 hour sleepless). 
 My sleep is mildly disturbed (1-2 hrs. sleepless). 
 My sleep is moderately disturbed (2-3 hrs. sleepless). 
 My sleep is greatly disturbed (3-5 hrs. sleepless). 
 My sleep is completely disturbed (5-7 hrs. sleepless). 
 
SECTION 5 – HEADACHES 
 I have no headaches at all. 
 I have slight headaches which come in-frequently. 
 I have moderate headaches which come in-frequently. 
 I have moderate headaches which come frequently. 
 I have severe headaches which come frequently. 
 I have headaches almost all the time. 
SECTION 10 – RECREATION 
 I am able to engage in all my recreation activities with no neck 
pain at all. 
 I am able to engage in all my recreation activities, with some 
pain in my neck. 
 I am able to engage in most, but not all of my usual recreation 
activities because of my neck pain. 
 I am able to engage in a few of my usual recreation activities 
because of pain in my neck. 
 I can hardly do any recreation activities because of pain in my 
neck. 
 I can’t do any recreation activities at all. 
           
 TOTAL SCORE =      /50
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28-Item General Health Questionnaire 
We should like to know if you have had any medical complaints, and how your health has been in general, 
over the past few weeks. Please answer ALL the questions on the following pages simply by underlining 
the answer which you think most nearly applies to you. Remember that we want to know about present and 
recent complaints, not those that you had in the past. It is important that you try to answer ALL the 
questions. Thank you very much for your co-operation. 
A1. Have you recently been feeling perfectly well and in good health? 
 better than usual  
 same as usual 
 worse than usual 
 much worse than usual 
 
A2. Have you recently been feeling in need of some medicine to pick you up?  
   not at all 
   no more than usual 
   rather more than usual 
   much more than usual 
 
A3. Have you recently been feeling run down and out of sorts? 
  not at all 
  no more than usual 
  rather more than usual 
   much more than usual 
 
A4. Have you recently felt that you are ill? 
 not at all 
 no more than usual  
 rather more than usual 
 much more than usual 
 
A5. Have you recently been getting any pains in your head? 
   not at all 
   no more than usual 
   rather more than usual  
   much more than usual  
 
A6. Have you recently been getting a feeling of tightness or pressure in your head? 
  not at all 
  no more than usual 
  rather more than usual 
  much more than usual 
 
A7. Have you recently been having hot or cold spells? 
  not at all 
  no more than usual 
  rather more than usual 
  much more than usual 
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B1. Have you recently lost much sleep over worry? 
  not at all 
  no more than usual 
  rather more than usual  
  much more than usual  
 
B2. Have you recently had difficulty staying asleep once your are off? 
  not at all 
  no more than usual 
  rather more than usual 
  much more than usual 
 
B3. Have you recently felt constantly under strain?  
  not at all 
  no more than usual  
  rather more than usual 
  much more than usual  
 
B4. Have you recently been getting edgy and bad-tempered? 
  not at all  
  no more than usual 
  rather more than usual  
  much more than usual  
 
B5. Have you recently been getting scared or panicky for no good reason? 
  not at all 
  no more than usual  
  rather more than usual  
  much more than usual  
 
B6. Have you recently found everything getting on top of you? 
  not at all  
  no more than usual  
  rather more than usual  
  much more than usual  
 
B7. Have you recently been feeling nervous and uptight all the time?  
 not at all  
  no more than usual  
  rather more than usual  
  much more than usual  
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C1. Have you recently been managing to keep yourself busy and occupied? 
  more so than usual  
  same as usual  
  rather less than usual  
  much less than usual  
 
C2. Have you recently been taking longer over the things you do? 
  quicker than usual  
  same as usual  
  longer than usual  
  much longer than usual  
 
C3. Have you recently felt on the whole you were doing things well? 
  better than usual  
  about the same  
  less well than usual  
  much less well  
 
C4. Have you recently been satisfied with the way you've carried out your task? 
  more satisfied  
  about the same as usual  
  less satisfied than usual  
  much less satisfied  
 
C5. Have you recently felt that you are playing a useful part in things? 
  more so than usual  
  same as usual  
  less useful than usual  
  much less useful  
 
C6. Have you recently felt capable of making decisions about things? 
  more so than usual  
  same as usual  
  less so than usual  
  much less capable 
 
 
C7. Have you recently been able to enjoy your normal day-to-day activities? 
  more so than usual  
  same as usual  
  rather less than usual  
  much less than usual  
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D1. Have you recently been thinking of yourself as a worthless person? 
  not at all  
  no more than usual  
  rather more than usual  
  much more than usual  
 
D2 Have you recently felt that life is entirely hopeless? 
  not at all  
  no more than usual  
  rather more than usual  
  much more than usual  
 
D3. Have you recently felt that life isn't worth living? 
  not at all  
  no more than usual  
  rather more than usual 
  much more than usual 
 
D4. Have you recently thought of the possibility that you might do away with yourself?  
 definitely not  
  I don't think so 
  has crossed my mind  
  definitely has  
 
D5. Have you recently found at times you couldn't do anything because your nerves were too bad? 
  not at all  
  no more than usual  
  rather more than usual  
  much more than usual  
 
D6. Have you recently found yourself wishing you were dead and away from it all? 
  not at all  
  no more than usual  
  rather more than usual  
  much more than usual  
 
D7. Have you recently found that the idea of taking your own life kept coming into your mind? 
  definitely not  
  I don't think so 
  has crossed my mind  
  definitely has  
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POST TRAUMATIC DIAGNOSTIC SCALE 
 
 
 
    
 Part 1   Part 2  
  
Many people have lived through or witnessed a very stressful 
and traumatic event at some point in their lives.  Below is a list 
of traumatic events.  Put a checkmark in the box next to ALL 
of the events that have happened to you or that you have 
witnessed. 
 
 (1)  Serious accident, fire, or explosion (for example, an 
industrial, farm, car, plane or boating accident) 
 
 (2)  Natural disaster (for example, tornado, hurricane, 
flood, or major earthquake) 
  
 (3)  Non-sexual assault by a family member or someone 
you know (for example, being mugged, physically 
attacked, shot, stabbed, or held at gunpoint) 
 
 (4)  Non-sexual assault by a stranger (for example, being 
mugged, physically attacked, shot, stabbed, or held at 
gunpoint) 
  
 (5)  Sexual assault by a family member or someone you 
know (for example, rape or attempted rape) 
  
 (6)  Sexual assault by a stranger (for example, rape or 
attempted rape) 
 
 (7)  Military combat or a war zone 
 
 (8)  Sexual contact when you were younger than 18 with 
someone who was 5 or more years older than you (for 
example, contact with genitals, breasts) 
  
 (9)  Imprisonment (for example, prison inmate, prisoner of 
war, hostage) 
  
(10)  Torture 
  
(11)  Life-threatening illness 
  
(12) X Other traumatic event 
  
(13) If you marked item 12, specify the traumatic event below.
   
MOTOR VEHICLE COLLISION 
______________________________________ 
 
 
IF YOU MARKED ANY OF THE ITEMS ABOVE, 
CONTINUE.  IF NOT, STOP HERE. 
 
   
(14) If you marked more than one traumatic event in Part 1, 
put a checkmark in the box next to the event that bothers 
you the most.  If you marked only one traumatic event in 
Part 1, mark the same one below. 
 
  Accident 
  Disaster 
  Non-sexual assault/someone you know 
  Non-sexual assault/stranger 
  Sexual assault/someone you know 
  Sexual assault/stranger 
  Combat 
  Sexual contact under 18 with someone 5 or more years 
older 
  Imprisonment 
  Torture 
  Life-threatening illness 
  Other 
 In the box below, briefly describe the traumatic event you 
marked above. 
____________________________________________ 
____________________________________________ 
____________________________________________ 
____________________________________________ 
____________________________________________ 
____________________________________________ 
 
 
Below are several questions about the traumatic event you just 
described above. 
 
(15) How long ago did the traumatic event happen? 
  (circle ONE) 
 1 Less than1month 
 2 1 to 3 months 
 3 3 to 6 months 
 4 6 months to 3 years 
 5 3 to 5 years 
 6 More than 5 years 
 
For the following questions, circle Y for Yes or N for No. 
 
During this traumatic event: 
(16) Y  N Were you physically injured? 
(17) Y  N Was someone else physically injured? 
(18) Y  N Did you think that your life was in danger? 
(19) Y  N Did you think that someone else’s life was in 
danger? 
(20) Y  N Did you feel helpless? 
(21) Y  N Did you feel terrified? 
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 Part 3     
  
Below is a list of problems that people sometimes have after 
experiencing a traumatic event.  Read each one carefully and 
circle the number (0-3) that best describes how often that 
problem has bothered you IN THE PAST MONTH.  Rate 
each problem with respect to the Motor Vehicle Collision 
you were involved in. 
 
 0 Not at all or only one time 
 1 Once a week or less / once in awhile 
 2 2 to 4 times a week / half the time 
 3 5 or more times a week / almost always 
 
(22) 0 1 2 3 Having upsetting thoughts or images 
about the traumatic event that came into 
your head when you didn’t want them to 
 
(23) 0 1 2 3 Having bad dreams or nightmares about 
the traumatic event 
 
(24) 0 1 2 3 Reliving the traumatic event, acting or 
feeling as if it was happening again 
 
(25) 0 1 2 3 Feeling emotionally upset when you were 
reminded of the traumatic event (for 
example, feeling scared, angry, sad, 
guilty, etc.) 
 
(26) 0 1 2 3 Experiencing physical reactions when you 
were reminded of the traumatic event (for 
example, breaking out in a sweat, heart 
beating fast) 
 
(27) 0 1 2 3 Trying not to think about, talk about, or 
have feelings about the traumatic event 
 
(28) 0 1 2 3 Trying to avoid activities, people, or 
places that remind you of the traumatic 
event 
 
(29) 0 1 2 3 Not being able to remember an important 
part of the traumatic event 
 
(30) 0 1 2 3 Having much less interest or participating 
much less often in important activities 
 
(31) 0 1 2 3 Feeling distant or cut off from people 
around you 
 
(32) 0 1 2 3 Feeling emotionally numb (for example, 
being unable to cry or unable to have 
loving feelings) 
 
(33) 0 1 2 3 Feeling as if your future plans or hopes 
will not come true (for example, you will 
not have a career, marriage, children, or a 
long life) 
  
(34) 0 1 2 3 Having trouble falling or staying asleep  
(35) 0 1 2 3 Feeling irritable or having fits of anger 
 
(36) 0 1 2 3 Having trouble concentrating (for example, 
drifting in and out of conversations, losing 
track of a story on television, forgetting 
what you read) 
 
(37) 0 1 2 3 Being overly alert (for example, checking to 
see who is around you, being uncomfortable 
with your back to a door, etc.) 
 
(38) 0 1 2 3 Being jumpy or easily startled (for example, 
when somewhat walks up behind you) 
 
(39) How long have you experienced the problems that you 
reported above?  (circle ONE) 
 
 1 Less than one month 
 2 1 to 3 months 
 3 More than 3 months 
 
(40) How long after the traumatic event did these problems 
begin?  (circle ONE) 
 
 1 Less than 6 months 
 2 6 or more months 
 
 
 
 
 
 
 
 
Part 4 
 
Indicate below if the problems you rated in Part 3 have 
interfered with any of the following areas of your life 
DURING THE PAST MONTH.  Circle Y for Yes or N for No. 
 
(41) Y  N Work 
(42) Y  N Household chores and duties 
(43) Y  N Relationships with friends 
(44) Y  N Fun and leisure activities 
(45) Y  N Schoolwork 
(46) Y  N Relationships with your family 
(47) Y  N Sex life 
(48) Y  N General satisfaction with life 
(49) Y  N Overall level of functioning in all areas of your life 
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Pain Catastrophizing Scale 
Sullivan MJL, Bishop S, Pivik J. (1995) 
________________________________________________________________________                                                                    
          Age:             Gender:  
 
       ------------                     --------------   
________________________________________________________________________ 
 
Everyone experiences painful situations at some point in their lives.  Such experiences may 
include headaches, tooth pain, joint or muscle pain.  People are often exposed to situations that 
may cause pain such as illness, injury, dental procedures or surgery. 
 
Instructions: 
We are interested in the types of thoughts and feelings that you have when you are in pain.  
Listed below are thirteen statements describing different thoughts and feelings that may be 
associated with pain.  Using the following scale, please indicate the degree to which you have 
these thoughts and feelings when you are experiencing pain.   
 
RATING 0 1 2 3 4 
MEANING Not at all To a slight 
degree 
To a 
moderate 
degree 
To a great 
degree 
All the time 
 
When I’m in pain … 
 
Number Statement Rating 
1 I worry all the time about whether the pain will end  
2 I feel I can’t go on  
3 It’s terrible and I think it’s never going to get any better  
4 It’s awful and I feel that it overwhelms me  
5 I feel I can’t stand it anymore  
6 I become afraid that the pain will get worse  
7 I keep thinking of other painful events  
8 I anxiously want the pain to go away  
9 I can’t seem to keep it out of my mind  
10 I keep thinking about how much it hurts  
11 I keep thinking about how badly I want the pain to stop  
12 There’s nothing I can do to reduce the intensity of the pain  
13 I wonder whether something serious may happen  
 
Copyright 1995 Michael J.L. Sullivan.  Reproduced with permission. 
Source: Sullivan MJL, Bishop S, Pivik J.  The pain catastrophizing scale: development and validation. Psychol 
Assess, 1995, 7:524-532. 
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S-LANSS 
1. In the area where you have pain, do you also have ‘pins and needles’, tingling or 
prickling sensations? 
a) NO – I don’t get these sensations 
b) YES – I get these sensations often 
2. Does the painful area change colour (perhaps looks mottled or more red) when 
the pain is particularly bad? 
a) NO – The pain does not affect the colour of my skin 
b) YES – I have noticed that the pain does make my skin look different from 
normal 
3. Does your pain make the affected skin abnormally sensitive to touch? Getting 
unpleasant sensations or pain when lightly stroking the skin might describe this. 
a) NO - The pain does not make my skin in that area abnormally sensitive to 
touch 
b) YES – My skin in that area is particularly sensitive to touch 
4. Does your pain come on suddenly and in bursts for no apparent reason when 
you are completely still? Words like ‘electric shocks’, jumping and bursting 
might describe this. 
a) NO – My pain doesn’t really feel like this 
b) YES – I get these sensations often 
5. In the area where you have pain, does your skin feel unusually hot like a burning 
pain? 
a) NO – I don’t have burning pain 
b) YES – I get burning pain often 
6. Gently rub the painful area with your index finger and then rub a non-painful 
area (for example, an area of skin further away or on the opposite side from the 
painful area).  How does this rubbing feel in the painful area? 
a) The painful area feels no different from the non-painful area 
b) I feel discomfort, like pins and needles, tingling or burning in the painful 
area that is different from the non-painful area 
7. Gently press on the painful area with your finger tip then gently press in the 
same way onto a non-painful area (the same non-painful area that you chose in 
the last question).  How does this feel in the painful area? 
a) The painful area does not feel different from the non-painful area 
b) I feel numbness or tenderness in the painful area that is different from the 
non-painful area   
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Appendix 5: Results 
A. Study 1: Between Group Comparison (Healthy Controls, WAD_Non Responders & 
WAD_Responders. 
 
A1: Visual Analogue Scale (VAS) vs. Group Independent t-test analysis. 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
WAD_NR 32 6.33 .34 1.93 5.63 7.03 
WAD_R 58 5.89 .24 1.84 5.41 6.38 
Combined 90 6.05 .20 1.87 5.41 6.38 
Diff  0.44 .41  -0.38 1.26 
t88 = 1.07 P = 0.29      
  
A2: Neck Disability Index (NDI) vs. Group Independent t-test analysis. 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
WAD_NR 32 23.3 1.28 7.25 20.7 26.0 
WAD_R 58 21.1 0.97 7.41 19.2 23.1 
Combined 90 21.9 0.78 7.39 20.4 23.5 
Diff  2.21 1.62  -1.01 5.42 
t88 =   1.36 P = 0.18      
A3: Pain of predominantly neuropathic origin (s-LANSS) vs. Group Mann-Whitney U 
analysis. 
Group Obs Rank Sum Expected 
WAD_NR 32 1534.5 7.25 
WAD_R 58 2560.5 7.41 
Combined 90 4095 4095 
z = 0.67 P = 0.51   
 
A3.1: Proportion of individuals with elevated s-LANSS (≥ 12) scores vs. Group Chi- 
Squared analysis. 
s-LANSS score Group Total 
 WAD_NR WAD_R  
≥ 12 14 32 46 
< 12 18 26 44 
Total 32 58 90 
 2 = 1.08 P = 0.30  
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A4: Pressure Pain Thresholds (PPT): Cervical Spine, Median Nerve and Tibialis Anterior 
Sites (log transformed data) vs. Group MANOVA analysis. 
Source Statistic df F (df1, df2) F Prob > F 
Group W 0.64 2 12.0 224.0 4.71 0.000 
 P 0.37  12.0 224.0 4.33 0.000 
 L 0.55  12.0 224.0 5.08 0.000 
 R 0.51  12.0 224.0 9.67 0.000 
Residual 117       
Total 119       
Number of obs = 120; W = Wilks' lambda L = Lawley-Hotelling trace    P = Pillai's trace    R = Roy's largest root 
A4.1: PPT Post Hoc Analysis – MANOVA test matrix: HC vs. Whiplash Groups’. 
Source Statistic df F (df1, df2) F Prob > F 
Group W 0.66 2 6.0 112.0 9.53 0.000 
 P 0.34  6.0 112.0 9.53 0.000 
 L 0.51  6.0 112.0 9.53 0.000 
 R 0.51  6.0 112.0 9.53 0.000 
Residual 117       
Total 119       
        
A4.2: PPT Post Hoc Analysis – MANOVA test matrix: WAD_R vs. WAD_NR. 
Source Statistic df F (df1, df2) F Prob > F 
Group W 0.96 1 6.0 112.0 0.71 0.64 
 P 0.04  6.0 112.0 0.71 0.64 
 L 0.04  6.0 112.0 0.71 0.64 
 R 0.04  6.0 112.0 0.71 0.64 
Residual 117       
Total 119       
A5: Cold pain thresholds (CPT) vs. Group Kruskal-Wallis analysis. 
Group Obs Rank Sum Mean Rank Group Diff LSD 
1 = HC 30 901.5 30.1 (1,2) 37.2
* 
2 = WAD_NR 32 2155.0 67.3 (1,3) 44.4* 
3 = WAD_R 58 4203.5 72.5 (2,3)   5.2 
2 = 31.1 P = 0.0001    *P > 0.05 
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A6: Heat pain thresholds (HPT) vs. Group Kruskal-Wallis analysis. 
Right Side of Neck 
Group Obs Rank Sum Mean Rank Group Diff LSD 
1 = HC 30 2690.0 89.7 (1,2) 37.4* 
2 = WAD_NR 32 1672.5 52.3 (1,3) 39.7* 
3 = WAD_R 58 2897.5 50.0 (2,3)   2.3 
2 = 28.2 P = 0.0001    *P > 0.05 
Left Side of Neck 
Group Obs Rank Sum Mean Rank Group Diff LSD 
1 = HC 30 2530.5 84.4 (1,2) 30.7* 
2 = WAD_NR 32 1719.5 53.7 (1,3) 32.5* 
3 = WAD_R 58 3010.0 51.9 (2,3)   1.8 
2 = 18.9 P = 0.0001    *P > 0.05 
A7: Brachial Plexus Provocation Test (BPPT) elbow extension range of motion (ROM) vs. 
Group one-way ANOVA analysis of log transformed data.  
Source SS Df MS F Prob > F 
Between groups 26.5 2 13.2 27.7 0.000 
Within groups 47.8 100 0.48   
Total 74.3 102 72.5   
2 = 31.1 P = 0.0001     
A7.1: Post hoc Analysis – BPPT.  
Row Mean -> 
Column Mean 
HC WAD_NR 
WAD_NR 
P value 
1.46 
0.000 
2 
WAD_R 
P value 
1.29 
0.000 
-0.16 
0.87 
           
A8: Nociceptive Flexion Reflex (NFR) vs. Group one-way ANOVA analysis of log 
transformed data.  
Source SS df MS F Prob > F 
Between groups 6.26 2 3.13 5.52 0.0051 
Within groups 65.90 116 0.57   
Total 72.1 118 0.61   
2 = 31.1 P = 0.0001     
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A8.1 Post hoc analysis – NFR threshold. 
Row Mean -> 
Column Mean 
HC WAD_NR 
WAD_NR 
P value 
-0.48 
0.043 
 
WAD_R 
P value 
-0.55 
0.005 
-0.068 
1.00 
A9: Range of motion (ROM: flexion, extension, side flexion – left and right, rotation – left 
and right) vs. Group MANOVA analysis. 
Source Statistic df F (df1, df2) F Prob > F 
Group W 0.31 2 8.0 228.0 22.9 0.000 
 P 0.70  8.0 230.0 15.6 0.000 
 L 2.21  8.0 226.0 31.2 0.000 
 R 2.20  4.0 115.0 63.0 0.000 
Residual 117       
Total 119       
Number of obs = 120; W = Wilks' lambda L = Lawley-Hotelling trace    P = Pillai's trace    R = Roy's largest root 
A9.1: Post hoc analysis ROM – MANOVA test matrix: HC vs. Whiplash Group’s.  
Source Statistic df F (df1, df2) F Prob > F 
Group W 0.31 1 4.0 114.0 62.3 0.000 
 P 0.69  4.0 114.0 62.3 0.000 
 L 2.19  4.0 114.0 62.3 0.000 
 R 2.19  4.0 114.0 62.3 0.000 
Residual 117       
        
A9.2: Post hoc analysis ROM - MANOVA test matrix: WAD_R vs. WAD_NR. 
Source Statistic df F (df1, df2) F Prob > F 
Group W 0.96 1 4.0 114.0 1.09 0.37 
 P 0.04  4.0 114.0 1.09 0.37 
 L 0.04  4.0 114.0 1.09 0.37 
 R 0.04  4.0 114.0 1.09 0.37 
Residual 117       
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A10: EMG of the superficial neck musculature (22mmHg, 24mmHg, 26mmHg, 28mmHg 
and 30mmHg) vs. Group MANOVA analysis. 
Source Statistic Df F (df1, df2) F Prob > F 
Group W 0.25 2 10.0 224.0 3.34 0.001 
 P 0.69  10.0 226.0 3.18 0.001 
 L 2.19  10.0 222.0 3.49 0.000 
 R 2.19  10.0 113.0 6.66 0.000 
Residual 116       
Total 118       
        
A10.1: Post hoc analysis: EMG MANOVA test matrix: HC vs. Whiplash Group’s.  
Source Statistic Df F (df1, df2) F Prob > F 
Group W 0.79 1 5.0 112.0 5.98 0.000 
 P 0.21  5.0 112.0 5.98 0.000 
 L 0.27  5.0 112.0 5.98 0.000 
 R 0.27  5.0 112.0 5.98 0.000 
Residual 116       
                   
A10.2: Post hoc analysis: EMG MANOVA test matrix: WAD_R vs. WAD_NR. 
Source Statistic Df F (df1, df2) F Prob > F 
Group W 0.93 1 5.0 112.0 1.70 0.14 
 P 0.07  5.0 112.0 1.70 0.14 
 L 0.08  5.0 112.0 1.70 0.14 
 R 0.08  5.0 112.0 1.70 0.14 
Residual 116       
          
A11:  Psychological distress (GHQ-28) vs. Group Kruskal-Wallis analysis. 
Group Obs Rank Sum Mean Rank Group Diff LSD 
1 = HC 30 810 27 (1,2) 49.9* 
2 = WAD_NR 32 2462 76.9 (1,3) 41.8* 
3 = WAD_R 58 3988 68.8 (2,3)   8.1 
2 = 38.2 P = 0.0001    *P > 0.05 
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A11.1: Proportion of individuals with psychological distress (GHQ-28) vs. Group Chi- 
squared analysis.   
GHQ-28 score Group Total 
 HC WAD_NR WAD_R  
≥ 23 28 11 21 60 
< 23 2 21 37 60 
Total 30 32 58 120 
Between Groups Between Whiplash Groups  
2 = 30.1 P < 0.0001 2 = 0.030 P = 0.86  
A12: Pain catastrophization (PCS) vs. Group (WAD_NR & WAD_R) Mann-Whitney U 
analysis. 
Group Obs Rank Sum Expected 
WAD_NR 32 1780 1456 
WAD_R 58 2315 2639 
Combined 90 4095 4095 
z = 2.7 P = 0.0063   
A12.1: Proportion of individuals in the two whiplash groups (WAD_NR & WAD_R) with 
elevated (≥30) PCS scores Chi-squared analysis.  
PCS Score Group Total 
 WAD_NR WAD_R  
< 30 16 49 55 
≥ 30 16 9 35 
Total 32 58 90 
 2 = 12.2 P = 0.001  
 
A13: Proportion of individuals in the two whiplash groups (WAD_NR & WAD_R) that 
fulfill the PTSD criteria (utilizing the PDS scale) Chi-squared analysis. 
Fulfill PDS Group Total 
Criteria? WAD_NR WAD_R  
No 18 41 59 
Yes 14 17 31 
Total 32 58 90 
 2 = 1.90 P = 0.17  
  
- 262 - 
A13.1: Post traumatic stress severity (PDS) scores vs. Group (WAD_NR & WAD_R)  
Mann-Whitney U analysis. 
Group Obs Rank Sum Expected 
WAD_NR 32 1655.5 1456 
WAD_R 58 2439.5 2639 
Combined 90 4095 4095 
z = 1.69 P = 0.09   
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B. Study 2: Participants Undergoing Radiofrequency Neurotomy Longitudinal 
Analysis of Physical Measures 
B1: VAS vs. Time repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 935.7 55 17.0 6.44 0.000 
Subject 410.3 52 7.9 2.98 0.000 
Time 507.9 3 169.3 64.0 0.000 
Residual 404.5 153 2.64   
Total 1340.2 208 6.44   
 
 
B1.1: Post-hoc analysis: VAS vs. Time. 
Source SS df MS F Prob > F 
Between groups 525.4 3 175.1 44.1 0.000 
Within groups 814.8 205 3.97   
Total 1340.2 208 6.44   
 
B2: NDI vs. Time repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 13635.3 55 247.9 15.8 0.000 
Subject 10745.3 52 206.6 13.2 0.000 
Time 2735.4 3 911.8 58.2 0.000 
Residual 2395.8 153 15.7   
Total 16031.1 208 77.1   
 
 
B2.1: Post-hoc analysis: NDI vs. Time. 
Source SS df MS F Prob > F 
Between groups 2890.0 3 963.3 15.0 0.000 
Within groups 13141.0 205 64.1   
Total 1340.2 208 77.1   
 
  
- 264 - 
B3: log Cervical Spine PPT vs. Time repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 41.7 55 0.76 12.4 0.000 
Subject 36.7 52 0.71 11.5 0.000 
Time 4.31 3 1.44 23.4 0.000 
Residual 9.37 153 0.06   
Total 51.1 208 0.25   
 
B3.1: Post-hoc analysis: log Cervical Spine PPT vs. Time. 
Source SS df MS F Prob > F 
Between groups 5.03 3 1.68 7.47 0.000 
Within groups 46.1 205 0.22   
Total 51.1 208 0.25   
 
B3.2: log Cervical Spine PPT vs. Group (t(2): prior to RFN) Independent t-test 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 5.83 0.07 0.37 5.70 5.97 
WAD_RF 53 5.28 0.07 0.50 5.14 5.42 
Combined 83 5.48 0.06 0.53 5.36 5.59 
Diff  0.55 0.10  0.34 0.76 
t81 =  5.29 P = 0.000      
 B3.3: log Cervical Spine PPT vs. Group (t(4): post-RFN) Independent t-test 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 5.83 0.07 0.37 5.70 5.97 
WAD_RF 50 5.61 0.07 0.47 5.47 5.74 
Combined 80 5.48 0.05 0.44 5.59 5.89 
Diff  0.22 0.10  0.027 0.42 
t78 =  2.26 P = 0.013      
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B4: log Median Nerve PPT vs. Time repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 29.9 55 0.54 11.2 0.000 
Subject 25.3 52 0.49 10.0 0.000 
Time 4.1 3 1.37 28.2 0.000 
Residual 7.4 153 0.05   
Total 37.3 208 0.18   
 
 
B4.1: Post-hoc analysis: log Median Nerve PPT vs. Time. 
Source SS df MS F Prob > F 
Between groups 4.63 3 1.54 9.69 0.000 
Within groups 32.7 205 0.16   
Total 37.3 208 0.18   
B4.2: log Median Nerve PPT vs. Group (t(2): prior to RFN) Independent t-test 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 5.91 0.06 0.31 5.79 6.02 
WAD_RF 53 5.50 0.06 0.43 5.38 5.93 
Combined 83 5.65 0.05 0.53 5.55 5.93 
Diff  0.55 0.09  0.23 0.59 
t78 = 1.02 P = 0.000      
B4.3: log Median Nerve PPT vs. Group (t(4): post-RFN) Independent t-test 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 5.91 0.06 0.31 5.79 6.02 
WAD_RF 50 5.83 0.05 0.36 5.72 5.93 
Combined 80 5.86 0.04 0.35 5.78 5.93 
Diff  0.08 0.08  -0.08 0.24 
t78 = 1.02 P = 0.31      
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B5: log Tibialis Anterior PPT vs. Time repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 32.3 55 0.59 15.1 0.000 
Subject 26.4 52 0.51 13.1 0.000 
Time 5.44 3 1.81 46.7 0.000 
Residual 5.94 153 .04   
Total 38.2 208 0.18   
 
B5.1: Post-hoc analysis: log Tibialis Anterior PPT vs. Time. 
Source SS df MS F Prob > F 
Between groups 5.86 3 1.95 12.4 0.000 
Within groups 32.4 205 0.16   
Total 38.2 208 0.18   
 
B5.2: log Tibialis Anterior PPT vs. Group (t(2): prior to RFN) Independent t-test 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 6.34 0.06 0.31 6.22 6.45 
WAD_RF 53 5.86 0.05 0.38 5.76 5.97 
Combined 83 6.04 0.05 0.42 5.94 6.12 
Diff  0.48 0.08  0.31 0.64 
t78 = 5.86 P = 0.000      
B5.3: log Tibialis Anterior PPT vs. Group (t(4): post-RFN) Independent t-test 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 6.34 0.06 0.31 6.22 6.45 
WAD_RF 50 6.22 0.06 0.40 6.11 6.34 
Combined 80 6.27 0.04 0.37 6.18 6.35 
Diff  0.11 0.09  -0.06 0.28 
t78 = 1.02 P = 0.18      
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B6: log Nociceptive Flexion Reflex Threshold (NFR) vs. Time repeated measures ANOVA 
analysis. 
Source Partial SS df MS F Prob > F 
Model 78.5 55 1.43 3.92 0.000 
Subject 68.5 52 1.32 3.62 0.000 
Time 9.44 3 3.15 8.65 0.000 
Residual 55.7 153 0.36   
Total 134.1 208 0.64   
 
B6.1: Post-hoc analysis: log NFR vs. Time. 
Source SS df MS F Prob > F 
Between groups 10.0 3 3.33 5.51 0.001 
Within groups 124.1 205 0.61   
Total 134.1 208 0.64   
B6.2: log NFR vs. Group (t(2): prior to RFN) Independent t-test 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 2.96 0.14 0.79 2.67 3.25 
WAD_RF 53 2.44 0.11 0.77 2.22 2.64 
Combined 83 2.63 0.09 0.81 2.45 2.80 
Diff  0.53 0.18  0.17 0.88 
t81 = 2.97 P = 0.004      
B6.3: log NFR vs. Group (t(4): post-RFN) Independent t-test 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 2.96 0.14 0.79 2.67 3.25 
WAD_RF 50 2.83 0.11 0.80 2.61 3.07 
Combined 80 2.88 0.09 0.79 2.71 3.06 
Diff  0.12 0.18  -0.24 0.49 
t78 = 0.67 P = 0.51      
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B7: log Brachial Plexus Provocation Test (BPPT) vs. Time repeated measures ANOVA 
analysis. 
Source Partial SS df MS F Prob > F 
Model 466.7 55 8.48 6.11 0.000 
Subject 339.3 52 6.52 4.70 0.000 
Time 121.8 3 40.6 29.2 0.000 
Residual 211.1 153 1.39   
Total 677.9 208 3.27   
 
 
B7.1: Post-hoc analysis: log BPPT vs. Time. 
Source SS df MS F Prob > F 
Between groups 127.5 3 42.5 15.8 0.000 
Within groups 550.4 205 2.70   
Total 677.9 208 3.27   
 
B7.2: log BPPT vs. Group (t(2): prior to RFN) Independent t-test 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 0.16 0.42 2.31 -0.70 1.02 
WAD_RF 53 3.19 0.13 0.98 2.92 3.46 
Combined 83 2.09 0.24 2.15 1.62 2.56 
Diff  -3.03 0.36  -3.75 -2.30 
t81 = -9.2 P = 0.000      
B7.3: log BPPT vs. Group (t(4): post-RFN) Independent t-test 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 0.16 0.42 2.31 -0.70 1.02 
WAD_RF 39 1.44 0.29 2.04 0.86 2.02 
Combined 69 0.96 0.25 2.21 2.71 1.45 
Diff  -1.28 0.49  -0.24 -0.29 
t67 = -2.61 P = 0.01      
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B8: Cold Pain Threshold (CPT) vs. Time repeated measures Friedman analysis. 
Friedman v1-v53 
Friedman 18.5 
Kendall 0.17 
P Value 0.0001 
 
B8.1: Post hoc Analysis – Wilcoxon signed-rank test. 
Time Period 1 2 3 
2 
P value 
0.65 
0.51 
  
3 4.18 4.12  
P value 0.000 0.000  
4 
P value 
4.56 
0.000 
4.62 
0.000 
1.57 
0.12 
 
B8.2: CPT vs. Group (t(2): prior to RFN) Mann Whitney U test. 
 
Group Obs Rank Sum Expected 
HC 30 745 1260 
WAD_RF 53 2741 2226 
Combined 83 3486 3486 
z = -4.89 P = 0.000   
 
B8.3: CPT vs. Group (t(4): post-RFN) Mann Whitney U test. 
 
Group Obs Rank Sum Expected 
HC 30 918.5 1215 
WAD_RF 50 2321.1 2025 
Combined 80 3486 3240 
z = -2.96 P = 0.003   
 
B9: Heat Pain Threshold (HPT) vs. Time repeated measures Friedman analysis. 
Friedman v1-v53 
Friedman 34.8 
Kendall 0.17 
P Value 0.000 
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B9.1: Post hoc Analysis – Wilcoxon signed-rank test. 
Time Period 1 2 3 
2 
P value 
-2.05 
0.04 
  
3 -5.29 -4.34  
P value 0.000 0.000  
4 
P value 
-5.09 
0.000 
-4.53 
0.000 
-0.71 
0.48 
B9.2: HPT vs. Group (t(2): prior to RFN) Mann Whitney U test. 
 
Group Obs Rank Sum Expected 
HC 30 1728 1260 
WAD_RF 53 1758 2226 
Combined 83 3486 3486 
z = -4.44 P = 0.000   
B9.3: HPT vs. Group (t(4): post-RFN) Mann Whitney U test. 
 
Group Obs Rank Sum Expected 
HC 30 1353 1215 
WAD_RF 50 1887 2025 
Combined 80 3486 3240 
z = 1.37 P = 0.17   
B10: Range of Motion (ROM) vs. Time repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 376820.3 55 6851.3 12.0 0.000 
Subject 18973.8 52 3647.6 6.38 0.000 
Time 179071.2 3 56690.4 104.5 0.000 
Residual 87435.9 153 571.5   
Total 464256.2 208 2232.1   
 
 
 
  
- 271 - 
B10.1: Post-hoc analysis: ROM vs. Time. 
Source SS df MS F Prob > F 
Between groups 187146.5 3 62382.2 46.2 0.000 
Within groups 277109.7 205 1351.8   
Total 464256.2 208 2232.0   
B10.2: ROM vs. Group (t(2): prior to RFN) Independent t-test. 
 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 274.8 4.84 26.5 264.9 284.7 
WAD_RF 53 165.2 4.59 33.4 156.0 174.4 
Combined 83 204.9 6.73 61.3 191.4 218.2 
Diff  109.6 7.11  95.42 123.7 
t81 = 15.4 P = 0.000      
B10.3: ROM vs. Group (t(4): post-RFN) Independent t-test. 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 274.8 4.84 26.5 264.9 284.7 
WAD_RF 53 227.7 5.19 36.7 217.3 238.1 
Combined 83 245.4 4.50 40.25 236.4 254.3 
Diff  47.1 7.69  31.8 62.4 
t78 = 6.12 P = 0.000      
B11: Cranio-cervical EMG (22mmHg) vs. Time repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 201.9 55 3.67 3.96 0.000 
Subject 195.6 52 3.76 4.06 0.000 
Time 7.14 3 2.38 2.57 0.057 
Residual 138.9 153 0.93   
Total 340.9 208 1.66   
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B11.1: EMG (22mmHg) vs. Group (t(2): prior to RFN) Independent t-test. 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 -3.32 0.22 1.22 -3.78 -2.86 
WAD_RF 53 -2.63 0.19 1.36 -3.00 -2.26 
Combined 83 -2.88 0.15 1.34 -3.17 -2.59 
Diff  -0.69 0.30  -1.29 -0.09 
t81 = -2.30 P = 0.024      
B11.2: EMG (22mmHg) vs. Group (t(4): post-RFN) Independent t-test. 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 -3.32 0.22 1.22 -3.78 -2.86 
WAD_RF 49 -2.84 0.17 1.17 -3.17 -2.50 
Combined 79 -3.02 0.14 1.20 -3.29 -2.75 
Diff  -0.48 -0.28  -1.03 0.07 
t77 = -1.75 P = 0.084      
B12: Cranio-cervical EMG (24 mmHg) vs. Time repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 181.3 55 3.30 3.31 0.000 
Subject 173.6 52 3.34 3.35 0.000 
Time 8.25 3 2.75 2.76 0.044 
Residual 152.6 153 1.00   
Total 333.9 208 1.61   
B12.1: Post-hoc analysis: 24mmHg EMG vs. Time. 
Source SS df MS F Prob > F 
Between groups 7.70 3 2.57 1.61 0.19 
Within groups 326.2 205 1.59   
Total 333.9 208 1.60   
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B12.2: EMG (24mmHg) vs. Group (t(2): prior to RFN) Independent t-test. 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 -2.55 0.24 1.32 -3.04 -2.06 
WAD_RF 53 -1.99 0.16 1.18 -2.31 -1.66 
Combined 83 -2.19 0.14 1.25 -2.47 -1.92 
Diff  -0.56 0.28  -1.12 -0.004 
t81 = -2.00 P = 0.048      
B12.3: EMG (24mmHg) vs. Group (t(4): post-RFN) Independent t-test. 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 -2.55 0.24 1.32 -3.04 -2.06 
WAD_RF 50 -2.43 0.18 1.29 -2.80 -2.06 
Combined 80 -2.48 0.14 1.29 -2.76 -2.19 
Diff  -0.12 -0.30  -0.72 0.48 
t78 = -0.40 P = 0.69      
B13: Cranio-cervical EMG (26 mmHg) vs. Time repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 192.4 55 3.50 3.99 0.000 
Subject 183.0 52  3.52 4.02 0.000 
Time 9.73 3 3.24 3.70 0.013 
Residual 133.2 153 0.88   
Total 325.6 208 1.57   
B13.1: Post-hoc analysis: 26mmHg EMG vs. Time. 
Source SS df MS F Prob > F 
Between groups 9.36 3 3.12 2.01 0.11 
Within groups 316.2 204 1.55   
Total 325.6 207 1.57   
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B13.2: EMG (26mmHg) vs. Group (t(2): prior to RFN) Independent t-test. 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 -2.22 0.25 1.34 -2.73 -1.72 
WAD_RF 53 -1.52 0.17 1.27 -1.87 -1.17 
Combined 83 -1.77 0.15 1.33 -2.06 -1.48 
Diff  -0.70 0.30  -1.29 -0.11 
t81 = -2.04 P = 0.020      
B13.3: EMG (26mmHg) vs. Group (t(4): post-RFN) Independent t-test. 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 -2.22 0.25 1.34 -2.73 -1.72 
WAD_RF 49 -2.01 0.16 1.11 -2.33 -1.69 
Combined 79 -2.09 0.14 1.20 -2.36 -1.82 
Diff  -0.21 -0.28  -0.77 0.34 
t77 = -0.76 P = 0.45      
B14: Cranio-cervical EMG (28 mmHg) vs. Time repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 189.3 55 3.44 4.81 0.000 
Subject 181.0 52  3.48 4.86 0.000 
Time 7.77 3 2.59 3.62 0.015 
Residual 109.5 153 0.72   
Total 298.8 208 1.44   
B14.1: Post-hoc analysis: 28mmHg EMG vs. Time. 
Source SS df MS F Prob > F 
Between groups 8.30 3 2.77 1.95 0.12 
Within groups 290.5 205 1.41   
Total 298.8 208 1.44   
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B14.2: EMG (28mmHg) vs. Group (t(2): prior to RFN) Independent t-test. 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 -1.89 0.23 1.25 -2.36 -1.42 
WAD_RF 53 -1.15 0.13 0.97 -1.41 -0.88 
Combined 83 -1.41 0.12 1.13 -1.66 -1.17 
Diff  -0.74 0.25  -1.23 -0.25 
t81 = -3.02 P = 0.003      
B14.3: EMG (28mmHg) vs. Group (t(4): post-RFN) Independent t-test. 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 -1.88 0.23 1.25 -2.36 -1.42 
WAD_RF 50 -1.69 0.18 1.26 -2.04 -1.33 
Combined 80 -1.76 0.14 1.25 -2.04 -1.49 
Diff  -0.20 -0.29  -0.78 0.38 
t78 = -0.69 P = 0.49      
B15: Cranio-cervical EMG (30 mmHg) vs. Time repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 183.8 55 3.34 4.87 0.000 
Subject 177.6 52  3.42 4.98 0.000 
Time 5.01 3 1.67 2.43 0.067 
Residual 105.0 153 0.69   
Total 288.8 208 1.39   
 
B15.1: EMG (30mmHg) vs. Group (t(2): prior to RFN) Independent t-test. 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 -1.60 0.22 1.20 -2.304 -1.15 
WAD_RF 53 -1.04 0.17 1.25 -1.39 -0.70 
Combined 83 -1.24 0.14 1.25 -1.52 -0.97 
Diff  -0.55 -0.28  -1.11 0.01 
t81 = -1.97 P = 0.053      
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B15.2: EMG (30mmHg) vs. Group (t(2): post-RFN) Independent t-test. 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
HC 30 -1.60 0.22 1.20 -2.04 -1.15 
WAD_RF 50 -1.45 0.19 1.37 -1.84 -1.06 
Combined 80 -1.50 0.15 1.30 -1.79 -1.21 
Diff  -0.15 0.30  -0.75 -0.45 
t78 = -0.49 P = 0.63      
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C. Study 3: Participants Undergoing Radiofrequency Neurotomy Longitudinal 
Analysis of Psychological Measures 
C1: GHQ-28 vs. Time Chi-squared analysis 
Time -> 
GHQ-28 Score 
1 2 3 4 Total 
< 23 19 20 32 33 104 
≥ 23 34 33 21 17 105 
Total 53 53 53 50 209 
  2 = 14.83 P = 0.002   
C1.1: GHQ-28 vs. Time repeated measures Friedman analysis. 
Friedman v1-v53 
Friedman 13.5 
Kendall 0.13 
P Value 0.001 
 
C1.2: Post hoc Analysis – Wilcoxon signed-rank test. 
Time 1 2 3 
2 
P value 
-0.47 
0.64 
  
3 3.03 4.31  
P value 0.003 0.000  
4 
P value 
3.77 
0.000 
3.85 
0.000 
0.10 
0.92 
 
C2.1: GHQ-28 (Somatic subscale) vs. Time repeated measures Friedman analysis. 
Friedman v1-v53 
Friedman 11.7 
Kendall 0.11 
P Value 0.003 
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C2.2: Post hoc Analysis – Wilcoxon signed-rank test. 
Time 1 2 3 
2 
P value 
-0.95 
0.34 
  
3 2.96 4.01  
P value 0.003 0.000  
4 
P value 
2.81 
0.005 
3.23 
0.001 
-0.96 
0.34 
 
C3.1: GHQ-28 (Anxiety/Sleeplessness subscale) vs. Time repeated measures Friedman 
analysis. 
Friedman v1-v53 
Friedman 7.99 
Kendall 0.08 
P Value 0.018 
 
C3.2: Post hoc Analysis – Wilcoxon signed-rank test. 
Time 1 2 3 
2 
P value 
-0.64 
0.52 
  
3 2.35 3.27  
P value 0.019 0.001  
4 
P value 
3.15 
0.002 
3.37 
0.001 
0.81 
0.42 
 
C4.1: GHQ-28 (Social Dysfunction subscale) vs. Time repeated measures Friedman 
analysis. 
Friedman v1-v53 
Friedman 14.5 
Kendall 0.14 
P Value 0.001 
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C4.2: Post hoc Analysis – Wilcoxon signed-rank test. 
Time 1 2 3 
2 
P value 
-0.28 
0.78 
  
3 3.22 4.24  
P value 0.001 0.001  
4 
P value 
3.05 
0.002 
3.21 
0.001 
0.93 
0.35 
 
C5.1: GHQ-28 (Severe Depression subscale) vs. Time repeated measures Friedman 
analysis. 
Friedman v1-v53 
Friedman 3.97 
Kendall 0.04 
P Value 0.14 
C5.2: PCS vs. Time Chi-squared analysis 
Time -> 
PCS Score 
1 2 3 4 Total 
< 24 43 41 46 45 175 
≥ 25 10 12 7 5 34 
Total 53 53 53 50 209 
  2 = 3.65 P = 0.30   
C6.1: PCS vs. Time repeated measures Friedman analysis. 
Friedman v1-v53 
Friedman 20.87 
Kendall 0.20 
P Value 0.000 
 
C6.2: Post hoc Analysis – Wilcoxon signed-rank test. 
Time 1 2 3 
2 
P value 
0.28 
0.78 
  
3 4.10 3.88  
P value 0.000 0.000  
4 
P value 
4.35 
0.000 
4.81 
0.000 
2.51 
0.01 
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C7: PDS (fulfilling PTSD criteria) vs. Time Chi-squared analysis 
Time -> 
PDS Score 
1 2 3 4 Total 
Not Fulfilling PTSD criteria 37 35 39 42 153 
Fulfilling PTSD criteria 16 18 14 8 56 
Total 53 53 53 50 209 
 2 = 4.67 P = 0.20  
C7.1: PDS Severity Score vs. Time repeated measures Friedman analysis. 
Friedman v1-v53 
Friedman 1.90 
Kendall 0.02 
P Value 0.39 
 
C7.2: PDS Symptom Score vs. Time repeated measures Friedman analysis. 
Friedman v1-v53 
Friedman 2.24 
Kendall 0.02 
P Value 0.33 
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D. Study 4: Return of Pain Longitudinal Analyses 
D1: NDI vs. Time repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 8550.6 54 158.3 8.79 0.000 
Age 
Gender 
Baseline Disability 
Subject 
34.6 
21.1 
4575.1 
272.1 
1 
1 
30 
20 
34.6 
21.1 
152.5 
13.6 
1.82 
1.17 
8.47 
0.76 
0.17 
0.28 
0.000 
0.76 
Time 1539.1 2 769.6 42.7 0.000 
Residual 1620.4 90 18.0   
Total 10171 144 70.6   
 
                     
   
D1.1: Post-hoc analysis: NDI vs. Time. 
Source SS df MS F Prob > F 
Between groups 1748 2 874.2 14.7 0.000 
Within groups 8422.6 142 59.3   
Total 10171 144 70.6   
 
Time 1 2 
2 
P value 
-7.67 
0.000 
 
3 
P value 
-0.91 
1.00 
6.76 
0.000 
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D2: log Cervical Spine PPT vs. Time repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 29.1 54 0.54 7.85 0.000 
Age 
Gender 
Baseline logPPTc 
Subject 
0.12 
0.09 
21.3 
0 
1 
1 
50 
0 
0.12 
0.09 
0.43 
 
1.75 
1.34 
6.22 
0.19 
0.25 
0.000 
Time 1.81 2 0.90 13.2 0.000 
Residual 6.17 90 0.07   
Total 35.2 144 0.24   
D2.1: Post-hoc analysis: log Cervical Spine PPT vs. Time. 
Source SS df MS F Prob > F 
Between groups 2.38 2 1.19 5.14 0.007 
Within groups 32.9 142 0.23   
Total 35.2 144 0.24   
 
Time 1 2 
2 
P value 
0.30 
0.005 
 
3 
P value 
0.12 
0.73 
0.19 
0.20 
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D3: log Median Nerve PPT vs. Time repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 20.0 54 0.37 7.42 0.000 
Age 
Gender 
Baseline logPPTm 
Subject 
0.10 
0.10 
12.1 
0.41 
1 
1 
48 
2 
0.10 
0.10 
0.25 
0.21 
1.97 
2.01 
5.06 
4.08 
0.16 
0.16 
0.000 
0.02 
Time 1.86 2 0.93 18.6 0.000 
Residual 4.5 90 0.05   
Total 24.5 144 0.17   
D3.1: Post-hoc analysis: log Median Nerve PPT vs. Time. 
Source SS df MS F Prob > F 
Between groups 2.32 2 1.16 7.41 0.001 
Within groups 22.2 142 0.16   
Total 24.5 144 0.17   
 
Time 1 2 
2 
P value 
0.30 
0.001 
 
3 
P value 
0.10 
0.70 
-0.20 
0.054 
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D4: log Tibialis Anterior PPT vs. Time repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 21.3 54 0.39 7.58 0.000 
Age 
Gender 
Baseline logpptT 
Subject 
0.02 
0.01 
12.8 
0.04 
1 
1 
48 
2 
0.47 
0.17 
5.13 
0.42 
0.47 
0.17 
5.13 
0.42 
0.50 
0.69 
0.000 
0.66 
Time 2.37 2 1.19 22.8 0.000 
Residual 4.68 90 0.05   
Total 26.0 144 0.18   
D4.1: Post-hoc analysis: log Tibialis Anterior PPT vs. Time. 
Source SS df MS F Prob > F 
Between groups 2.73 2 1.36 8.34 0.000 
Within groups 23.2 142 0.16   
Total 26.0 144 0.19   
 
Time 1 2 
2 
P value 
0.33 
0.000 
 
3 
P value 
0.15 
0.22 
-0.17 
0.13 
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D5: log NFR vs. Time repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 52.1 54 0.97 2.23 0.000 
Age 
Gender 
Baseline logNFR 
Subject 
0.08 
0.01 
17.0 
8.60 
1 
1 
22 
28 
0.08 
0.01 
1.79 
0.71 
0.17 
0.02 
1.79 
0.71 
0.68 
0.89 
0.03 
0.85 
Time 15.4 2 7.70 17.8 0.000 
Residual 38.5 89 0.43   
Total 90.7 143 0.63   
D5.1: Post-hoc analysis: log NFR vs. Time. 
Source SS df MS F Prob > F 
Between groups 16.9 2 8.45 16.2 0.000 
Within groups 73.9 141 0.52   
Total 90.7 143 0.63   
 
Time 1 2 
2 
P value 
0.45 
0.006 
 
3 
P value 
-0.41 
0.02 
-0.86 
0.000 
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D6: log BPPT vs. Time repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 51.4 53 0.97 4.87 0.000 
Age 
Gender 
Baseline logBPPT 
Subject 
0.40 
0.34 
28.1 
0.55 
1 
1 
45 
4 
0.40 
0.34 
0.63 
0.14 
2.03 
1.73 
3.14 
0.69 
0.000 
Time 22.5 2 11.2 56.4 0.000 
Residual 16.1 90 0.20   
Total 67.5 134 0.50   
D6.1: Post-hoc analysis: log BPPT vs. Time. 
Source SS df MS F Prob > F 
Between groups 21.4 2 10.7 30.7 0.000 
Within groups 46.4 133 0.35   
Total 67.7 135 0.50   
 
Time 1 2 
2 
P value 
-0.86 
0.000 
 
3 
P value 
-0.02 
1.00 
0.84 
0.000 
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D7: CPT vs. Time one-way repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 9380.2 54 173.7 6.35 0.000 
Age 
Gender 
Baseline Cold 
Subject 
0.01 
4.12 
7364.6 
7.79 
1 
1 
48 
2 
0.01 
4.13 
153.4 
3.90 
0.00 
0.15 
5.61 
0.14 
0.98 
0.70 
0.000 
0.87 
Time 933.4 2 466.7 17.1 0.000 
Residual 2461.7 90 27.4   
Total 11941 144 82.2   
D7.1: Post-hoc analysis: CPT vs. Time. 
Source SS df MS F Prob > F 
Between groups 1018.0 2 509.0 6.69 0.002 
Within groups 10823.9 142 76.2   
Total 11941.9 144 82.2   
 
Time 1 2 
2 
P value 
-6.04 
0.002 
 
3 
P value 
-1.29 
1.00 
4.75 
0.031 
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D8: HPT vs. Time one-way repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 1357.5 54 25.1 5.11 0.000 
Age 
Gender 
Baseline Heat 
Subject 
29.8 
29.0 
1157.4 
25.7 
1 
1 
49 
1 
29.8 
29.0 
23.6 
25.7 
6.06 
5.89 
4.80 
5.23 
0.016 
0.017 
0.000 
0.025 
Time 170.8 2 85.4 17.4 0.000 
Residual 442.7 90 4.92   
Total 1800.2 144 12.5   
                 
D8.1: Post-hoc analysis: HPT vs. Time. 
Source SS df MS F Prob > F 
Between groups 190.8 2 95.4 8.42 0.000 
Within groups 1609.4 142 11.3   
Total 1800.2 144 12.5   
 
Time 1 2 
2 
P value 
2.72 
0.002 
 
3 
P value 
1.22 
0.244 
-1.50 
0.11 
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D9: ROM vs. Time one-way repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 220119.1 54 4076.3 7.65 0.000 
Age 
Gender 
Baseline ROM 
Subject 
35.0 
27.9 
100192.3 
1926.0 
1 
1 
46 
4 
35.0 
27.9 
2178.1 
481.5 
0.07 
0.05 
4.09 
0.90 
0.80 
0.82 
0.000 
0.47 
Time 96812.9 2 48406.4 90.8 0.000 
Residual 47962.8 90 532.9   
Total 268081.8 144 1861.7   
D9.1: Post-hoc analysis: ROM vs. Time. 
Source SS df MS F Prob > F 
Between groups 103776.7 2 51888.4 44.8 0.000 
Within groups 164305.1 142 1157.1   
Total 268081.8 144 1861.7   
 
Time 1 2 
2 
P value 
61.5 
0.000 
 
3 
P value 
14.9 
0.11 
-46.5 
0.000 
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D10: EMG (22mmHg) vs. Time one-way repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 141.1 54 2.61 3.45 0.000 
Age 
Gender 
Baseline logDNF22 
Subject 
0.13 
0.11 
133.7 
0.24 
1 
1 
48 
2 
0.13 
0.11 
2.80 
0.12 
0.17 
0.14 
3.68 
0.16 
0.68 
0.71 
0.000 
0.85 
Time 4.98 2 2.49 3.29 0.042 
Residual 68.2 90 0.76   
Total 209.3 144 1.45   
D10.1: Post-hoc analysis: EMG (22mmHg) vs. Time. 
Source SS df MS F Prob > F 
Between groups 6.07 2 3.03 2.12 0.124 
Within groups 209.3 142 1.43   
Total 215.4 144 1.45   
 
D11: EMG (24mmHg) vs. Time one-way repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 125.9 54 2.33 3.25 0.000 
Age 
Gender 
Baseline logDNF24 
Subject 
0.82 
2.59 
120.5 
 
1 
1 
50 
0.82 
2.59 
2.41 
1.15 
3.62 
3.36 
 
0.29 
0.06 
0.000 
Time 3.81 2 1.90 2.65 0.076 
Residual 63.9 89 0.72   
Total 189.8 143 1.33   
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D12: EMG (26mmHg) vs. Time one-way repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 146.8 54 2.72 4.11 0.000 
Age 
Gender 
Baseline logDNF26 
Subject 
0.00 
0.00 
133.9 
0.01 
1 
1 
49 
1 
0.00 
0.00 
2.73 
0.01 
0.00 
0.00 
4.12 
0.02 
0.95 
0.98 
0.000 
0.89 
Time 7.76 2 3.88 5.86 0.004 
Residual 59.6 90 0.66   
Total 206.4 144 1.43   
D12.1: Post-hoc analysis: EMG (26mmHg) vs. Time. 
Source SS df MS F Prob > F 
Between groups 8.47 2 4.23 3.04 0.051 
Within groups 198.0 142 1.39   
Total 206.4 144 1.43   
 
D13: EMG (28mmHg) vs. Time one-way repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 118.5 54 2.19 4.01 0.000 
Age 
Gender 
Baseline logDNF28 
Subject 
0.72 
0.00 
105.9 
 
1 
1 
50 
0.73 
0.00 
2.11 
 
1.32 
0.00 
3.87 
0.25 
0.95 
0.000 
Time 5.29 2 2.65 4.84 0.010 
Residual 49.2 90 0.55   
Total 167.7 144 1.16   
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D13.1: Post-hoc analysis: EMG (28mmHg) vs. Time. 
Source SS df MS F Prob > F 
Between groups 6.22 2 3.11 2.73 0.069 
Within groups 161.5 142 1.14   
Total 167.7 144 1.16   
 
D14: EMG (30mmHg) vs. Time one-way repeated measures ANOVA analysis. 
Source Partial SS df MS F Prob > F 
Model 111.9 54 2.07 3.59 0.000 
Age 
Gender 
Baseline logDNF30 
Subject 
0.03 
0.10 
96.0 
0.06 
1 
1 
48 
2 
0.03 
0.10 
2.00 
0.03 
0.04 
0.18 
3.47 
0.05 
0.83 
0.67 
0.000 
0.95 
Time 1.60 2 0.80 1.39 0.254 
Residual 51.9 90 0.58   
Total 163.7 144 1.14   
 
D15: GHQ-28 vs. Time repeated measures Friedman analysis. 
Friedman v1-v42 
Friedman 23.2 
Kendall 0.28 
P Value 0.000 
 
D15.1: Post hoc Analysis – Wilcoxon signed-rank test. 
Time 1 2 
2 
P value 
4.43 
0.000 
 
3 
P value 
1.50 
0.130 
-3.15 
0.002 
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D16: PCS vs. Time repeated measures Friedman analysis. 
Friedman v1-v42 
Friedman 13.80 
Kendall 0.16 
P Value 0.001 
 
D16.1: Post hoc Analysis – Wilcoxon signed-rank test. 
Time 1 2 
2 
P value 
4.52 
0.000 
 
3 
P value 
0.51 
0.612 
-2.60 
0.009 
D17: PDS (fulfilling PTSD criteria) vs. Time Chi-squared analysis. 
Time -> 
PDS Score 
1 2 4 Total 
Not Fulfilling PTSD criteria 35 42 31 108 
Fulfilling PTSD criteria 18 8 12 38 
Total 53 50 43 146 
 2 = 4.42 P = 0.11  
D17.1: PDS Severity Score vs. Time repeated measures Friedman analysis. 
Friedman v1-v42 
Friedman 2.39 
Kendall 0.03 
P Value 0.30 
D17.2: PDS Symptom Score vs. Time repeated measures Friedman analysis. 
Friedman v1-v53 
Friedman 2.24 
Kendall 0.02 
P Value 0.33 
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E: Study 5: Predictors of Cervical Radiofrequency Neurotomy Success 
E1.1: Proportion of individuals by gender in the two whiplash groups (Success and Less 
Successful) Chi-squared analysis 
RFN Group Total 
Successful? Female Male  
Yes 28 12 40 
No 8 5 13 
Total 36 17 53 
 2 = 0.57 P = 0.57  
 
E1.2: Age vs. Group (Success and Less Successful) Independent t-test 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
Success 40 45.4 1.8 11.1 41.8 48.9 
Less Success 13 42.7 2.8 10.1 36.6 48.8 
Combined 53 44.7 1.5 10.9 41.7 47.7 
Diff  2.7 3.5  -4.3 9.6 
t51 =  0.76 P = 0.45      
E1.3: Duration of Symptoms vs. Group (Success and Less Successful) Mann Whitney U 
analysis 
Group Obs Rank Sum Expected 
Success 40 1025 1080 
Less Success 13 407 351 
Combined 53 1431 1431 
z = -1.2 P = 0.25   
E1.4: Pain vs. Group (Success and Less Successful) Independent t-test 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
Success 40 5.4 0.33 2.1 4.7 6.0 
Less Success 13 6.1 0.41 1.5 5.2 7.0 
Combined 53 5.5 0.27 1.9 5.0 6.1 
Diff  -0.7 0.6  -2.0 0.5 
t51 =  -1.15 P = 0.26      
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E1.5: Disability vs. Group (Success and Less Successful) Independent t-test 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
Success 40 40 2.3 14.3 35.9 45.0 
Less Success 13 51 5.0 18.0 40.5 62.2 
Combined 53 43 2.2 15.8 38.8 47.5 
Diff  -1.1 4.9  -20.7 -1.2 
t51 =  -2.2 P = 0.03      
E1.6: logPPTc vs. Group (Success and Less Successful) Independent t-test 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
Success 40 5.32 0.07 0.42 5.2 5.5 
Less Success 13 5.16 0.20 0.71 4.7 5.6 
Combined 53 5.3 0.07 0.50 5.1 5.4 
Diff  0.16 0.16  -0.16 -0.48 
t51 =  1.01 P = 0.32      
E1.7: logPPTtibant vs. Group (Success and Less Successful) Independent t-test 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
Success 40 5.9 0.06 0.36 5.8 6.0 
Less Success 13 5.9 0.12 0.44 5.6 6.1 
Combined 53 5.9 0.05 0.38 5.8 6.0 
Diff  0.16 0.12  -0.23 0.26 
t51 =  0.11 P = 0.91      
E1.8: Cold vs. Group (Success and Less Successful) Independent t-test 
Group Obs Mean Std. Err. Std. Dev. [95% Conf. Interval] 
Success 40 16.6 1.5 9.2 13.6 19.5 
Less Success 13 19.7 2.7 9.9 13.8 25.7 
Combined 53 17.4 1.3 9.4 14.8 20.0 
Diff  -3.1 3.0  -9.2 2.9 
t51 =  -1.05 P = 0.30      
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E1.9: Pain catastrophization (PCS) vs. Group (Success and Less Successful) Mann-
Whitney U analysis. 
Group Obs Rank Sum Expected 
Success 40 960 1080 
Less Success 13 472 351 
Combined 51 1431 1431 
z = -2.49 P = 0.013   
E1.10: Post Traumatic Stress Severity (PDS) vs. Group (Success and Less Successful) 
Mann-Whitney U analysis. 
Group Obs Rank Sum Expected 
WAD_NR 40 1039 1080 
WAD_R 13 392 351 
Combined 53 1431 1431 
z = -0.85 P = 0.39   
 
E2.1: Univariate Logistic Regression: Predictor Variable = Pain 
 OR Std. Err. Z P > |Z| [95% Conf. Interval] 
Pain 0.82 0.14 -1.14 0.25 0.58 1.15 
LR chi2 1.37      
Prob > chi2 0.25      
E2.2: Univariate Logistic Regression: Predictor Variable = Disability 
 OR Std. Err. Z P > |Z| [95% Conf. Interval] 
Pain 0.91 0.04 -2.08 0.037 0.84 0.99 
LR chi2 4.80      
Prob > chi2 0.029      
E2.3: Univariate Logistic Regression: Predictor Variable = Pain Catastrophization 
 OR Std. Err. Z P > |Z| [95% Conf. Interval] 
Pain 0.94 0.03 -2.37 0.018 0.89 0.99 
LR chi2 6.36      
Prob > chi2 0.012      
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E2.4: Univariate Logistic Regression: Predictor Variable = LogPPTcervical 
 OR Std. Err. Z P > |Z| [95% Conf. Interval] 
Pain 1.99 1.35 1.01 0.31 0.52 7.52 
LR chi2 1.07      
Prob > chi2 0.30      
 
E2.5: Univariate Logistic Regression: Predictor Variable = LogPPTtibant 
 OR Std. Err. Z P > |Z| [95% Conf. Interval] 
Pain 1.10 0.94 0.11 0.91 0.21 5.84 
LR chi2 0.01      
Prob > chi2 0.91      
E2.6: Univariate Logistic Regression: Predictor Variable = Cold 
 OR Std. Err. Z P > |Z| [95% Conf. Interval] 
Pain 0.96 0.04 -1.04 0.30 0.85 1.04 
LR chi2 1.17      
Prob > chi2 0.28      
E2.7: Univariate Logistic Regression: Predictor Variable = Post Traumatic Stress Severity 
 OR Std. Err. Z P > |Z| [95% Conf. Interval] 
Pain 0.96 0.03 -1.29 0.20 0.91 1.01 
LR chi2 1.65      
Prob > chi2 0.20      
E3: Correlations between Predictor Variables 
 Pain 
Catastrophization 
Post Traumatic 
Stress Severity 
Disability 
Pain Catastrophization 
P Value 
1.00   
Post Traumatic Stress Severity 
P Value 
0.77* 
0.000 
1.00  
Disability 
P Valeu 
0.56* 
0.000 
0.56* 
0.000 
1.00 
E4.1: Stepwise Multivariable Logistic Regression: Predictor Variable = Disability 
 OR Std. Err. Z P > |Z| [95% Conf. Interval] 
Disability 0.91 0.04 -2.08 0.037 0.83 0.99 
LR chi2 4.80      
Prob > chi2   0.03      
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E4.2: Stepwise Multivariable Logistic Regression: Predictor Variable = Pain 
Catastrophization 
 OR Std. Err. Z P > |Z| [95% Conf. Interval] 
PCS 0.94 0.03 -2.37 0.018 0.89 0.99 
LR chi2 6.36      
Prob > chi2 0.012      
 
E5.1: Diagnostic Accuracy in Predicting “Success” for Predictor Variable = Pain 
Catastrophization (PCS) 
 True (“Success”)  
Classified by PCS + - Total 
+ 38 10 48 
- 2 3 5 
Total 40 13 53 
 
Classified + if predicted Pr(D) >= .5 
True D defined as GROCcut != 0 
----------------------------------------------------------------- 
Sensitivity    Pr( +| D)   95.00% 
Specificity                        Pr( -|~D)   23.08% 
Positive predictive value        Pr( D| +)   79.17% 
Negative predictive value        Pr(~D| -)   60.00% 
----------------------------------------------------------------- 
False + rate for true ~D         Pr( +|~D)   76.92% 
False - rate for true D          Pr( -| D)       5.00% 
False + rate for classified +    Pr(~D| +)   20.83% 
False - rate for classified -    Pr( D| -)     40.00% 
----------------------------------------------------------------- 
Correctly classified                                             77.36% 
----------------------------------------------------------------- 
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E5.2: ROC Curve for Predictor Variable = PCS 
 
 
E5.3: Diagnostic Accuracy in Predicting “Success” for Predictor Variable = Disability 
 True (“Success”)  
Classified by Disability + - Total 
+ 39 10 49 
- 1 3 4 
Total 40 13 53 
 
Classified + if predicted Pr(D) >= .5 
True D defined as GROCcut != 0 
----------------------------------------------------------------- 
Sensitivity    Pr( +| D)   97.50% 
Specificity                        Pr( -|~D)   23.08% 
Positive predictive value        Pr( D| +)   79.59% 
Negative predictive value        Pr(~D| -)   75.00% 
----------------------------------------------------------------- 
False + rate for true ~D         Pr( +|~D)   76.92% 
False - rate for true D          Pr( -| D)       2.50% 
False + rate for classified +    Pr(~D| +)   20.41% 
False - rate for classified -    Pr( D| -)     25.00% 
----------------------------------------------------------------- 
Correctly classified                                             79.25% 
----------------------------------------------------------------- 
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E5.4: ROC Curve for Predictor Variable = Disability 
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